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A protein (Mr 24 K) that co-purifies with porcine skin lysyl oxidase (Mr 34 K)
has been characterised. Five variants of the 24 K protein were identified by Mono Q
FPLC, as were 4 variants of lysyl oxidase. By amino acid analysis, the 24 K protein is
particularly rich in tyrosine, and isoelectric focussing shows it to be acidic, so the name
TRAMP (Tyrosine Rich Acidic Matrix Protein) is used to identify this protein. By
amino acid sequence analysis and immunoblotting, TRAMP is unrelated to lysyl
oxidase, though it is identical (in all but 4 residues) to a 22 K extracellularmatrix
protein from bovine skin that associates with dermatan sulphate proteoglycan. TRAMP
is not a proteoglycan, however, as mass spectrometry indicates a molecular mass only
150 Da greater than that predicted from the amino acid sequence, and treatment with a
number of deglycosylating enzymes does not alter the electrophoretic migration of the
protein. Sequence analysis, mass spectrometry and susceptibility to sulphatase
treatment indicates the presence of sulphated tyrosine residues in TRAMP. Although
TRAMP occurs as a quantitatively minor component in skin, it shows a widespread
tissue distribution. TRAMP does not appear to affect the activity of lysyl oxidase on an
elastin substrate. However, turbidity time data shows that sub-equimolar concentrations
ofTRAMP accelerate the in vitro formation of fibrils from purified, lathyritic (i.e. non
cross-linked) rat skin type I collagen. The fibrils which form are well ordered with a D-
periodicity similar to those observed in vivo, though fibrils formed in the presence of
TRAMP are significantly thinner. TRAMP binds to collagen fibrils as shown by co-
sedimentation, and once formed, fibrils are more resistant to low temperature
solubilisation. TRAMP may have a important role in the early, nucleation stages of
fibril formation. Since it is already known that lysyl oxidase activity on a collagen
substrate is increased by prior assembly of the molecules into fibrils, TRAMP may
influence lysyl oxidase activity indirectly via aggregation of the substrate, regulating
subsequent cross-linking, and providing a possible mechanism for the regulation of
collagen metabolism, and ultimately connective tissue structural integrity. The further
observation that TRAMP associates with dermatan sulphate proteoglycans, and that
dermatan sulphate proteoglycans may inhibit collagen fibrillogenesis, may provide an
additional level of control whereby the mechanical properties of tissues can be
modulated.
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1.1 The Extracellular Matrix
In all vertebrates, structural integrity is maintained by connective tissues such as
bone, tendon and skin. The properties of these tissues which allow it to withstand
applied forces are conferred by the extracellularmatrix (ECM). The ECM consists of
collagens, elastin(s), proteoglycans (PGs) and structural glycoproteins (SGPs) that are
secreted by cells and assembled locally into an organised network. The collagens and
elastin(s) form the fibrous scaffolding of connective tissues, while the PGs and SGPs
fill the interstices between cells and ECM. For an overview of recent results in ECM
biochemistiy, see Labat-Robert etal. (1990). The molecules of the matrix combine in
many ways to produce amultiplicity of different structures, designed for a variety of
mechanical roles, for example resistance to tensile, compressive and shear forces.
A large amount of information has emerged in recent years regarding the structure
and biological functions ofproteins in the ECM. New collagen types have been
described and several glycoproteins and PGs have been isolated (Cunningham, 1987;
van der Rest & Garrone, 1991). Cell-surface receptors mediating interactions between
the ECM and different cell types have received much attention (Albelda & Buck,
1990). In some cases it has been shown that these components are involved in cell
migration, adhesion and differentiation, these functions being exerted via multiple
matrix-matrix and cell-matrix interactions.
1.2 The Collagens
The collagens constitute a family of related proteins that are assembled in a variety
of supra-molecular structures in extracellular matrices. Fourteen different collagens are
reported to date and there is no reason to believe this is the final number. Additionally
there are proteins with collagen-like motifs, but are not called collagens (Hulmes,
1992).
The different collagens are referred to as collagen types and are designated by
roman numerals I-XIV. All these molecules contain at least one triple-helical region
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composed of 3 polypeptide chains (a-chains) with a characteristic Gly-Xaa-Yaa repeat
sequence, where Xaa and Yaa can be any amino acid but are often proline and
hydroxyproline, respectively. Because the inflexible peptide bonds formed by proline
and hydroxyproline are flanked by highly flexible bonds (formed by glycine), the
individual a-chains must form a triple helix (Prockop, 1990). Although characterised
by a triple helical structure along most of there length, the collagens exhibit a wide
diversity in other structural and chemical features. Such diversity results from the
different genes which synthesise the various collagen chains. Post-translational
modifications extend this diversity.
Vertebrate collagens can be classified (Table 1.1) on the basis of their size and self
assembly (van der Rest & Garrone, 1991). The fibrillar collagens (I, II, III, V and XI;
Fig. 1.1) represent the largest collagen subclass and form fibrils composed of 67 nm
(D) staggered molecules. Collagens IX, XII and XIV represent another subclass which
do not form fibrils but instead appear to be associated with fibrils: for example collagen
IX is cross-linked to type II collagen fibrils in cartilage (Vaughan etal., 1988).
Collagens IX, XII and XIV are multidomain molecules containing triple helical
domains interrupted by non-collageneous regions. The non-collageneous domain acts
as a flexible hinge (Gordon etal., 1989) which permits, at least for type IX, a portion
of the molecule to associate laterally with the fibril surface, leaving other domains
projecting outward (Vaughan etal., 1988; Yada etal., 1992). This may mean that the
projecting domain can interact with cells or other components of the ECM. Due to their
molecular structure, the subclass containing collagens IX, XII and XIV are referred to
as FACITs (Fibril Associated Collagens with Interrupted Triple-helices). The other
non-fibrillar collagens (IV, VI, VII, VIII, X) are more difficult to classify, however
distinct kinds ofassembly occur allowing further subdivisions (Fig. 1.1). Collagens
IV andVIII form sheets which constitute basement membranes and Descemet's
membrane, respectively. Type VII collagen assembles into anchoring fibrils that bind
epithelial basement membranes and entrap collagen fibrils from the underlying stroma
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Table 1.1 Vertebrate collagens
Type a-chains Most common Representative tissues
molecular form
Fibrillar collagens
I al(I),a2(I) [al(I)]2 a2(I) skin, tendon & bone
II al(II) [al(II)]3 cartilage & vitreous humour
in al(III) [al(III)]3 skin, lung & vascular system
V al(V), a2(V), [al(V)]2 a2(V) collagen I containing tissues
o3(V)
XI al(XI), a2(XI), al(XI) a2(XI) a3(XI) collagen II containing tissues
a3(XI)
Nonfibrillar collagens
IV al(IV), a2(IV), [al(IV)]2 a2(IV) basement membranes
a3(IV), a4(IV),
a5(IV)
VI al(VI), ct2(VI), al(VI) a2(VI) a3(VI) skin & cartilage
«3(VI)
VH al(VII) [al(VII)]3 dermal-epidermal junction
VIE al(VIII), a2(VIII) [al(VIII)]3 ? Descement's membrane
IX al(IX), a2(IX), al(IX) a2(IX) a3(IX) cartilage & vitreous humour
a3(IX)
X al(X) [al(X)]3 hypertrophic zone of cartilage
XII al(XII) [ctl(XII)]3 tendon & skin
XIII al(XIII) [al(XIII)3 ? skin & intestine
XIV al(XIV) [al(XIV)]3? collagen I containing tissues
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Figure 1.1 Collagen molecules and supramolecular assemblies
Schematic representation of collagen molecules (left panel) and collagen aggregates.
The molecules (not drawn to scale) are orientated with their N-termini to the left, triple
helical domains are drawn as solid lines and globular domains by filled circles. Vertical
arrows (drawn on the molecules) indicate the sites of action of the processing
proteinases (adapted from van der Rest & Garrone, 1991).
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to "cement" the two structures together. Collagen VI forms thin, beaded filaments that
may interact with fibrils and cells (van der Rest & Garrone, 1991).
The triple-helical conformation characteristic of all collagens is a unique structure
among proteins (Prockop, 1990). This conformation results from the unique primary
sequence of collagen a-chains. Three chains which may or may not be identicle,
combine via their (Gly-Xaa-Yaa)n sequences to form a triple helix. The relatively large
amount ofhydroxyproline in the structure serves to stabilise the triple-helical
conformation under physiological conditions. Steric restrictions require that the centre
of the helix be occupied by glycyl residues. It is thought that the triple helical regions
may serve as molecular rods that can physically separate globular domains in a protein.
However the triple helix has another important property. From the structure, the amino
acids in the Xaa and Yaa position have ther side chains pointing out away from the
helix, thus offering a high potential for lateral associations, particularlywith other triple
helices.
1.2.1 Fibrillar (Quarter-Staggered) Collagens (I, II, III, V, XI)
Collagens I, II, III, V, and XI were assigned to this group on the basis of their
protein and gene structures. The molecules are composed of chains with a molecular
weight of 95 kDa or greater and are characterised by the presence of a 300 nm
uninterrupted helical domain. Short telopeptides at each end of the molecules serve as
cross link-sites which stabilise the fibrillar assembly. Structural integrity in tissues is
conferred by highly organised fibrils, the basic structure being provided by type I
collagen in most tissues (e.g. tendon, skin, bone, lung, cornea) and by type II in
tissues such as cartilage and vitreous humour. Collagens III and V represent, at least in
mature tissues, quantitativelyminor components which are found in collagen I
containing tissues except in bone where type III is missing (Birk etal., 1988;
Fleischmajer etal., 1990). In cartilage, type XI collagen is associated with type II
(Mendler etal., 1989).
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Electron microscopic studies of collagen fibrils indicate that the individual collagen
molecules are arranged in a quarter stagger array (for review see Mayne and Burgeson,
1987). According to the Hodge-Petruska model of fibril axial structure (Hodge &
Petruska, 1963), the collagen molecules overlap each other by integral multiples of 67
nm (D). Since each molecule is 300 nm (4.4 D) long, a gap of approximately 40 nm is
left between the ends of non overlapping molecules (Fig. 1.1). This assembly is a
direct consequence of the unique properties of the molecule.
Although fibril-forming collagens have been shown to form fibrils by themselves
in vitro, they appear to participate in heterotypic fibrils in vivo, i.e. composite fibrils
made from two or more collagen types (Keene etal., 1987; Mendler etal., 1989;
Linsenmayer eta]., 1990). Mixtures of collagen types are not required for the
formation of the fibrils, but seem to be involved in the control of fibril lateral growth
and diameter (Birk etal., 1990a; van der Rest etal., 1990). Immunoelectron
microscopy has shown that fibrils of tendon, skin and amnion are copolymers of at
least collagens I and III (Keene et al., 1987). Collagens I and V are codistributed in
small diameter (20 nm) fibrils ofadult corneal stroma, whose regular organisation are
essential for corneal transparency (Birk etal., 1988). Cartilage fibrils are composed of
collagens II, IX and XI (Mendler etal., 1989). It seems likely that other combinations
may exist.
Collagens I, II, III, V and XI are very similar and are clearly derived from a single
ancestral gene. However while collagens I and II are fully processed before their
insertion into fibrils, collagens V and XI retain an N-terminal extension containing a
short triple helical region and a globular domain. By allowing different collagens to
bind and participate in fibrillar assemblies, probably via triple helix-triple helix
interactions, the property of the fibril can be altered. The diverse nature of the globular
domains located at the N-terminus in types V and XI probably plays a vital role in
adding to or altering the nature of the fibril (van der Rest et al., 1990). For example
globular domains projecting from the surface of a fibril may act to limit the lateral
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growth of the fibril.
1.2.1.1 Structure of Procollagen I
Procollagen I, the precursor of fibrillar type I collagen, represents the major
intracellular form of collagen. The molecule is larger than the final collagen product by
virtue of extension propeptides at the amino (N) and carboxy (C) termini bordering the
central triple helix (Fig. 1.2). The fibrillar procollagens (II, III, V & XI) all show
similar domain structures (Mayne & Burgeson, 1987). During the conversion of
procollagen I to collagen I, the propeptides are enzymatically removed leaving short
non-helical extensions called telopeptides. The C-terminal telopeptide is about 25
amino acids long and the N-terminal telopeptide is 16-18 amino acids in length. The
procollagen molecule consists of two a 1(1) and one a2(I) chains. Both chains are
genetically distinct, although small amounts of homotrimeric type I collagen with chain
composition [al(I)]3 have also been detected in skin (Grant & Ayad, 1988). The
procollagen a-chains (also called pro a-chains) first associate by hydrophobic and
electrostatic interactions among the C-propeptide which is then stabilised by interchain
disulphide bonds (Prockop, 1990).
The central domain of the procollagen I molecule consists of three chains with the
sequence (Gly-Xaa-Yaa)nwhere each chain forms a left handed polyproline II helix.
The three chains associate forming a right handed superhelix called the triple helix,
apart from short extra-helical end regions of different conformation at the N- and C-
termini (Bachinger& Davis, 1991). The conformation of the helix is such that the
peptide bonds linking adjacent amino acids are buried within the interior of the
molecule, the stucture is therefore highly resistant to general proteolysis. The helix,
which is 300 nm long and 1.5 nm wide, is stabilised by hydrogen bonds between the
amino groups ofglycine and the carboxyl groups of the Xaa residue in an adjacent
chain. The presence of4-hydroxyproline serves to stabilise the collagen triple helix by
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(Pihlajaniemi etal., 1991).
Amino acid sequences derived from cDNA indicate that there are three distinct
domains in the N-propeptide (Vuorio & de Crombrugghe, 1990). The N-propeptide
consists of a large (65-71 residues), cys-rich domain (COL1) which is absent from the
pro a2(I) chain, a short triple helical region and a small globular domain that links to
the N-telopeptide. Both propeptides contain intrachain disulphide bonds, whereas
interchain disulphides are only present between the C-terminal propeptides (Koivu &
Myllyla, 1987). The cys residues which form these disulphides are highly conserved in
the propeptides. The N-propeptide shows considerable variation among the different
fibrillar procollagens and between the same procollagen in different species.
The function of the N-propeptide is not understood, although it appears to regulate
collagen fibril diameter (Chapman, 1989). Another possible role has been suggested as
a negative feedback inhibitor of collagen biosynthesis at the translational level (Fouser
etal., 1991). The C-propeptide has also been implicated in regulating biosynthesis
(Raghow & Thompson, 1989).
The C-propeptide of fibrillar procollagens shows a high degree of sequence
similarity among different types and species. The molecule has a globular structure
which contains interchain disulphide bonds located close to the triple helix. The
structure is stabilised by two intrachain disulphides formed by four C-terminal cys
residues (Vuorio & de Crombrugghe, 1990). Carbohydrate groups (mannose and N-
acetylglucosamine) are present in the C-propeptide; the function of these is unknown,
but the sequence around the carbohydrate attachment site is highly conserved.
Several functional roles for the C-propeptide have been suggested and partially
demonstrated. The folding of the propeptide and formation of the inter- and intrachain
disulphides precede triple helix formation and allows for correct registration of the
three a-chains. It is believed that chain association forming the triple helix occurs in a
zipper-like fashion starting from the C-terminal end (Engel & Prockop, 1991).
Mutations which alter the domain structure have confirmed that the C-propeptide is
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important for correct chain alignment (Willing et ah, 1990). It has further been
suggested that the C-terminal domain dertermines whether the a-chains form homo or
heterotrimeric molecules (Vuorio & de Crombrugghe, 1990). Following enzymatic
cleavage, the C-propeptide of type II collagen has been found to accumulate in the
matrix ofmineralising cartilage and may play a role in the mineralisation process
(Olsen, 1991).
1.2.2 Non-Fibrillar Collagens
While fibrillar collagens constitute a closely related group within the collagen
superfamily, the non-fibril-forming collagen group is very heterogeneous both
structurally and functionally (Vuorio and de Crombrugghe, 1990).
1.2.2.1 FACITs (IX, XII, XIV)
Collagens IX, XII and XIV are described as FACIT collagens (Fibril Associated
Collagens with Interrupted Triple-helices; Shaw & Olsen, 1991). They do not form
fibrils by themselves, but specifically associate with fibrillar collagen. Their structure
strongly suggests that they represent molecular bridges between individual collagen
fibrils and among collagen assemblies and other ECM components (Gordon & Olsen,
1990). A common, short triple helical domain (COL1), represents the major region of
sequence similarity between collagens IX, XII and XIV (van der Rest etal., 1990).
This structure conservation suggests the domain may play a similar function in each of
the types.
Collagen IX is found in several tissues with type II collagen containing fibrils such
as cartilage and the primary stroma of chick cornea (Shaw & Olsen, 1991; Yada et al.,
1992). While the exact function of this disulphide bonded, heterotrimeric molecule is
unknown, a considerable amount of structural information has been obtained. Collagen
IX is 200 nm in length, and contains 3 short triple-helical domains interspersed
between 4 non-collageneous (NC) globular domains (Fig. 1.1). Collagen IX is
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synthesised in two forms, a collagen form and a proteoglycan form (Ayad etal., 1991;
Yada etal., 1992). The molecule consists of three distinct polypeptide chains (al(IX),
a2(IX) and a3(IX)), ofwhich the a2(IX) polypeptide bears the chondroitin sulphate
side chain. The NC3 domain contains the attachment site for the single
glycosaminoglycan (GAG) chain. A five residue loop, which gives rise to an observed
kink on the NC3 domain, contains a serine residue to which the GAG is bound. The
size of the GAG chain is highly variable among different tissues. For example, the
molecular weight of the chondroitin sulphate chain in vitreous humour is about ten
times larger than the cartilage form (Yada et al., 1992). Further variation is also
produced by the use of two promoters in the gene encoding a 1 (IX), producing two
forms of collagen IX with different amino terminal domains (Gordon & Olsen, 1990).
Collagen IX has been found to bind periodically along the surface of type II fibrils
(Vaughan et al., 1988). The isolation of cross-links between the N-telopeptide of
collagen II and the COL2 domain of collagen IX show the interaction to be highly
specific (Fig. 1.1; van der Rest & Garrone, 1991). The GAG chain may mediate
interactions between collagen II and proteoglycans. In addition the NC4 domain is
basic (estimated pi 10) and could interact with acidic GAG chains. Fibril diameters in
collagen II assemblies may also be regulated by the specific interaction with collagen
IX (Ninomiya etal., 1990).
Collagen XII is a homotrimer consisting of three al(XII) chains, with a molecular
weight of approximately 220 K (Dublet etal., 1989). Immunolocalisation studies have
indicated that collagen XII is present as a quantitatively minor component in dense
connective tissues containing collagen I (Gordon etal., 1991), although direct fibril
associations has not yet been observed. Each chain of the collagen XII molecule
contains 2 triple helical (COL) domains, one ofwhich is structurally very similar to
collagen IX, other homologies also exist which may indicate a common ancestor. Such
similarities suggest that collagen XII is fibril associated. However considerable
differences between collagens IX and XII also exist. A large N-terminal globular
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domain accounts formost of the protein, the collageneous domains comprising less
than 10 % of the molecule. Rotary shadowing visualises the collagen XII molecule as
having a cross shape (Fig. 1.1).
Collagen XIV is the latest of the FACITs to be recognised. It is a homotrimeric
molecule found in skin and tendon. It contains the characteristic triple helical (COL1)
domain associated with all FACIT collagens. Primary indications are that, although
very similar, collagen XIV is clearly distinct from collagen XII (Gordon etal., 1991).
1.2.2.2 Collagens Forming Sheets
Collagens IV and VIII are found in basement membrane and Descemet's
membrane, respectively. These collagens constitute a group ofmolecules that are
involved in the formation of protein sheets that surround tissues. In comparison to the
fibrillar collagens there is no clear similarity between collagens IV and VIII. Collagen
VII occurs in close proximity to basement membrane where it occurs in the form of
anchoring fibrils, because of this I have included collagen VII in this part of the
introduction.
1.2.2.2.1 Basement Membrane Collagens (IV, VII)
Basement membranes are thin (30-40 nm), specialised extracellular matrices found
at the interface of epithelial and endothelial cell layers with their adjacent connective
tissue, or surrounding muscle, nerve, and adipose cells (Yurchenco & Schittny, 1990).
They play an important role in supporting epithelial tissue, modulating cellular activities
and also serve as molecular sieves (e.g. in the glomerulus). A number of distinctive
macromolecules constitute basement membranes including collagen IV, laminins,
heparan sulphate and chondroitin sulphate proteoglycans, and nidogen (entactin).
These major components provide the supramolecular lattice and the contact sites for
cellular receptors. An important step in the formation of basement membranes is the
selfassembly of collagen IV, which together with laminin forms large and complex
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networks to which other components may bind (Fox etal., 1991).
Collagen IV is a heterotrimer with chain composition [al(IV)]2a2(IV). Clear
evidence exists for the presence ofadditional chains in some basement membranes
which have been designated a3(IV), a4(IV) and a5(IV), although there is no
indication that they can form heterotrimers with either al(IV) or a2(IV) (van der Rest
& Garrone, 1991). A partial deletion in the gene which codes for the a5(IV) chain, has
recently been shown to be responsible for Alport's syndrome, a heritable condition
resulting in progressive loss of kidney function (Barker etal., 1990; Kuivaniemi et
al., 1991). The collagen IV molecule contains a central triple helical region
(approximately 400 nm in length) interrupted at several positions by short non-triple
helical regions. The positions of the interruptions are conserved in several species, and
correspond to areas of increased molecular flexibility, as observed by electron
microscopy after rotary shadowing (Yurchenco & Schittny, 1990; Hulmes, 1992). The
N-terminus of the molecule contains a further triple helical domain (called 7S)
separated from the main helix by a kink. At the C-terminus there is a large globular
(NCI) domain. Both domains are involved in intermolecular interactions mediating
collagen IV assembly. The 7S domains associate to form a "spider" like tetramer, in
which two pairs of anti-parallel molecules overlap by about 30 nm (Fig. 1.1).
Interactions in the NCI domains also take place, forming dimers which are stabilised
by covalent linkages (van der Rest & Garrone, 1991; Reiser etal., 1992). Type IV
collagen assembly in basement membranes has been reviewed by Yurchenco and
Schittny (1990).
Collagen VII forms anchoring fibrils (about 800 nm long) which originate in the
basement membrane and project into the underlying stroma. These fibrils often entrap
interstitial collagen fibrils and appear to anchor the basement membrane to the matrix
(Burgeson etal., 1990). The molecule is thought to be a homotrimer, it contains a large
(420 nm long) triple helix containing non-helical discontinuities, with a small globular
NC2 domain (probably at the C-terminus; Parente etal., 1991). A large (3 x 150 kDa)
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non-helical domain (NCI), which shows a tridentate structure, is located at the other
end. During assembly the molecules associate forming anti-parallel dimers overlapping
at the C-terminus by 60 nm. Intermolecular disulphide bonds within the overlap
stabilise the structure (Burgeson et al., 1990), and the NC2 domain appears to be
cleaved during this process. The dimers then laterally aggregate in register to form the
anchoring fibril (Fig. 1.1).
The importance of anchoring fibrils is clearly demonstrated in the phenotype of
recessive dystrophic epidermolysis bullosa, characterised by blistering of the skin and
external mucous membranes (Bruckner-Tuderman et al., 1989). The blisters result
from separation of the basement membrane from the underlying matrix. In this
disorder, histological and biochemical studies show that both collagen VII and
anchoring fibrils are absent or abnormal.
1.2.2.2.2 Descemet's Membrane Collagen (VIII)
Collagen VIII was initially reported by Sage et al. (1983). The model proposed by
Benya and Padilla (1986) predicted a homotrimeric molecule made up of 60 kDa
chains. The polypeptide predicted from the cDNA agrees well with this structure
(Gordon & Olsen, 1990). The molecule consists of a short (130 nm) triple helix
containing several non-helical interruptions, bordered by two globular regions (Fig.
1.1). Descemet's membrane, produced by corneal endothelial cells, consists of a
unique hexagonal network composed of collagen VIII (Fig. 1.1; Gordon & Olsen,
1990; Sawada et al., 1990). The function is not understood but it may be important in
withstanding intraocular pressure (Hulmes, 1992).
1.2.2.3 Collagen VI
Collagen VI shows a widespread distribution in the ECM and appears to be
important in maintaining the integrity of specific tissues (e.g. blood vessels, skin;
Kielty et al., 1991). The three chains of collagen VI have a short (approximately 100
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nm) triple helix which is extensively glycosylated having both N and O-linked
carbohydrate. The helix is characterised by the presence of a large number ofarginine-
glycine-aspartate (RGD) sequences. Such sequences are required for the interaction of
several ECM proteins (e.g. fibronectin, collagens, laminins, vitronectin) to cell surface
receptors of the integrin type (Ruoslahti, 199 la). The large terminal globular domains
which flank the triple helix, account for over two thirds of the molecular mass. These
non-collageneous regions consist mainly of repetitive A domains ofvonWillebrand
factor (Kielty etal., 1990) a widely occuring protein motif (Colombatti & Bonaldo,
1991). The functions of the A domain include adhesion between cells, between cells
and ECM components, and between different ECM components. The presence of large
numbers ofRGD sequences together with ECM binding A modules suggests collagen
VI plays a central role in cell-matrix interactions.
During the assembly of collagen VI, dimerisation occurs by anti-parallel
association of two molecules, where the molecules overlap for most of their length,
and then dimers aggregate laterally forming tetramers (Fig. 1.1). This assembly is
stabilised by disulphide bonds rather than the lysine derived cross-links found in most
other collagens. These tetramers associate end-to-end forming long thin "beaded"
filaments with a 100 nm periodicity (Fig. 1.1). These filaments which are found in
close association with the cell surface show a high degree of flexibility (Kielty etal.,
1991).
1.2.2.4 Collagen X
Collagen X is localised to the hypertrophic zone of calcifying cartilage where it is
produced in large amounts by chondrocytes (Schmid etal., 1990). The structure of the
cDNA and gene for this short chain collagen is highly homologous over more than 75
% of the polypeptide chain to collagen VIII (Gordon & Olsen, 1990). The triple helical
domain in collagen X contains 8 imperfections in the Gly-Xaa-Yaa repeat, similar
imperfections are located in conserved regions in collagen VIII. The strong homology
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between collagens X and VET suggest that they may form similar supramolecular
structures. Immunolocalisation studies have shown collagen X occuring as fine
filamentous networks, showing some similarity to the hexagonal lattice of Descemet's
membrane, there is also some co-localisation with collagen II fibrils (Schmid &
Linsenmayer, 1990; van der Rest & Garrone, 1991). Possible functions for collagen X
include participation in calcification of the cartilage matrix, and facilitation of matrix
turnover (Schmid et al„ 1990).
1.2.2.5 Collagen XIII
Collagen XIH has so far only been identified at the cDNA level (Tikka et al.,
1991). The presumptive translation product for this unique short-chain collagen
molecule shows three triple-helical and four non-collageneous domains (Vuorio & de
Crombrugghe, 1990). The most striking feature of collagen XIII is the existence of
alternative splicing, which affect both the collageneous and non-collageneous domains.
The function of collagen XIII is not known and there is as yet no information on its
molecular conformation.
1.3 Other Components of the Extracellular Matrix
1.3.1 Elastin
The elasticity and resilience of tissues such as skin, lung and blood vessels are
conferred in part by a network of elastic fibres. Mature elastic fibres are composed of
two distinct components, elastin and small (10-12 nm) microfibrils composed of
several glycoproteins including fibrillin (Sakai etal., 1986; Kielty etal., 1991). There
is no definite agreement on the number and proportion of the different glycoproteins
present in these microfibrillar structures (Moczar etal., 1989). Elastin, the main
component of elastic fibres, is initially synthesised as a soluble polypeptide of -70 K
(for a review on elastin see Rosenbloom etal., 1991). The newly synthesised
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polypeptides undergo intracellular post-translational modifications, including
hydroxylation of certain prolyl residues. The elastin polypeptides are then transported
to the cell surface for cross-linking and fibre assembly. The fibrillogenesis of elastic
fibres is initiated by deposition ofmicrofibrils which form a scaffold onto which
individual elastin molecules align (Uitto etal., 1991). The alignment is stabilised by
lysyl-oxidase-mediated cross-linking of certain lysine residues. The formation of
intermolecular cross-links called desmosines contribute to the insolubility of elastin
(Reiser etal., 1992).
The deduced amino acid sequence from the human elastin cDNA depicts alternating
regions of cross-link domains and hydrophobic domains rich in glycine, proline and
valine residues. These domains are encoded by separate exons (Uitto etal., 1991).
Although elastin is encoded by a single gene, alternative splicing generates several
elastin isoforms. Therefore it can be presumed that significant variation in the function
of the elastic fibres would occur. However the significance of alternative splicing has
not been elucidated in detail.
1.3.2 Proteoglycans
Proteoglycans (PGs; reviewed by Gallagher, 1989; Oldberg etal., 1990; Kjellen &
Lindahl, 1991) are ubiquitous components of extracellular matrices and cell surfaces
which are necessary for stable assembly of the ECM and functional cell-matrix
interactions.
Proteoglycans constitute a diverse class of complex macromolecules that contain a
core protein with one or more covalently attached glycosaminoglycan (GAG) chains.
Glycosaminoglycans consist ofhexosamine (D-glucosamine or D-galactosamine) and
either hexuronic acid (D-glucuronic acid or L-iduronic acid) or galactose units (in
keratan sulphate) that are arranged in alternating, unbranched sequence, and carry
sulphate substituents in various positions. Several structurally distinct types ofPGs
have been described. The common GAGs include hyaluronan (HA) which does not
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occur as a PG but in the free form, the galactosaminoglycans, chondroitin sulphate
(CS) and dermatan sulphate (DS), and the glucosaminoglycans heparan sulphate (HS),
heparin, and keratan sulphate (KS). Each proteoglycan has a trivial name that refers
either to biological activity (e.g. decorin, which binds to and decorates the surface of
collagen fibrils; Fleischmajer etal., 1991a) or to sequence (e.g. serglycin, which
contains a large alternating sequence of serine and glycine residues; Avraham etal.,
1989). Proteoglycans may either be secreted and deposited in the ECM (e.g. aggrecan,
versican, biglycan, decorin , fibromodulin; Esko, 1991), anchored to the plasma
membrane (syndecan, betaglycan; Esko, 1991) or located intracellularly in secretory
granules (e.g. serglycin; Avraham etal., 1989).
By amino acid sequence analysis, potentially important domains have been
identified within core proteins from several PGs (Kjellen & Lindahl, 1991). Among
the few PGs of known sequence, the large aggregating PGs of cartilage contain an HA
binding domain and a lectin domain capable of binding simple sugars (Halberg etal.,
1988). The large fibroblast PG versican (Zimmerman & Ruoslahti, 1989) contains
domains similar to those of the cartilage PG, suggesting that both PGs are capable of
the same interactions. The small PGs biglycan (chondroitin sulphate proteoglycan; also
called PG-1) and decorin (dermatan sulphate proteoglycan; also called PG-II, DSPG-II
and PG-S2) are also closely related through their amino acid sequence (Choi etal.,
1989). As more sequence data becomes available, more detailed comparisons may be
made. At present evidence exists that the cell surface PG syndecan represents a family
of related PGs (Bernfield & Sanderson, 1990; Brauker etal., 1991) with high
homology in their cytoplasmic amino terminal domains and variable extracellular
domains. The specific GAG chains which are attached to the core proteins determine
many biological activities of PGs. The binding of GAGs to various ECM molecules,
cell-cell adhesion molecules and growth factors appears to be charge dependent
because the strength of binding is largely determined by the degree of sulphation of the
GAG (Jackson etal., 1991). For example, the more highly sulphated the GAG, the
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better it will bind to fibronectin. Thus heparin binds most strongly, while HS, DS and
CS bind less well (Klebe & Mock, 1982). The core protein appears to regulate the
effects ofGAGs by primarily acting as a scaffold for the immobilisation and
appropriate spacing ofGAG chains. For example, serglycin, produced by rat yolk sac
tumor cells, contains closely spaced CS-chains (Bourdon etal., 1986) and inhibits the
attachment of these cells to fibronectin (Brennan etal., 1983). It has been proposed
that binding of the CS-chains to fibronectin sterically hinders the interaction of the
protein with its cell-surface receptor (Hautanen etal., 1989). The effect is only seen
with the intact PG but not with free CS-chains.
As well as their mechanical support functions, PGs are involved in highly diverse
biological roles, including cell-cell and cell-matrix adhesion and regulation of cell
growth (Kjellen & Lindahl, 1991). By virtue of there interactions with ECM molecules
(e.g. collagens, fibronectin, thrombospondin, vironectin, laminin; Kjellen & Lindahl,
1991), cell adhesion is mediated in part through cell surface PGs (Akiyama etal.,
1990; Esko, 1991). For example the membrane bound PG syndecan (Bernfield &
Sanderson, 1990) can bind collagen and fibronectin through its HS chains and mediate
cell attachment. It has been proposed that cell adhesion to the ECM through PGs is an
auxiliary mechanism that complements integrin mediated adhesion (LeBaron etal,
1988). Soluble PGs can inhibit cell adhesion to fibronectin and collagen (Brennan et
al, 1983; Rosenberg etal., 1986), and they appear to do this by preventing the
binding of an integrin to the cell attachment site by steric hindrance (Hautanen etal.,
1989). Several observations also indicate that PGs influence cell growth (Ruoslahti,
1989). For example, Yamaguchi and Ruoslahti (1988) found that expression ofhuman
decorin in Chinese hamster ovary (CHO) cells led to a decreased growth rate and
altered morphology of the cells. It was further demonstrated that decorin exerted these
effects by sequestering transforming growth factor (TGF)-(3 (Yamaguchi etal., 1990),
a growth stimulatory factor for CHO cells.
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1.3.3 Glycoproteins
Several multidomain ECM glycoproteins have been characterised. These include
fibronectin, laminin, vitronectin, thrombospondin, tenascin and nidogen (entactin). For
a briefoverview on each of these molecules see Yamada (199 la). As far as their
biological role is concerned, several of them have been shown to play a crucial role in
cell-matrix interactions (Akiyama etal., 1990; Sage & Bornstein, 1991). Fibronectin is
the most well understood example. This molecule helps mediate cell adhesion,
embryonic cell migration and wound healing (Labat-Robert etal., 1990). Fibronectin
was the first protein shown to interact with specific cell membrane receptors (integrins)
through a arg-gly-asp or R-G-D sequence ofamino acids. Recent studies on ECM
glycoproteins, reveal that many contain common features. For example the molecules
contain specialised polypeptide domains involved in binding to specific cell surface
receptors as well as to other matrix constituents, such as collagen and heparin/heparan
sulphate. Major parts of these molecules are also comprised of fibronectin or EGF like
repeats (Albelda& Buck, 1990; Elices etal., 1991; Engel, 1991). Various forms of
fibronectin (Schwarzbauer, 1991), laminin (Mercurio, 1990) and tenascin (Nies etal.,
1991) are generated by gene duplication or alternative splicing to produce families of
closely related proteins which have been shown to be developmentally regulated. A
considerable amount of complexity exists between these cell interactive glycoproteins,
and in their potential cell-matrix/matrix-matrix interactions. However it is important to
remember that a cell often interacts with a complex mixture ofmatrix constituents, each
ofwhich may contribute in regulating cell behavior.
1.3.4 Sulphated Proteins
Tyrosine sulphation is a widespread post-translational modification in ECM
proteins, e.g. nidogen/entactin, fibronecin, dermatan sulphate proteoglycan (Huttner,
1988), procollagens III and V (Jukkola etal., 1990), bone sialoprotein II (Ecarot-
Charrier etal., 1989; Midura etal., 1990) and fibromodulin (Antonsson etal., 1991).
21
The site of tyrosine sulphation in fibromodulin is an N-terminal, tyrosine-rich region in
which tyrosine is every second or third residue (Antonsson etal., 1991). In types III
and V procollagen, the anion is also located at the N-terminus and is the reason for the
low isoelectic point of these proteins (Jukkola etal., 1990). Tyrosine sulphation occurs
in the trans Golgi and is one of the last processing steps before proteins exit the Golgi
complex. The reaction is catalysed by tyrosyl-sulpho-transferase which recognises
specific tyrosine residues in exposed protein domains adjacent to acidic amino acids
(Huttner, 1984; Hortin etal., 1986). The modification appears to be irreversible and
therefore results in a permanent alteration in the structure of the protein (Huttner, 1988;
Jukkola etal., 1990). Most tyrosine sulphated proteins are secretory (Antonsson et
al., 1991). The role of tyrosine sulphation in ECM proteins has not been extensively
investigated, though desulphation of fibronectin affects its binding affinities to fibrin,
gelatin and heparin (Suiko & Liu, 1988). Functional studies should be facilitated by the
use of chlorate, which is a potent non toxic inhibitor of sulphation in intact cells
(Jukkola etal., 1990).
1.4 Cell/Matrix Interactions
Although many ECM proteins such as collagen and elastin contain inherent self
assembly properties which foster their deposition and supramolecular assembly, cells
ultimately dictate the composition and location of regional matrices. Cellular
interactions with basement membranes and the ECM are vital in a number ofbiological
processes which require specific cellular adhesion and migration of cells including
embryonic development, tumour cell metastasis, wound healing and the maintenance of
tissue integrity. However the interaction ofa cell with its environment must be a
dynamic one, since cells which ordinarily remain attached in vivomust be capable of
diminishing the adhesive force to enable rounding and division, and cell movement
also requires that interactions with the matrix are constantly being made and broken
(Akiyama etal., 1990; Sage & Bornstein, 1991).
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The major adhesive molecules for epithelial and mesenchymal cells include
fibronectin, collagens I, n, III, IV, V and XI, laminin, vitronectin and
nidogen/entactin, although it is recognised that some of these molecules bind via
indirect linkages. For example laminin has been shown to bind heparan sulphate
proteoglycan, promote cell attachment and bind to collagen IV generally via nidogen
(Beck et al., 1990; Fox et al., 1991). Recent advances in the molecular basis of these
interactions have converged on the concept that many cell interactions are dependent on
specific adhesive ligand recognition sequences (Yamada, 1991b).
The complex interactions that occur between cell and cell and cell and
matrix are mediated through several different families of receptor, which include
peripheral and integral membrane glycoproteins and proteoglycans (Albelda & Buck,
1990). The integrins in particular play a pivotal role in mediating the adhesion of cells
to fibronectin, collagen and laminin by recognising different specific peptide sequences
in each (Yamada, 1991b). The observation that integrins are seen at regions of cell-to-
cell contact further suggests that they also may be important in cell-cell interactions as
well as cell-matrix interactions (Albelda & Buck, 1990).
Integrins (reviewed by Ruoslahti, 1991a; 1991b) are a family of transmembrane a-
P heterodimeric glycoproteins, which have been divided into three major subfamilies
each containing a common p-subunit non-covalently associated with multiple a-
subunits. Because integrins with the same p-subunit but with a different a-subunit
often bind different ligands, it was suggested that the a-domain dictates ligand
specificity. However Cheresh etal. (1989) have shown that the association of a
vitronectin receptor (which normally doesn't bind fibronectin) a-subunit, with a P-
subunit expressed by carcinoma cells results in aquisition of fibronectin-binding
activity. This implies that the ligand-binding site requires both subunits (Cheresh etal.,
1989). The organisation of the integrins is complicated by the finding that a-subunits
may be associated with more than one p-subunit. Currently, at least 15 different aP
subunit combinations exist (Elices et al., 1991). Both subunits contain a large amino-
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terminal extracellular domain, a single hydrophobic transmembrane sequence and short
carboxy-terminal cytoplasmic domains. The interaction between integrins and
cytoskeletal actin filaments has been shown to be via an indirect linkage involving talin
and vinculin (Burridge etal., 1988) and requires the cytoplasmic domain of the (3-
subunit (Albelda & Buck, 1990). Ligand binding occurs through the amino domain
and is a cation-dependent process involving the recognition of specific amino acid
sequences within the ligand. The RGD sequence, originally described for fibronectin
but found in a number of othermatrix proteins which includes collagen,
thrombospondin, vitronectin and laminin is the best described (Albelda & Buck,
1990). A single adhesive protein can also contain several different sequences, which
are recognised by the same receptor or by other distinct receptors, and provides a
single cell with a large repertoir of possible interactions. The regulation of integrins is
still unclear, although existing data indicates that binding specificity and activity may be
controlled at various stages, such as RNA splicing, post-translational modifications,
calcium concentrations and by the membrane-lipid environment (Kirchhofer etal.,
1991).
Integrins may play a central role in development by transmitting and transducing
mechanical signals into a biochemical response, although other transmembrane
receptors (e.g. syndecan, cadherin) may also mediate force transmission. During
wound healing, fibroblasts produce wound contraction by exerting tension on their
ECM adhesions. Control ofwound reorganisation appears to depend on whether or not
the a5(31 integrin receptors are expressed on the cell surface (Ingber, 1991). Cell-
generated tension is transmitted over fibronectin-containing microfibrils (ligands for
a5(31 integrins) which act as cables linking fibroblasts to each other and to the
collageneous matrix, thus determining the spatial orientation and morphology of
connective-tissue components. Hence integrins may function as mechanoreceptors,
providing a gating function for signal transduction by either supporting or prohibiting
force transmission between ECM and the cytoskeleton (Ingber, 1991).
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Besides their importance in cellular processes, integrins are involved in platelet
aggregation and imune functions. Some diseases are already known to be caused by
mutation in integrin genes (Ruoslahti, 1991a). Knowledge of the targetted RGD amino
acid sequences for many integrins can be exploited to design compounds controlling
cell adhesion for therapeutic purposes. For example in the hereditary disorder
Glanzmanns thrombasthenia, there is a deficiency in the group Ilb/IIIa integrin
receptor. Platelets from such individuals fail to aggregate in response to activation.
Group Ilt/nia is therefore an attractive target for therapeutic manipulation ofplatelet
aggregation. RGD peptides that neutralise the activity ofgroup Ilh/IIIa provide a
possible inhibition of platelet aggregation (Ruoslahti, 199 la). Highly active RGD
peptides also exist in nature. Proteins called disintegrins are found in certain snake
venoms that have an active RGD sequence in a highly conserved disulphide loop.
Disintegrins inhibit group Iltyllla and other integrins and are potent inhibitors of
platelet aggregation. However because of their apparent lack of specificity, these
molecules seem to be less suitable as therapeutic agents than synthetic peptides (Gould
etal., 1990).
In addition to the integrins, other receptors for the ECM components exist
(reviewed in McDonald, 1989; Albelda & Buck, 1990). The mechanisms by which
cells coordinate the activity of these various receptors is unknown, however a huge
diversity in receptor functions exists and provides cells with varied capabilities to
recognise adhesive substrates.
Recently, evidence has been accumulating that the inhibition of cell attachment and
spreading may be equally important for tissue morphogenesis and development.
Several anti-adhesive proteins have been described which include SPARC (Secreted
Protein Acidic and Rich in Cysteine) and the large disulphide linked glycoprotein
tenascin, although the biological importance of these molecules still remains to be fully
realised (Chiquet-Ehrismann, 1991).
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1.5 Collagen I Biosynthesis
Collagen synthesis is a complex process involving the regulated expression of
members of the large collagen gene superfamily as well as many co-translational and
post-translational modifications (Table 1.2) catalysed by at least nine specific enzymes
and several non specific ones. This section, unless stated otherwise, deals only with
collagen I and is intended as a brief overview. For a more detailed treatment of this
subject, the reader is referred to Olsen (1991) and references therein.
1.5.1 Synthesis of Preprocollagen
At least 25 genes code for the constituent chains of the various collagen types (for
reviews on collagen gene structure and expression, see Raghow & Thompson, 1989;
Byers, 1990; Ramirez etal., 1990; Vuorio & de Crombrugghe, 1990; de Crombrugghe
etal., 1991). A minimum of nine distinct genes code forthe fibrillar collagens, the
genes being dispersed in the human genome, the exception being al(III) and a2(V)
which are co-localised on chromosome 2. The genes are large (15-50 kb) with complex
exon structures (>50 exons). The exons must be appropriately transcribed and spliced
to produce a mature mRNA. The overall organisation of the fibrillar collagen genes is
highly similar. A small but variable number of exons (<10) codes for the signal peptide
and N-propeptide. The C-propeptide is encoded by 4 exons and the major triple helix
by around 44 exons. The beginning and end of the triple helix are coded for by so-
called joining exons, which also code for telopeptide and propeptide regions. All the
triple helical exons start with a complete codon for Gly, and end with a complete codon
for the amino acid in the Yaa position, thus the exons are a multiple of 9 bp encoding a
single collagen triplet. Because the majority of the triple helical exons are 54 bp (or
multiples of 54), it was proposed that the fibrillar collagen genes evolved through
duplication, recombination and point mutations in a primordial collagen gene. The
introns show no such conservation in length, and vary between 86 and 2000 bp in
humans. Invertebrate collagens show a different gene organisation (Vuorio & de
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Table 1.2. Co-translational and post-translational modifications in the
synthesis of collagen I
Biosynthetic Modification Biological Function
Intracellular
Removal of signal peptide Membrane translocation
Proline 3-hydroxylation Unknown
Proline 4-hydroxylation Stable triple helix
Lysine hydroxylation Cross link formation; O-
glycosylation ofhydroxylysine
residues
O-glycosylation ofhydroxylysine residues Possible role in fibrillogenesis
N-glycosylation ofasparagine residues Not known
Disulphide bonding and chain association Triple helix formation
Triple helix formation Functional protein
Extracellular





Cross linking Formation of stable fibrils
It should be remembered that in the other collagens not all the extracellular
modifications occur, and that other collagens may undergo additional modifications, for




Regulation of synthesis can be exerted through control of mRNA levels by
regulation of gene transcription and RNA maturation or the stability ofmRNA. In
collagen there is a good correlation between the rate of synthesis and the level of
mRNA. Therefore regulation of collagen production appears to be influenced at the
transcriptional level rather than by control ofmRNA translation. There are two broad
categories of gene regulation. The first is in response to demands in the developmental
program and leads to unique tissue-specific collagen types. For example collagen X is
transiently expressed in the zone of calcification in hypertrophic cartilage. The second
category of regulation involves the modulation of collagen genes by biological and
pharmacological agents. For example cell-cell interactions, cytokines and growth
factors all profoundly influence collagen biosynthesis. Most of the attention to
regulatory elements have been focussed on the 5' end of the gene, and several DNA
binding proteins have been found which exert positive and negative effects on
transcription. For collagens I and II there is evidence that sequences located in the first
intron are important in transcriptional regulation.
The al and a2 chains of procollagen I are coordinated products of the COL1A1
and COL1A2 genes located on chromosomes 17 and 7 respectively. There is a large
difference in size between the 2 genes, but the relative size and location of the exons
are similar. Collagen polypeptides are translated from mature mRNA on membrane
bound polysomes. The procollagen is synthesised as a high molecular weight
precursor called preprocollagen (Peltonen etal., 1985). The preprocollagen contains a
short amino terminal hydrophobic signal sequence typical of secretoiy proteins, which
is rapidly processed by a membrane-bound signal peptidase activity as the molecule
enters the lumen of the ER. The signal peptide serves as a vector to ensure
translocation across the RER membrane, which occurs via interactions with
cytoplasmic and membrane bound receptors (Palmiter et al., 1979; Walter & Lingappa,
1986; Olsen, 1991). During and shortly after chain elongation and translocation into
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the RER several lysine residues and virtually all prolyl residues in the Yaa position of
the triple helix are hydroxylated.
1.5.2 Co-translational and Post-translational Modification of
Procollagen
1.5.2.1 Hydroxylation of Proline and Lysine Residues
Three enzymes belonging to a group called the 2-oxoglutarate dioxygenases are
responsible for the hydroxylating activity associated with the ER (Table 1.2). Two of
the enzymes convert some prolyl residues to 4-hydroxyproline or 3-hydroxyproline,
and the third enzyme converts some lysyl residues to 5-hydroxylysine (Olsen, 1991).
Their reactions require ferrous iron, 2-oxoglutarate, 02and ascorbate.
Peptide-bound proline (lysine) + 02 + 2-oxoglutarate
Fe2+ + ascorbate
Peptide-bound hydroxyproline (hydroxylysine) + C02 + succinate
The 2-oxoglutarate is stoichometrically decarboxylated during hydroxylation to
form succinate. Ascorbate is a highly specific requirement and appears to be necessary
to reduce Fe3+ (formed during the reaction) to Fe2* (Olsen, 1991; Peterkofsky, 1991).
In ascorbate deficiency (scurvy), the chains of fibrillar procollagens are
underhydroxylated, and do not form stable triple helices at 37 °C. This leads to
intracellular degradation ofunfolded chains or delayed secretion ofnon functional
protein. Ascorbate also acts at the level of transcription, specifically increasing mRNA
levels (Chan etal., 1990; Houglum etal., 1991). All three hydroxylases are sequence
specific and require a peptide bound substrate in a random coil conformation.
Prolyl 4-hydroxylase converts prolyl residues in Gly-Xaa-Pro sequences to 4-
hydroxyproline. Under physiological conditions the formation of a stable triple helix
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require about 100 hydroxyprolines per chain. Therefore nucleated growth of the triple
helix is delayed until the chain aquires the necessary content ofhydroxyproline. The
delay ensures that nucleation and propagation of the triple helix occurs in an orderly
manner (Prockop, 1990; Kuivaniemi eta]., 1991). The active prolyl 4-hydroxylase is a
a2P2 tetramer of 240 K, where a and (3 are two types of subunit (both glycoproteins)
ofaround 60 K. A proportion (30-99 %) of the enzyme remains inactive, and the ratio
ofactive to inactive enzyme is proportional to the rate of collagen synthesis. The
conversion of inactive to the active form may be important in regulating synthesis. The
enzyme also has an associated protein-disulphide-isomerase activity (Olsen, 1991;
Pihlajaniemi etal., 1991). Prolyl 3-hydroxylase hydroxylates prolyl residues at the
Xaa position in Gly-Xaa-Hypro sequences to 3-hydroxyproline. Very little 3-
hydroxyproline is found in collagen and its physiological role is not known.
Lysyl 5-hydroxylase is a dimer composed of two 90 K subunits, the enzyme
hydroxylates lysyl residues at the Yaa position in Gly-Xaa-Yaa sequences to 5-
hydroxylysine (Olsen, 1991; Jiang & Ananthanarayanan, 1991). Around 5-10
hydroxylysines are produced in each chain, some ofwhich are required for the
glycosyl transferase enzymatic addition ofO-linked carbohydrate units to the e-
hydroxyl groups on the lysine side chain. However within the telopeptide there is an
exception to the sequence specificity, which may suggest that a different enzyme is
required. The hydroxylysines synthesised within the telopeptides are ofparticular
importance because they are involved in intra- and inter-molecular cross-links which
stabilise the assembly of the triple helical monomers in collagen fibrils. Recent data has
suggested that the conformational requirement for lysyl hydroxylation in collagen is the
presence of a "bent" structure, such as a (3- turn with lysine in the second position of
the turn, and that the presence of a polyproline-II type structure aids the effective
binding of the substrate at the enzymes active site (Jiang & Ananthanarayanan, 1991).
All modifications cease as soon as the protein folds into a triple helix as the post-
translational enzymes cannot interact with the triple helical protein. In effect, the degree
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ofprotein modification is regulated by its folding into a triple helical conformation
(Kuivaniemi etal., 1991; Torre-Bianco eta]., 1992).
1.5.2.2 Glycosylation of Asparaginyl and Hydroxylysyl Residues
O-glycosylation of collagen occurs by the manganese-dependent enzymatic
addition ofgalactose or ofglucose and galactose utilising UDP-sugars as substrate.
The two enzymes responsible, galactosyl-hydroxylysyltransferase and
glucosylgalactosyl-hydroxylysyltransferase, modify peptide bound hydroxylysines,
which are in non-helical conformation. The modification lags behind chain synthesis
by about 200-300 residues (Prockop & Kivirikko, 1984; Byers, 1990).
The biological function ofO-glycosylation is not known, it is clear however that it
is not essential for secretion of the molecule. Two possible roles have been proposed,
one involved in directing molecular assembly (Rogozinski etal., 1983) and the second
in modulating cross-link formation (Robins & Bailey, 1974). Amudeswari et al. (1987)
showed that the kinetics of in vitro fibril assembly decreased after glycosylation and
increased after deglycosylation. A mechanism was proposed in which the sugar chains
have to be redirected axially before fibril formation could procede. It was also
suggested that the glycosylation may have some influence on fibril structure;
specifically it has been suggested that an increase in glycosylated hydroxylysine
residues will decrease the diameters of in vitro formed fibrils because of steric effects.
The extent ofglycosylation may also effect collagen/matrix interactions as well as
interactions with the cell surface, but these remain to be critically tested (Kagan, 1986;
Torre-Bianco etal., 1992).
The C-propeptide contains an asparagine linked oligosaccharide. The biosynthesis
of asparaginyl N-linked units occurs in the RER by transfer of a mannose-rich
oligosaccharide side chain to an acceptor site containing the sequence Asn-Xaa-
Sei/Thr. The transfer has been shown to involve a lipid carrier (Kivirikko & Myllyla,
1982; Olsen, 1991).
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1.5.2.3 Disulphide Bonding and Triple Helix Formation
Both propeptides ofprocollagen I contain intramolecular disulphide bonds,
intermolecular disulphides are present only in the C-propeptide. The stabilisation of the
C-propeptide by disulphides is required for efficient folding of the triple helix (Koivu
& Myllyla, 1987). Protein disulphide isomerase plays a key role in catalysing
disulphide exchange in the molecular asssembly of collagen. Remarkably, protein
disulphide isomerase is identical to the (3 subunit ofprolyl 4-hydroxylase (Freedman
etal., 1989). Disulphide bonding accompanies chain registration (the association of
pro a-chains in the correct stoichiometiy) and precedes helix formation (Hulmes,
1992). In support of this is the finding that chain association and interchain disulphide
bonding are processes that can procede in the absence ofprolyl hydroxylation and
triple helix formation.
Procollagen assembly differs from the folding of any other protein and begins with
the association of the C-propeptide domains (Kuivaniemi etal., 1991). For the helix to
extend the full length of the a-chain it is important that the molecules are in register, in
the sense that the Gly-Xaa-Yaa tripeptide unit in one chain is hydrogen-bonded to the
corresponding unit in the other chains. Primary associations through the C-propeptide
provides the correct registration. The folding of the helix then occurs through a zipper¬
like mechanism of nucleated growth in which a nucleus of triple helix is formed at the
C-terminus which is then propagated to the N-terminus (Engel & Prockop, 1991).
Because pro a-chains contain a large number of sterically symetrical gly-pro and pro-
hypro bonds, spontaneous isomerisation from the trans to cis configuration is a
frequent occurance. Therefore chain folding occurs at a rate determined by cis^trans
isomerisation which probably requires catalysis by a specific isomerase (Engel &
Prockop, 1991).
Several mutations that substitute glycine residues for amino acids with bulkier side
chains have been defined. These mutations distort the conformation of the helix and
delay its folding N-terminal to the site of the mutation. Because the hydroxylases and
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glycosyl transferases are only active on random coil collagen substrates, a delay in
folding leads to over-modification of the pro a-chains, as observed in a number of
heritable disorders (Byers, 1990; Kuivaniemi etal., 1991; Tsuneyoshi etal., 1991).
1.5.3 Intracellular Transport and Secretion of Procollagen
Once the procollagen molecules are completely folded they are transported from the
RER through the Golgi system and then to the cell surface where they are secreted
(Marchi & Leblond, 1984). Secretion is reduced ten fold by a, a'-dipyridyl, an
inhibitor ofhydroxylation, therefore helix formation is required for secretion. Prior to
secretion, procollagen is concentrated in secretory vesicles where, unlike the D-
staggered assemblies that occur in collagen fibrils, procollagen molecules align in
register (Hulmes, 1992). Environmental factors strongly influence the form of
procollagen assembly since high concentrations ofpurified procollagen form D-
staggered arrays in vitra Both propeptides appear to be located at the surface of the
assembly (Mould etal., 1990).
1.5.4 Proteolytic Processing of Procollagen
Following secretion of procollagen molecules into the extracellular matrix, both the
N and C-propeptides must be removed, for the collagen molecules to form stable fibrils
with normal morphology. Three distinct enzymes have been described so far that are
responsible for processing procollagens I-III. The enzymes are procollagen N-
proteinases (removal ofN-propeptides) and procollagen C-proteinase (removal ofC-
propeptide). The incorporation of collagens I and III into fibrils requires a different N-
proteinase for each type. The need for two different N-proteinases allows for
independent control of processing, and assembly in tissues containing both types.
(Peltonen etal., 1985; Hulmes, 1992)
All the processing enzymes described so far are sequence-specific, neutral,
calcium-dependent metalloproteinases. Procollagen 1A1 N-proteinase is a high
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molecular weight (500 K) complex. The complex consists of four subunits, ranging in
molecularweight between 60 K-160 K, where the two largest subunits probably
possess the catalytic activity (Hojima etal., 1989). Unlike C-proteinase, the enzyme
has a specific requirement for the native conformation of the cleavage site which
apparently consists of a hairpin loop in each of the three pro a-chains (Torre-Bianco et
al., 1992). Further to this, it has been shown that the absence of the 18 amino acid
residues that surround and include the N-proteinase cleavage site in the pro a2(I) chain
drastically slows the rate of cleavage of the pro al(I) chains (Watson etal., 1992).
These observations demonstrate that cleavage of the pro a 1(1) chains by procollagen
N-proteinase occurs at a maximum rate only when the procollagen molecule contains
three pro a-chains and when the cleavage sites have the correct spatial organisation.
When N-terminal processing is defective, fibrils with an altered morphology are often
observed. Defects may arise from reduced proteinase activity (e.g. dermatosporaxis) or
mutations which alter the N-proteinase cleavage site (e.g. Ehlers-Danlos syndrome
type VII), rendering the mutant procollagen resistant to cleavage (Watson etal., 1992).
Because the collagen triple helix folds in a C-N terminal direction any in-frame deletion
anywhere in the helix is transmitted to the N-propeptide (Dombrowski etal., 1989). As
well as impaired fibril formation, there may also be a disturbance in the suggested
feedback regulation of collagen synthesis by the free N-propeptides which may affect
the quantity or quality of the secreted molecules. Procollagen C-proteinase is a
monomer of 90 K, enzymic activity has been shown to be enhanced by a 34-55 K
connective tissue glycoprotein (Kessler etal., 1990).
The pathway ofprocollagen processing (i.e. via pN-collagen, procollagen lacking
the C-propeptides; or pC-collagen, procollagen lacking the N-propeptides) appears to
vary with collagen type (Fessler etal., 1981) and stage in development (Mellor etal.,
1991). Processing intermediates can persist in normal tissue (Veis etal., 1973), and
immunoelectron microscopy has revealed an association ofN-propeptides and C-
propeptides with small and large diameter fibrils, respectively (Fleischmajer etal.,
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1987). By in vitro reconstitution experiments, it was demonstrated that persistence of
the N-propeptide distorts fibril morphology from normal cylindrical to fluted and sheet¬
like structures of thickness 8 nm (Hulmes etal., 1989a; Holmes etal., 1991), some of
which resembled abnormal fibrils seen in viva For example, structures were observed
which resembled the "spider like" fibrils seen in dermatosporactic animals. Holmes et
al (1991) demonstrated that the N-propeptides are found at the surface of the growing
assembly in a "folded-back" conformation, and may block further growth by
preventing the side-by-side association of collagen molecules. It has since been
demonstrated that treatment ofhieroglyphic fibrils, that are copolymers of collagen and
abnormal pN-collagen (pN-collagen"ex6, pN-collagen that lacks the 18-amino acid
residues encoded by exon 6 of the COL1A2 gene; Watson etal., 1992) with N-
proteinase results in partial cleavage of the pN-collagen"ex6 in which the abnormal
pNa2(I) chains remain intact (Watson et al., 1992). The further observation that the
hieroglyphic fibrils were resolved to cylinders supports the view that there is
considerable fluidity between collagen molecules within a collagen fibril (Chapman,
1989). That the relative proportions of collagen to pN-collagen"ex6 did not change
following cleavage of the pNal(I) chains by N-proteinase and that partially cleaved
pN-collagen"ex6 molecules were present in large diameter fibrils suggest that some of
the abnormal molecules must be present within the body of the cylindrical fibril. It
seems that the partially cleaved N-propeptides adopt a more extended conformation that
permits their incorporation into fibrils (Kadler, personal communication).
1.5.5 Ordered Aggregation and Collagen Cross-Link Formation
Procollagen I is relatively soluble and is found in the medium of cultured
fibroblasts as monomers with solubilities of 1 mg/ml or more (Kadler etal., 1990).
The high solubility ofprocollagen appears to be conferred mainly by the C-propeptide
domain, since pN-collagen, produced by cleaving the C-propeptide, has a solubility of
approximately 0.15 mg/ml (Mould etal., 1990). The solubility of the protein is
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decreased around 2000 fold following processing of the propeptides to generate
collagen. Collagen that leaves solution spontaneously polymerises into highly
organised fibrils. Fibrillogenesis therefore appears to be largely controlled by the
proteolytic cleavage of the propeptides (Prockop, 1990; Kuivaniemi etal., 1991).
Fibrillogenesis in v/Vois much more complex and is highly regulated by a variety of
factors. Fibril assembly is discussed in section 1.8.1.
1.5.5.1 Fibril Structure
Much of today's understanding of collagen fibril structure has come from both
electron microscopy (Chapman & Hulmes, 1984) and X-ray diffraction studies
(Brodsky et al, 1988). Tendon collagen (predominantly type I), occurs in a highly
ordered form in rat tail, and this has proven to be an ideal material for study by X-ray
diffraction techniques.
1.5.5.1.1 Axial Structure
Collagen axial structure refers to the molecular structure of the fibril projected onto
the fibril axis. Refinements made with respect to staining techniques for electron
microscopy together with X-ray diffraction data culminated in the Hodge-Petruska
model for the one dimensional arrangement of collagen molecules (Hodge & Petruska,
1963; Fig. 1.3). The collagen fibrils show a D periodicity along their length, this
periodicity results from collagen molecules which are staggered with respect to each
other by 67 nm (Parry, 1988). However the length of the collagen molecule (300 nm)
is not an integral multiple of the D period and it follows that the fibril stucture will have
alternating regions of dense molecular packing (the overlap regions of length 0.47 D)
and less dense molecular packing (the gap regions of length 0.53 D; Fig. 1.3). The 67
nm repeat produces a dramatic diffraction pattern when tendons are placed in a narrow
X-ray beam. The intensities of the meridional reflections derive from the axial electron
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Figure 1.3 One-dimensional molecular packing in collagen fibrils
Diagramatic representation of a negatively stained collagen fibril (a). The pattern of
alternating light and dark bands reflects the axial packing of collagen molecules (300
nm long) shown in (b), where the dark bands correspond to the heavy metal stain
entering the gaps between the molecular ends. The molecules in (b) are staggered by 67
nm with respect to each other. Each collagen molecule (c) may be regarded as
composed of five segments (labelled 1-5) each of length 67 nm except for segment 5
which is 0.47 x 67 nm long. The same numbering of the segments is used in Fig. 1.4
(adapted from Miller, 1982).
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distribution ofamino acids along the length of the collagen molecule. These amino
acids form a pattern which repeats every 67 nm (or 234 ± 1 residues). Oppositely
charged amino acids tend to occur close enough to each other to form ion pairs and
hydrophobic interactions are maximised. Hence, when one collagen molecule is
displaced by 67 nm with respect to another, a strong interaction can be expected
between them (Hulmes etal., 1973; Miller, 1982; Jones & Miller, 1991). The one
dimensional model for the packing of collagen molecules has been confirmed at low
resolution (5 nm) from the pattern of bands in positively stained collagen fibrils and at
higher resolution (1.6 nm) by a correspondence between the observed X-ray
meridional reflection intensities and the predicted intensities calculated from the amino
acid sequence (Hulmes etal., 1977).
1.5.5.1.2 Lateral structure
Evidence comes mainly from electron microscopy and medium angle X-ray
diffraction for a well defined microfibrillar substructure in native collagen fibrils. In the
original microfibril model proposed by Smith (1968), the structural unit ofpacking
was a group of five molecules closely packed with helical symmetry. These discrete
structures (microfibrils) are D-periodic with approximate diameter 3.8 nm, and were
thought to be packed together in a tetragonal, three-dimensional lattice. Although
consistent with most of the EM data and some of the diffraction data, the model is not
proven. The structure proposed by Hulmes andMiller (1979) based on a
reinterpretation ofX-ray data from rat tail tendon is consistent with quasi-hexagonal
molecular packing of individual collagen molecules (Fig. 1.4). The diffraction patterns
of rat tail tendon show a series of sharp equatorial or near equatorial Bragg reflections
which are derived from the lateral arrangement ofmolecules in the direction
perpendicular to the fibril axis. These reflections represent a discrete sampling of an
ordered lattice which demonstrates that the collagen I fibril is a true three dimensional
crystal with lateral as well as axial order (Brodsky etal., 1988). The parameters of the
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Figure 1.4 Quasi-hexagonal lateral arrangement of molecules in the
collagen fibril
This represents a transverse section through a fibril, and shows the lateral arrangement
of collagen molecules in the structure proposed by Hulmes and Miller (1979). The
numbers refer to the five segments (labelled 1-5 as in Fig. 1.3) of the collagen
molecule. The crystallographic unit cell (a = 3.9 nm, b = 2.67 nm, y = 104.6°)is
shown by broken lines (adapted from Miller, 1982).
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triclinic unit cell which describes this structure is interpreted in terms of the quasi-
hexagonal arrangement of collagen molecules shown in Figure 1.4. The fanning of the
near equatorial reflections in the diffraction pattern is consistent with a straight
molecular tilting ofaround 4° when veiwed perpendicular to the fibril axis (Hulmes &
Miller, 1979). The absence of reflections at high angles attributable to the molecular
segments within the gap region led to the suggestion that these segments were more
mobile than those in the overlap region (Fraser & Trus, 1986; Fraser etal., 1987). It
has been proposed that the gap region may be required for lysyl oxidase to diffuse into
the interstices of fibrils and initiate cross-link formation (Linsenmeyer, 1991). A
network ofaromatic residues in the telopeptide may also be vital in stabilising the
correct molecular orientations in preparation for cross-linking (Jones & Miller, 1991).
Crystalline molecular packing has also been shown for collagen II in the fibrils of
lamprey notochord sheath (Eikenberry et al., 1984). However the quasi-hexagonal
triclinic unit cell is not consistent with that for collagen II (Eikenberiy etal., 1984), as
the equatorial x-ray diffraction pattern for notochord sheath appears to indicate that the
spacing between planes ofmolecules are larger than those in rat tail tendon. X-ray
diffraction patterns of bone and skin show only a single broad equatorial maximum,
which indicates a low degree of order in these tissues. In crystalline fibrils, some
diffuse equatorial scattering is also apparent and constitutes a background to the
discrete reflections. This diffuse scatter may indicate lateral disorder which may be
static (i.e. due to the presence of a number of fixed conformations) or dynamic (i.e.
due to the motion ofmolecules). Experimental results from nuclearmagnetic resonance
spectroscopy (Torchia, 1982; Sarkar etal., 1983) indicate that fluidity of contact exists
between adjacent collagen I molecules, and implies that molecules in fibrils continually
reorientate about their long axes.
Although the quasi-hexagonal model is consistent with measurements of fibril
density and accounts for most of the diffraction data, it is in conflict with other models
since it does not provide for an ordered intermediate substructure (Piez & Trus, 1981).
40
As a compromise, the compressed microfibril model was proposed (Piez & Trus,
1981). The idea was to compress a 5-stranded microfibril and place it in the quasi-
hexagonal unit cell, the molecules of the compressed micofibril having a left handed
supercoil ofpitch 400-700 residues. Recently a new structure has been proposed
which also has a microfibrillar level oforganisation, with the molecules in the
microfibrils packed in a slightly distorted hexagonal lattice (Kajava, 1991). In this
model several closely packed molecules form a bunch which are linked "head to tail"
and penetrate each other a distance of 30 nm forming a microfibril. These microfibrils
then associate together such that different zones with different densities appearwithin
the fibril which aquires axial regularity with a 67 nm repeat (Kajava, 1991). However
the model does not account for the biochemical data on the position of several collagen
cross-link sites, which presupposes a 4D stagger configuration between individual
molecules (Reiser etal., 1992). Kajava's model also predicts reflections on the X-ray
diffraction map, which show a poor correspondence with the observed X-ray pattern
(Wess, personal communication).
Tissues such as skin and aorta which contain collagens I and III have a slightly
shorter (65 nm) D-period, this smaller axial periodicity has been shown to be directly
related to the tilt of the molecules. The measured mean tilt angle of 9° causes an axial
contraction, which results in twisting of the collagen fibril (Folkhard etal., 1987).
Raspanti etal. (1989) found that several tissues contained two distinct classes of fibril,
one having helical microfibrils at an angle ofabout 18° to the fibril axis, the other
having slightly wavy or zig-zag microfibrils. The helically arranged fibrils were present
in tissues rich in collagen III and tended to form small fibrils with a uniform diameter,
whereas the zig-zag morphology was characteristic of the large heterogeneous
population of collagen I fibrils in tendon. These observations suggested that the overall
morphology may identify the different types of collagen fibril (Raspanti etal., 1989).
Collagen networks may present different types of twist dependent on the variation of
fibrillar orientation in the collagen network. So far three types of twist have been
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identified, planar, cylindrical and toroidal. Both planar and cylindrical twists are
observed in vitro and in vivo, whereas the toroidal twist has only been observed in
vitro (Gaill et al., 1991).
1.5.5.2 Lysyl Oxidase
Lysyl oxidase (Protein-lysine-6-oxidase; EC 1.4. 3. 13) is a specific copper
dependent amine oxidase that functions extracellularly. The enzyme initiates the
formation of aldehyde-derived inter- and intra-molecular cross-links in collagen and
elastin by the oxidative deamination of certain lysine or hydroxylysine amino acid
residues. Cross-links form spontaneously by condensations involving side chain
aldehydes and unreacted e-amino groups. Continuous inter-molecular condensations of
this kind convert soluble monomers of collagen or elastin into insoluble fibres in the
ECM (for reviews on lysyl oxidase and collagen cross-linking see: Kagan, 1986;
Ricard-Blum & Ville, 1989; Last et al., 1990; Kagan & Trackman, 1991; Reiser et al.,
1992). The biomechanical stability and turnover of collagen is critically dependent on
cross-linking, so lysyl oxidase plays a key role in collagen function and metabolism.
The activity of lysyl oxidase on a collagen substrate in vitro is markedly increased
by prior assembly of the molecules into fibrils (Siegel, 1974). This indicates that
biosynthesis of the aldehyde cross-link intermediate probably occurs after the onset of
fibril formation in vivo. Therefore cross-linking may be related to the rate of fibril
assembly as well as the activity of lysyl oxidase. Hence factors which modulate the
kinetics of fibril formation may also modulate the extent of subsequent cross-linking.
The binding of lysyl oxidase to preformed collagen fibrils has been characterised
(Cronlund et al., 1985). The results indicate that lysyl oxidase binds to the triple helix,
with the catalytic site positioned on the non-helical telopeptide. The above observations
led to the suggestion that lysyl oxidase binds to the collagen molecules at sites remote
from the lysines (or hydroxylysines) to be oxidised, but which become juxtaposed to
these residues when molecules are assembled in D-staggered arrays.
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Lysyl oxidase has been purified from several sources including bovine aorta and
lung (Kagan etal., 1979; Cronlund & Kagan, 1986), human placenta (Kuivaniemi et
al., 1984) and porcine skin (Shackleton & Hulmes, 1990a), these preparations yielding
Mj. values of 30-34 K on SDS-PAGE. The presence ofmultiple ionic variants have
been observed in enzyme preparations from bovine aorta (Kagan etal., 1979; Williams
& Kagan, 1985), bovine cartilage (Sullivan & Kagan, 1982), human placenta
(Kuivaniemi etal., 1984) and porcine skin (Cronshaw etal., 1993). By SDS-PAGE,
these variants have the same molecularweight and exhibit a high degree of structural
similarity as evidenced by the nearly identical peptide maps obtained from proteolytic
digests (Sullivan & Kagan, 1982; Williams & Kagan, 1985) or CNBr digests
(Cronshaw et al., 1993) of each. Moreover substrate specificities (toward collagen,
elastin and alkylamines), inhibition profiles, and kinetic parameters of each of the
variants are similar, consistent with the same catalytic mechanism for each of these
enzyme forms (Kagan etal., 1979; Sullivan & Kagan, 1982). The origin of the
enzyme variants is not known, since only one gene for lysyl oxidase has been found in
rat genomic DNA (Trackman etal., 1990). Thus multiple forms of lysyl oxidase may
stem from post-translational modifications. Studies with purified preparations of lysyl
oxidase confirm that copper provides a catalytic or structural role in the enzyme that is
essential to the expression of enzyme activity (Iguchi & Sano, 1985; Gacheru etal.,
1990). The highly purified enzymes of chick bone (Iguchi & Sano, 1985) and bovine
aorta (Gacheru etal., 1990) contained 1 g atom of tightly bound copper per 32 K
monomer, whereas the metal free enzymes are catalytically inert. Nutritional studies
indicate that copper defficiency results in both a reduction in cross-link formation and
an increase in elastin degradation, while restoration of copper reverses these effects
(Gacheru etal., 1990; Tinker etal., 1990). Thus the activity oflysyl oxidase appears
to be essential to the accumulation as well as the prevention of loss of connective tissue
protein. Although the enzyme also requires a functional carbonyl cofactor, its chemical
identity has not been firmly established. Early investigations involving spectral
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analyses of chick aorta lysyl oxidase (Bird & Levene, 1982) led to the suggestion that
pyridoxal phosphate was the organic cofactor for lysyl oxidase. More recently,
resonance Raman spectroscopy of an active site peptide of the bovine aortic enzyme
implicated pyrroloquinoline quinone (PQQ) as the functional carbonyl (Williamson et
al., 1986). Although PQQ had previously been reported to be the cofactor of one other
mammalian enzyme, i.e. bovine serum amine oxidase (Lobenstein-Verbeek etal.,
1984), a recent report contradicts the presence of PQQ and, instead, provides strong
support for the presence of 6-hydroxydopa at the active site of the enzyme (Janes et al.,
1990). Although a detailed analysis of the organic cofactor in lysyl oxidase has still to
be done, it is of interest that a dietary deficiency of PQQ in rats decrease the
accumulation of lysyl oxidase, and produce lathyritic symptoms (van der Meer &
Duine, 1986). Feeding of PQQ reverses these effects (van der Meer & Duine, 1986),
therefore a quinone possibly 6-hydroxydopa serves as a catalytic centre for the enzyme
(Kagan & Trackman, 1991; Romero-Chapman et al., 1991).
Lysyl oxidase appears to follow a "ping-pong" kinetic course of reaction with the
order of substrate binding and product release as shown below (possible enzyme
intermediates are represented below the line; Kagan & Trackman, 1991).
rch2nh2 rcho o2 h2o2 nh3
rch2nh2 rcho 02 hp2
This proposed chemical mechanism assumes a PQQ-like o-quinone cofactor in which
the amine substrate is initially oxidised to the aldehyde during which the carbonyl
cofactor is reduced by the passage of two electrons from the a-carbon of the substrate
(Kagan & Trackman, 1991). Upon binding of 02, the enzyme is reoxidised to form
and release H202. The role of copper has still to be firmly established, however it was
44
shown that the metal-free apo-enzyme cannot catalyse the first half of the reaction in
which the aldehyde is formed (Gacheru etal., 1990).
Romero-Chapman and co-workers isolated 40 and 32 K forms of the enzyme from
rat skin, both ofwhich showed apparent lysyl oxidase activity. Antibodies raised
against the 40 K form detected the 32 K form in immunoblots, the inference being that
the 32 K form is processed from the 40 K form (Romero-Chapman etal., 1991). The
above observations complement those ofTrackman etal (1990; 1991) who have
characterised lysyl oxidase from a rat aorta cDNA library. Their observations suggest
that lysyl oxidase is first synthesised as a 46-48 K precursorwith obvious tryptic
cleavage sites that could generate products of 32 K and 40 K. In a study byWakasaki
and Ooshima (1990), a 48 K form of lysyl oxidase was observed after cell-free
translation.
Although lysyl oxidase doesn't appear to be glycosylated (Sullivan & Kagan,
1982), an N-glycosylation site was found in the sequence encoding the 32 K protein,
which is immediatedly followed by a thr- and ser-rich sequence. Further glycosylation
sites are found in the sequence encoding the precursor, thus raising the possibility that
N and O-glycosylation of the pro-lysyl oxidase molecule may occur (Trackman etal.,
1990; Trackman etal., 1991; Kagan & Trackman, 1991; Hamalainen etal., 1991).
Serafini-Fracassini etal. (1981) isolated a 34.4 Kglycoprotein from bovine
ligamentum-nuchae. This preparation displayed lysyl oxidase activity towards an
elastin substrate, however the protein was unusually resistant to BAPN. The 34.4 K
protein was however similar to structural glycoproteins closely associated with nascent
elastic fibres, thus raising questions concerning the role of this catalytically active
glycoprotein in connective tissue fibre synthesis. Recently the human lysyl oxidase
gene has been mapped to the long arm of chromosome 5 (Hamalainen etal., 1991).
The human enzyme appears to be synthesised as a 45 K protein containing a putative
signal peptide of 21 residues and an N-terminal propeptide, which is cleaved to
produce a 30 K enzyme.
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Lysyl oxidase has been localised and found to be associated with the microfibrillar
network surrounding elastic fibres, and within elastic fibres themselves (Kagan &
Trackman, 1991). Other workers have localised the enzyme on and within elastin and
collagen fibres of human placenta, skin and aorta (Baccarani-Contri etal., 1990). The
apparent association of lysyl oxidase with the microfibrillar network implies that new
tropoelastin molecules are cross-linked as they are added to the growing elastic fibre.
The level of enzyme activity is markedly decreased in two X-linked recessively
inherited human connective tissue diseases, Ehlers-Danlos syndrome type IX and
Menkey's syndrome (Kagan, 1986). On the basis of these findings it was assumed that
the lysyl oxidase gene was located on the X chromosome. Nevertheless both disorders
appear to be associated with disturbances in copper metabolism (Kagan & Trackman,
1991). Hence it was not known whether the decrease in activity was due to a reduction
in intracellular copper or impaired synthesis of lysyl oxidase. Recently the assignment
of the lysyl oxidase gene to chromosome 5 indicates that the low enzyme activity
associated with both disorders appears to be secondary to a decrease in available
copper (Hamalainen etal., 1991). The non-availability of copper leads to a further
consequence in the synthesis and or degradation of lysyl oxidase as patients with type
IX Ehlers-Danlos syndrome contain virtually undetectable levels of tissue enzyme
(Byers etal., 1980).
The activity of lysyl oxidase responds to changes in levels of certain hormones: for
example, testosterone has been shown to increase the activity approximately 5 fold in
cultured aortic smooth muscle cells (Bronson etal., 1987). A lysyl oxidase enhancer
from porcine skin has also been found (Shackleton & Forbes, unpublished
observations). The enhancer, which has no lysyl oxidase activity on its own, but
which can increase lysyl oxidase activity several fold, has a molecular weight greater
than 10 K, is relatively heat stable but is inactivated by freezing.
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1.5.5.3 Collagen Cross-links
The nature and position of cross-links has long been the subject of conjecture, the
ultimate cross-link produced reflecting the steric relationship of the individual collagen
molecule within the fibril structure. Oxidation of lysine (or hydroxylysine) in the
interstitial collagens is restricted to one lysine in the N-terminal telopeptide (residue
9N) and one in the C-terminal telopeptide, the lysines in the triple helical region are not
normally oxidised. Native isolated cross-links are consistent with cross-linking
between the C-terminal telopeptide lysine (residue 16C) ofboth al chains, and triple
helical lysine (residue 87) on both al and a2 chains of neighbouring molecules. The
a2(I) and a2(V) chains lacks the C-terminal aldehyde site (Eyre etal., 1984; Yamauchi
etal., 1989). The same homologous sites of cross-linking are conserved for collagens
I, II, III and V. Only four locations have been established: two non-helical aldehyde
sites, one at each end of the molecule, and two triple helical sites which correspond to
hydroxylysine residues (Ricard-Blum & Ville, 1989). In the al chain of collagen XI,
three of the conserved sites have been identified (Bernard etal., 1988). Conserved
regions in the triple helix between residues 941-951 and 101-111, which are adjacent
to Lys 9N and Lys 17C respectively, both bear an overall positive charge (Kagan et
al., 1984). Since lysyl oxidase is more active on a positively charged substrate, these
conserved regions may provide the appropriate electostatic potential for binding of the
enzyme (Kagan 1986). Hence the correct binding and orientation of lysyl oxidase to
the suseptible lysine residues may necessitate the requirement for the quarter stagger
relationship between monomers in collagen fibrils. To account for the arrangement of
collagen cross-links, Davison and Brennan (1983) proposed a model for the
organisation of collagen molecules in the fibril. Their model supported the postulated
lamellar arrays of in register molecules with consistent polarity, as described in the
quasi-hexagonal model ofHulmes and Miller (1979).
Collagen cross-links appear to arise from one of two general biosynthetic
pathways, those initiated by lysyl oxidase, and those derived from non-enzymatically
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glycosylated lysine and hydroxylysine (Reiser eta]., 1992). These early glycation
products undergo a series of reactions to form what is referred to as advanced Maillard
products. These cross-links appear to be prevalent in diabetic subjects and have been
associated with abnormalities in the physiochemical properties of collagen with long
term clinical complications (Buckingham & Reiser, 1990; Reiser eta]., 1991; Reiser et
a]., 1992). Relatively little is known about the chemistry of sugar derived cross-links
compared to the lysyl oxidase initiated cross-links. However both pathways involve
lysine and hydroxylysine, so it is likely some relationship exists between them.
The first step in lysyl-oxidase-mediated cross-linking involves the oxidative
deamination of specific lysine and hydroxylysine residues to their corresponding
aldehydes called allysine and hydroxyallysine respectively (Fig. 1.5). These aldehydes
stoichiometrically condense with other lysyl or hydroxylysyl residues to form Schiff
bases (aldimines) or with other aldehydes to form aldol cross-links (Ricard-Blum &
Ville, 1989). Some of these reducible cross-links are more stable than one might expect
for a Schiff base, as they may undergo an amido-rearrangement to form ketoamines
(Last et al., 1990). Intramolecular cross-links are formed when two allysine residues
within the same molecule combine to produce a condensation product called allysine
aldol. During the last twenty years, a variety of di, tri and tetrafunctional cross-links
have been identified in collagen I. These cross-links are produced by reactions
involving lysine, hydroxylysine and histidine residues. Cross-links between different
collagens (e.g. I and III) have also been isolated (Henkel & Glanville, 1982) and in
cartilage pyridinoline residues covalently link molecules of collagen IX to molecules of
collagen II (Eyre etal., 1987).
Aldehyde-derived intermolecular cross-links are conveniently divided into two
classes. The initial cross-links on both pathways are reducible aldimines or ketoamine
rearranged products. Acid-labile histidine based cross-links which are derived from
lysine aldehydes predominate in skin, whereas hydroxylysine aldehydes which form
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Figure 1.5 Collagen cross-links
Tissue specificity and maturation changes in cross-linking, showing the structures of
the principal cross-links in mature tissue (adapted from Kagan, 1986; Ricard-Blum &
Ville, 1989).
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Tendon may contain both types, the dominant form depending on the location of the
tissue. Variations in mechanical and physical properties among different connective
tissues may be due in part to differences in cross linking. In general the hydroxylysine
route predominates in tissues that bear large mechanical loads (Eyre etal., 1984). The
amounts of the reducible cross-links have been shown to decrease with age; this led to
the hypothesis that the reducible components were intermediates that were converted to
a mature, stable, non reducible form, thus accounting for the increased stability of
mature tissue (Barnard etal., 1987).
The functional importance of cross-links has been demonstrated both in animal
models and in cross-linking experiments in vitro. (3-aminopropionitrile (BAPN), is a
potent irreversible inhibitor of lysyl oxidase (Tang etal., 1983). The ability of BAPN
to inhibit collagen cross-linking results in an increased fragility of all connective
tissues, with a concomitant elevation in the solubility of collagen. The kinetics of the
inhibition is consistant with that of an active-site-directed inhibitor (Tang etal., 1983).
The control of cross-linking is potentially ofgreat clinical significance as there are
several disorders including rheumatoid arthritis and osteoarthritis in which the
symptoms may be alleviated by mobilising the rapid proliferation of collagen that
characterise these conditions (Robins, 1982; Kagan, 1986). Decreasing the number of
cross-links not only reduces the tensile strength of collagen fibres, but also renders
them more susceptible to degradation by collagenase (Vater etal., 1979). Hence the
dose ofBAPN must be balanced against potential reductions in tissue tensile integrity
and other undesirable effects.
In addition to the lysine-derived cross-links, disulphide bonds are found in some
collagens. Collagens III, IV, VI and VII are stabilised by both intra- and inter-
molecular disulphide bonds whereas collagens IX and XII contain only intramolecular
disulphides (Ricard-Blum & Ville, 1989).
Over the past two decades significant advances have been made in the
understanding of collagen cross-link biochemistry. For example, it has been shown
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that the cross-linking pattern in the collagens differs widely depending on the tissue
and age of the organism, and that cross-linkmaturation results in improved collagen
resistance to catabolic enzymes. However many questions still remain unanswered,
such as the biological significance of the various cross-links. The regulation of cross¬
link biosynthesis is still poorly understood, as is the relationship between lysyl oxidase
initiated cross-links and sugar derived cross-links.
1.6 Disorders of Collagen
Collagen biosynthesis and degradation are highly complex processes comprising
many steps, disruption at any of these steps become manifest as diseases. Collagen
may also be influenced by non-collageneous components and abnormalities of these
components can result in a number of other disorders (Tzaphlidou, 1992). Point
mutations in fibrillar collagens result in a variety of skeletal and tissue abnormalities
such as osteogenesis imperfecta and certain Ehlers-Danlos syndromes (Steinmann et
al., 1991; Watson etal., 1992). Disease may also result when aberrant cells infiltrate
pre-assembled extracellular matrices to mount an inflamatoiy response such as that
found in rheumatoid arthritis.
Osteogenesis imperfecta (01) is a heritable disorder characterised by brittleness of
bones. Over 80 mutations have been described to date in the genes encoding for
procollagen I. Single base changes that substitute glycine for amino acids with bulkier
side chains account for most of the mutations and reflect the strict requirement for
glycine at every third position along the collagen triple helix (Steinmann etal., 1991).
Mutations that cause OI also include insertions and deletions ofDNA as well as
splicing mutations which lead to exon skipping (Deak etal., 1991; Kuivaniemi etal.,
1991). The severity of the disease is varied and appears to correlate with the position of
the mutation (Byers, 1990; Khillan etal., 1991). In general mutations near to the C-
terminal are lethal, whereas mutations approaching the N-terminus produce milder




chains from the C to N-terminus (Engel & Prockop, 1991). Any mutation which
interferes with the folding can destabilise the triple helix C-terminal to the substitution
causing the chains to spend longer in non helical conformation. Because the degree of
post-translational modification is increased by any delay in folding, over-modified
proteins are produced. The extent of the over-modification is therefore inversely related
with distance of the substitution from the C-terminus. Post-translational over-
modification is seen in a series ofmutations which cause OI, although it remains to be
established what contribution it makes to the phenotypic changes seen in the disease
(Torre-Bianco etal., 1992). Most mutations lower the thermal stability of the collagen
molecule such that folding is impaired and secretion prevented. Unfolded molecules
accumulate intracellularly and are slowly degraded, so less ECM is produced. Normal
pro a-chains may also associate and become disulphide-linked to mutant chains. Thus
both normal and mutant chains are degraded intracellularly in a process called
procollagen suicide. Alternatively, when mutant procollagen molecules allow folding of
the three chains, a conformational change such as a flexible kink can be introduced into
the triple helix. When these distorted molecules are secreted, they copolymerise with
normal collagen which disrupts their selfassembly into fibrils (Khillan etal., 1991).
Ehlers-Danlos syndrome (EDS), a heterogenous group ofheritable disorders
characterised by hypermobility ofjoints and abnormalities in skin, is classified into 11
types based on clinical and biochemical findings. By virtue ofmarked joint
hypermobility and frequent joint dislocation, EDS type VII is distinct from other forms
ofEDS. The biochemical basis of the disorder is a failure to process the N-propeptide
ofprocollagen I. Hence EDS type VII was thought to be the human counterpart of
dermatosporaxis (fragile skin), originally described in cattle and sheep.
Dermatosporaxis is caused by the absence ofN-proteinase activity; however in EDS
type VII a mutation causes skipping of exon 6. Exon 6 contains the coding sequence
for the N-propeptide cleavage site and therefore cleavage of the procollagen by
procollagen N-proteinase is prevented in molecules which contain the mutation. The
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persistence of the N-propeptide in collagen drastically alters fibril formation so that
fibrils are irregular in cross section (Hulmes etal., 1989a; Kuivaniemi etal., 1991;
Watson etal., 1992).
1.7 Matrix Degradation
Two principal methods exist for matrix degradation: extracellular secretion of
catabolic enzymes (e.g. neutral metalloproteinases) and the internalisation ofmatrix
molecules followed by lysosomal degradation (for reviews, see Alexander & Werb,
1989; Matrisian, 1990; Alexander & Werb, 1991; Woessner, 1991).
Matrixmetalloproteinases (MATRIXINs) comprise of at least seven members
which range in size from 28-92 K. These zinc-containing enzymes are responsible for
degradation of ECM and basement membrane components during normal
embryogenesis, tissue remodelling, and in many disease processes such as arthritis and
cancer. Members of the MATRIXIN family share the following characteristics:
(i) They contain a zinc ion at the active centre.
(ii) The proteinases are initially secreted in zymogen form, which are activated upon
autocatalytic removal of a 10 K amino propeptide.
(iii) The enzymes cleave one or more constituents of the matrix.
(iv) They are inhibited by tissue inhibitors ofmetalloproteinases (TIMPs).
The matrix metalloproteinases can be divided into three groups which comprise the
collagenases, gelatinases and stromelysin. The collagenases and stromelysins have
three functional domains; an amino propeptide of around 80 amino acids containing a
free cysteine residue which may be required for the maintenance of latency of the
proenzyme form, a catalytic domain of about 180 amino acids which is required for
peptide bond cleavage as well as co-ordinating calcium and zinc binding to the enzyme,
and a C-terminal domain containing around 200 amino acids which is thought to be
involved in matrix binding (Murphy etal., 1992).
Interstitial collagenase cleaves collagens I, II and III. In collagen I, cleavage in the
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triple helical domain produces a three quarter and one quarter length fragment called
TCa and TCb respectively, these fragments rapidly denature and become suitable
substrates for gelatinase and stromelysin. The cleaved peptides may be further
fragmented in the matrix or degraded by cysteine proteases (cathepsins) in lysosomes.
The observations ofMurphy etal. (1992) showed that the specific action of
collagenase on triple helical collagen was determined by the presence of the C-terminal
domain, which appears to orientate the enzyme's catalytic domain at the single cleavage
site. The discovery of the FACIT collagens changed ideas about degradation of
collagen matrices. These collagens may well coat fibril bundles and protect the internal
fibrils from attack by interstitial collagenase. Therefore degradation may involve an
initial cleavage of the FACITs by stromelysin. The regulation of proteolysis is under
tight control at several levels. Transcription ofMATRIXIN genes may be stimulated by
growth factors and cytokines. This induction, can when necessary, be blocked by
biological agents such as transforming growth factor-beta (for review see Roberts et
al., 1990). The activity of the metalloproteinases may also be regulated during
conversion from the latent to the active enzyme form. Finally, proteinase activity is
dependent on the balance between the enzymes and their inhibitors (e.g. TIMPs, a2
macroglobulin).
TIMP (also called TIMP 1) is a 28.5 K glycoprotein which binds reversibly and
with high affinity, forming a 1:1 complex with interstitial collagenase (Woessner,
1991). The mechanism of inhibition is unknown, although it was suggested that TIMP
may interact with the active site zinc ion to render the enzyme inactive. With the
exception of elastin, which is efficiently digested with neutrophil elastase, the
MATRIXINs are capable of degrading most of the ECM components. However a
macrophage elastase which is inhibitable by TIMP has been found (Banda & Werb,




Matrix assembly is a dynamic process which occurs when an organism undergoes
morphogenesis, growth and regeneration (for a review see: Birk et al., 1991). Since
over 90 % of the organic matter in skin, tendon, ligament and bone is collagen, the
physical properties of tissues are determined to a large extent by the three dimensional
organisation of collagen fibrils. Fibrillar arrays of collagen show a variety of tissue
specific patterns that range from the tight, orthogonal network in bone to the bundles of
parallel fibrils found in tendon. Even in tissues which show the same heterotypic
mixtures of fibrillar collagen molecules, the collagen fibrils still exhibit diversity in
their spatial organisation. Hence tissue specific variation cannot be explained simply by
the tissue-dependent expression ofunique fibrillar collagen types. However, it is likely
that molecules or domains that are expossed on the fibrillar surface are involved in
complex interactions which determine the spatial organisation of fibrils. It has been
suggested that the tissue specific expression of non-fibrillar collagens contribute to
histological variability. Matrix assembly is thought to take place initially via non-
covalent interactions of the molecular components, which are later stabilised by
covalent bonds (Yurchenco & Schittny, 1990). PGs in particular HSPG probably play
a vital role in this process due to their ability to bind several matrix components
(including collagen, laminin and fibronectin). In addition to the integrins, cell surface
proteoglycans may also provide a vital role in connecting ECM components to the
cytoskeleton (Carey, 1991). Finally, cell-mediated control over the stoichiometry of the
different ECM components as well as the discharge ofmacromolecules into the
extrcellular space is important in determining matrix architecture. Therefore the cellular
regulation ofmixing during packaging or at the site of secretion provides a mechanism
where a variety of components can be combined in several ways to produce a huge
diversity of connective tissue structures (Birk etal., 1990b).
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1.8.1 Fibril Formation
Generally, collagen fibrillogenesis is the formation of fibrillar structures by the
ordered assembly of collagen molecules. However the term cannot be used to describe
the assembly of all collagens, because not all collagens form structures recognisable as
fibrils. Unlike the molecules of collagens I, II, III, V and XI, for example, the FACIT
collagens do not form fibrils, but do assemble in specific ways to form complex
networks most suited for their biological role (Fig. 1.1).
The in vitro assembly of collagen molecules into fibrils is a classic example ofan
entropy driven self-assembly process. At physiological ionic strength and pH, and at a
temperature above 30 °C, the axial registration ofmolecules is established and leads to
the formation ofD-periodic fibrils (George & Veis, 1991). Thus it is evident that the
information to build D-staggered fibrils is contained in the amino acid sequences of the
fibril-forming collagens (Vies & Payne, 1988).
Assembly of collagen fibrils in vivo is more complex and is probably influenced by
other components of the ECM (e.g. proteoglycans), as well as by post-translational
modifications of the collagen molecule. It is now well documented that many collagen
fibrils are composed of two or more collagen types. Heterotypic interactions between
different collagens have been proposed as a possible mechanism for fibril diameter
limitation (van der Rest & Garrone, 1991). It has also been proposed that
proteoglycans bind to specific regions on collagen fibrils (Scott 1991), and regulate
their assembly and final diameter (Brown & Vogel, 1989). The rate of removal of the
N-propeptide strongly influences fibrillogenesis, and limited persistence ofpN-
collagen is associated with small diameter fibrils (Mellor etal., 1991). In addition, cells
influence extracellular events through their control over secretion of the different
macromolecular components (Ploetz etal., 1991). It is evident from the sharp diameter
distributions of collagen fibrils in a variety of connective tissues that a stringent control
over lateral growth can be exerted in wVo(Vies & Payne, 1988; Chapman, 1989),
though the factors which control lateral and axial growth and hence determine fibril
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diameters remain to be elucidated. It is also clear that the orientation and interfibrillar
spacing ofmatrix assemblies are subject to cell-mediated, tissue-dependent control,
although the exact factors which regulate and determine the supramolecular architcture
of fibrils in different tissues are poorly understood (Ploetz et al., 1991; Sage &
Bornstein, 1991).
1.8.1.1 Collagen I Fibrillogenesis in Vitro
Collagen I fibril assembly has been studied for several decades (Wallace, 1990). In
the classical system, fibrils are reconstituted in vitro by taking a cold acidic solution of
collagen (e.g. 4 °C; pH 2.5 - 3) to warm neutral conditions (e.g. 34 °C; pH 7.4). The
fibrils which ultimately form are usually well ordered D-periodic fibrils similar to those
observed in vivo, although it is usually more difficult to reproduce fibril diameters
(Veis & Payne, 1988; Hulmes, 1992). Over the years, the nature of the collagen
preparations used has changed as understanding has advanced. Preparations containing
aggregates derived from cross-linking or containing molecules that had been altered by
proteolysis were used in early studies of fibrillogenesis. More recently workers prefer
to use largely monomelic collagen solutions which are as free from degradation as
possible; these efforts have resulted in a significant advance in understanding fibril
assembly (Wallace, 1990).
1.8.1.1.1 Fibrillogenic Pathways
Holmes et al. (1986) analysed and defined three general routes by which fibrils
reconstitute in vitro : cold start, warm start and simultaneous. In a typical warm start
procedure, equal volumes of acidic collagen solution and double strength neutral buffer
are preincubated to the desired temperature and then mixed rapidly. In the cold start
procedure, the solutions are first mixed and then rapidly heated to the desired
temperature. Although both pathways have the same end point of fibrillogenic
conditions, the two routes do not yield identical kinetics for fibrillogenesis and the
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fibrils formed are different in terms of diameter distribution (Holmes etal., 1986; Veis
& Payne, 1988).
The kinetics of assembly as followed by turbidity shows the presence of a lag
phase during which there is no apparent increase in optical density followed by a rapid
sigmoidal growth phase and a stable gel which slowly matures. The length of the lag
phase is inversely related to both the total collagen concentration and the amount of
oligomers in the solution (Na etal., 1986a). Data has also shown that the final
absorbance can be correlated with the diameter of the fibrils (McPherson etal., 1985).
A critical concentration for polymerisation can also be demonstrated (Kadler etal.,
1987).
Decreasing the temperature results in rapid fibril disassembly. Upon rewarming the
solution growth begins almost instantaneously but with a shortened lag phase (Na,
1989; Na etal., 1989). This shortening of the lag phase upon second heating is called
the "thermal memory effect" and its existence suggests that some change must take
place which imprints the prior thermal history of the preparation. In a pure collagen I
system, homogeneous nucleation theory would predict that the lag phase is related to
the probability of forming an aggregate of sufficient size to be capable of supporting
fibril growth. When it dissasembles the collagen may still contain nucleation centres or
some oligomers which can readily form centres later. Because the lag phase may be
restored by transferring the solution to acidic pH, this may also suggest that any
residual structures are stabilised by acid-labile, Shiff-base cross-links (Na, 1989),
although it does not explain why thermal memory is lost as the solution is allowed to
stand over several days at 4 °C (Veis & Payne, 1988). A further explanation of the
"memory" effect is that a thermally driven conformational transition occurs either in the
helix and/or the telopeptides of the collagen molecule. Using dynamic light scattering,
Payne etal. (1986) showed that no significant differences existed between "naive"
solutions of collagen and ones which already exhibited thermal memory, a result which
suggests that a subtle change in the state of the collagen molecules rather than extensive
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changes in the degree ofaggregation are responsible for the memoiy effect. It was also
demonstrated that no large scale changes in the distribution ofmonomers or aggregates
occur until near the end of the lag phase (Payne etal., 1986). Recent data from FTIRS
(Fourier Transform InfraRed Spectroscopy) also appears to support this by showing
that there is no apparent change in the hydrodynamic parameters of collagen monomers
during the lag phase (George & Veis, 1991).
Fibrils which are formed at 35 °C and above tend to be narrow in diameter and
loosly packed. However by using a new system for reconstituting collagen, larger
diameter fibrils with tighter packing can be assembled following the enzymatic removal
of the C-propeptide from pC-collagen by purified procollagen C-terminal proteinase
(Kadler etal., 1990b). The kinetics ofassembly are similar to fibrils which are
reconstituted following neutralisation and warming ofacidic collagen solutions, though
the rate of enzyme processing provides an additional tier of control. Collagen fibrils
generated in this way made it possible for the first time to follow their growth with time
lapse photography. Using dark-field light microscopy the first formed fibrils display
shape polarity having one blunt end and one highly tapered tip (Kadler etal., 1990a).
The fibrils grow longitudinally by the addition ofmonomers to the tapered tip and
laterally by further additions ofmolecules to fill in the highly symmetric tips
(Kuivaniemi etal., 1991). Later in the process of fibril assembly, pointed projections
appear at the blunt ends and the fibril then grows in both directions. Mass
measurements by STEM (Scanning Transmission Electron Microscopy) revealed that
the mass per unit length along both kinds of tips increased linearly over distances of
around 100 D-repeats from the fibril end. Fine tips from different fibrils exhibited near
identical growth behavior, whereas course tips displayed less regular growth patterns
(Holmes, personal communication). The pattern of cross striations in the pointed tips
indicate that all the molecules were orientated such that the N-termini were directed
towards the tips, thus indicating a switch in molecular polarity within the fibril (Kadler
etal., 1990a). These results are consistent with the growth of fibrils from acid
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extracted collagen which display symmetrical tips. The above results are also consistent
with the in vivo observations ofBirk et al. (1990b) who demonstrated using three
dimensional reconstructions from serial sections of embryonic chick tendon which
identified individual fibrils (diam. 40 nm) of length approximately 10 |im, and the
fibrils had a rapidly tapering and a gradually tapering end
1.8.1.1.2 Parameters Governing Collagen I Self-Assembly
A number of studies have indicated that the collagen triple helix in solution is a
semiflexible structure with several subdomains of enhanced flexibility, the hypothesis
being that molecules first have to bend to fit within fibrils (Veis & Payne, 1988;
George & Veis, 1991). The short N- and C-terminal telopeptides constitute smaller but
very important domains. It has already been proposed that both specific ionic and
hydrophobic interactions are involved in the initial reaction between the extrahelical
peptides and the helix, and this is believed to be the first step in ordered fibril formation
(George & Veis, 1991). The importance of the telopeptide regions during the
nucleation and growth of collagen fibrils has been demonstrated by disrupting these
regions with proteases such as pepsin. Pepsin-treated collagen apparently cannot
participate in lateral growth as efficiently or effectively as does intact collagen
(McPherson eta]., 1985), and the pepsinised molecules (with partially cleaved
telopeptides) assemble to form fibrils with little or no D-periodic banding (Gelman et
al., 1979). The N and C-terminal extrahelical regions lie in an axially condensed form
and appear to have different functions. In the C-terminal telopeptide, there is a
hydrophobic region ("the hydrophobic cluster") which is thought to direct the lateral
assembly ofearly aggregates and hence control final fibril diameter, whereas the N-
terminal region appears to direct linear growth (Capaldi & Chapman, 1984). However
the fact that fibrils can be formed from molecules which lack the extrahelical peptides
indicate that the intrinsic molecular properties necessary for fibril growth must be
inherent to a certain extent on interactions between the collagen helices. The presence
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ofaldehydes in the collagen molecule also influences the kinetics of fibrillogenesis. It
appears that, in vivo, aldehydes are generated only after the final assembly of the
molecules into fibrils, so that any modelling of the natural fibrillogenic process should
be done with lathyritic collagen (Brennan & Davison, 1981).
In general, the assembly ofmonomelic protein molecules into aggregated
structures may be mediated by hydrogen bonding, hydrophobic effects, electrostatic
interactions and entropic and dispersional forces (Wallace, 1990). Reconstitution of
pure type I collagen can generate fibrils ofwidely differing morphologies depending on
the conditions of fibrillogenesis (McPherson etal., 1985). For collagen, the rate of
fibril assembly is markedly dependent on temperature and ionic strength, which implies
that hydrophobic and electrostatic forces respectively play a prominant role. In general,
increasing the salt concentration or lowering the pH lengthens the lag phase. This effect
may be attributed to a shielding of intermolecular electrostatic interactions. However if
a distortion of the triple helix is required for molecules to be incorporated into fibrils,
perhaps fibrillogenesis is inhibited as much by restricting the conformational transition
(Fraser etal., 1987; George & Veis, 1991). Phosphate ions are unique and exhibit pH
dependent effects, producing maximum retardation at the initiation of the growth phase
between pH 7.1 to 7.5. Above physiological concentrations of phosphate, the fibrils
displayed larger diameters (Nemeth-Csoka & Tasnadi, 1981; Veis & Payne, 1988).
Many other simple compounds modulate the kinetics of fibrillogenesis. Glucose
(Rathi etal., 1989) and urea (Fessler & Tandberg, 1975) were both found to inhibit
fibril assembly in a concentration-dependent manner. The glucose appears to act by
weakening intermolecular forces within the fibril, while urea seems to dissociate nuclei
in the process of fibril growth (Hayashi & Nagai, 1972). It has been suggested that
glucose binds to collagen and interferes with the interaction between the telopeptide
regions and the triple-helical receptor sites on adjacent 4D staggered molecules (Rathi
etal., 1989). Since it has already been shown that lysyl oxidase activity on a collagen
substrate is increased by prior assembly of the molecules into fibrils (Siegel, 1974),
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glucose may also reduce subsequent cross-linking through the inhibition of fibril
formation. Lien etal. (1984) proposed that the high glucose environment in diabetic
subjects may prevent cross-linking ofnewly formed collagen and thus lead to a
selective depletion of these molecules. Their results were supported by animal models
which in diabetic rats showed an enhanced catabolism ofnewly synthesised collagen.
1.8.1.1.3 Kinetics and Thermodynamics of Self-Assembly
Self-assembly of collagen monomers into fibrils is primarily entropy driven with
thermodynamic parameters similar to the polymerisation of other proteins (e.g. actin,
flagellin; Kadler etal., 1987). The endothermic nature of in vitro fibril assembly
implies that hydrophobic interactions are the major interactions governing the assembly
process. These interactions are driven by the entropy increase resulting from the loss of
surface water from the monomer as the molecule enters the fibril aggregate phase
(Kuivaniemi etal., 1991). Increasing the temperature from 29 to 35 °C accelerates the
rate ofassembly in a predictable manner (Kadler etal., 1990b). However between 37
to 41 °C the rate of fibril formation is markedly limited by micro-unfolding of the
monomer (Kadler etal., 1988).
Because fibril reconstitution displays two-phase kinetics (a lag phase followed by
an exponential growth phase) a useful way to think of assembly is in terms of
nucleated growth (Wood & Keech, 1960; Hulmes, 1992). The rate-limiting step is the
formation of a critical nucleus from a small number ofmonomers. Once formed,
growth proceeds by the further addition ofmolecules. At any given time, depending on
the reaction conditions, these two processes may proceed simultaneously. Such a
model has been widely used in the assembly of other proteins (e.g. actin, tubulin).
However collagen assembly is distinctly different in that the final polymeric structure is
formed by the addition ofmonomers in both lateral and longitudinal directions,
whereas in actin and tubulin growth only occurs in length (Kadler etal., 1990a;
Hulmes, 1992).
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1.8.1.1.4 Molecular Specificity of Self-Assembly
As already pointed out, the telopeptide regions have major, but different effects on
the course of self-assembly. In native collagen aldehydes are present in the telopeptide
domains. If these aldehydes are reduced prior to the initiation of fibrillogenesis, then
thermal memory is retained, but the aggregates formed do not have the long term
stability exhibited when the aldehydes are present (Veis & Payne, 1988). Reduction
following nucleation was found to stabilise the memory effect, even after dialysis into
acetic acid. This data suggests that aggregates of some kind form during nucleation. It
has been proposed that nucleation is dependent on the telopeptides assuming specific
conformations favourable for the 4D-overlap interactions (Helseth etal., 1979;
Fleischmajer etal., 1991b). In the model ofHelseth etal. (1979), the N-telopeptide
forms a (3-turn placing the potential cross-linking lysine at the end of the turn. The
interaction registering the N-telopeptide to its receptor region at residue 930 of a
neighbouring molecule results from a specific alignment of ionic and hydrophobic
groups. A similar interaction between the C-telopeptide and its receptor site at residue
87 of ocl(I) has also been suggested (Capaldi & Chapman, 1982). A nucleus formed in
this way not only dictates the molecular assymetry of the resultant fibril, but must
exhibit a unique topology which is important for fibril growth.
1.8.1.1.5 Investigation of the First Formed Aggregates During Self-
Assembly
Many workers have endeavoured to experimentally determine the nature of the
nuclei or the first formed aggregates in the fibril forming process. The emphasis of
these studies has been to determine the length and molecular weight of these structures,
the problem however is the low concentration of nuclei. Gelman etal. (1979) proposed
that, after a temperature dependent conformational change, intermediate subassemblies
form that are less than 8 nm in diameter, but with lengths greater than 1500 nm.
However Silver and Trelstad (1980) concluded from their dynamic light scattering
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(DLS) studies that 4D-staggered dimers and trimers represent the first formed
aggregates. Although more recent DLS data was unable to establish the existence of
any new lag-phase aggregates, this does not mean that they have failed to form, since it
has been shown that DLS is unlikely to detect the presence of less than 5 % by weight
ofdimers and trimers (Payne etal., 1986). The presence ofvery small numbers of
aggregates is entirely consistent with nucleation theories.
Electron microscopy data using the cold start technique to initiate fibril
reconstitution showed that late in the lag phase long, narrow, filamentous aggregates
without any apparent banding were present. These subassemblies then proceed to
assemble into long thin D-periodic filaments. The lag phase appears to terminate when
these filaments begin to aggregate laterally (Gelman etal., 1979). Holmes etal. (1986)
made a direct comparison of the initial structures which form mid way through the lag
phase. At this point non banded thin filaments predominated in the cold start, whereas
the warm start produced thin D-periodic fibrils. Other workers have employed
formaldehyde fixation to arrest the self assembly process and showed that the first
formed aggregates are dimeric, with the most prevalent dimer having a 4D-stagger
between constituent molecules (Kadler& Chapman, 1986; Ward etal., 1986).
1.8.1.1.6 Models for Self-Assembly Pathways
There is disagreement about whether the aggregates formed during the lag phase
are unstable nuclei that grow by monomer addition or subfibrillar components that
grow in a multistep process. In a nucleated growth process, the nature of the fibrils
formed would depend on the concentration of stable nuclei. In a myltistep process,
monomers build intermediate aggregates which then coalesce linearly and laterally to
form D-periodic fibrils (Trelstad, 1982). Silver (1981) concluded that the lag phase
terminated when the molecular weight of the aggregate exceeded 930 K and the results
were consistent with the formation ofa linear 4D staggered trimer, further growth
occuring by linear and lateral addition of trimeric units. By using glycerol to inhibit
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fibril formation, Na etal. (1986b) demonstrated that a minimal or critical concentration
of collagen for fibril assembly is required. Further to this, collagen was shown to be
monomelic at subcritical concentrations. Electron microscopy data showed the
formation of unhanded microfibrils with diameters in the range 3-15 nm early in the lag
phase, whereas larger diameter banded fibrils coexisted with the microfibrils near the
end of the lag phase. These results suggested a cooperative nucleation growth
mechanism adopting as an intermediate the 5-stranded microfibril originally conceived
by Smith (1968). It appeared that the banded fibrils were formed through the lateral
packing of the microfibrils (Na etal., 1986b; Na etal., 1989). However the evidence
for microfibrils in intact fibrils is inconclusive (Hulmes, 1992).
1.8.1.1.7 In Vitro Fibril Formation of Collagen I from Different
Tissues
As it is known that collagen I fibrils have different ranges of diameters in various
tissues, it is of interest to carry out a comparative analysis of in vitro fibrillogenesis for
collagen I extracted from different tissues. Collagen I extracted from mammalian
corneas showed smaller rate constants for both the lag and growth phase, and formed
smaller diameter fibrils compared to scleral collagen I (Birk & Silver, 1984a).
Fibrillogenesis of corneal collagen, which is characterised by the highest content of
hydroxylysine-linked glycoside, appears to suggest that there may be some correlation
between glycosylation and kinetics of fibril formation. It was also postulated that the
increased glycosylation of corneal collagen I may be a factor controlling fibril lateral
growth and thus determine to a certain extent the precise architecture of the corneal
stroma. The study by Valli etal. (1986) is also in agreement with these proposals. To
explain the data it was suggested that the addition of sugar moities to corneal collagen
decreases the mobility of the collagen molecule and/or an intermediate in the fibril
assembly process (Valli etal., 1986).
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1.8.1.1.8 In Vitro Fibrillogenesis of Different Collagens
Very few comparisons have been made concerning the in vitro assembly of the
other fibrillar collagens (II, IE, V & XI). All four types form fibril structures with
characteristic D-periodicity, though the kinetics of assembly differ. The time course of
fibril formation was in the order HI > II > I (Birk & Silver, 1984b). The diameters for
the fibrils formed in vitro also correlated closely with those formed in vivo. These
studies were carried out on pepsinised collagen, thus partial degradation of the
telopeptides would have occured. Birk and Silver (1984b) concluded that differences in
helix-helix interactions were responsible for the differences in rate constants and that
these interactions may be involved in determining fibril structure. However pepsin
treatment of collagen does not remove the entire telopeptide, hence the molecule retains
a small component of the telopeptide which may still influence fibril assembly and
morphology (Veis & Payne, 1988).
1.8.1.2 Factors Affecting the Kinetics of Fibril Formation, and
Regulation of Fibril Diameter
1.8.1.2.1 Interactions Between Collagen Types
It is now well documented that many collagen fibrils are heterotypic and are
composed of two or more different collagen types (van der Rest & Garrone, 1991).
The study of Keene etal. (1987) demonstrated the existence of fibrils containing both
collagens I and III. Indirect evidence showed that collagen HI may be involved in the
regulation of fibril diameter, since collagen I tends to form large diameter fibrils (100-
500 nm) whereas collagen HI fibrils rarely exceed 60 nm in diameter, and fibrils
composed of both collagens have intermediate sized fibrils (Grant & Ayad, 1988;
Fleischmajer et al., 1990). Immunolocalisation studies indicate that the fibrils of
several tissues including skin and tendon are copolymers of at least collagens I and HI
(Keene et al., 1987; Birk et al., 1990a). The observation that the amino-propeptide of
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pN-collagen III is exised far more slowly than the equivalent peptide ofpN-collagen I
may suggest that the rate ofproteolytic exision of the collagen III amino-propeptide
may partially limit collagen assembly and regulate fibril diameter (Keene etal., 1987).
It has also been demonstrated that the N-propeptides of collagen III were present at the
surface of collagen I fibrils that had apparently reached full growth (Fleischmajer et
al., 1990). Studies also suggest that the presence of collagen III serves as a limiting
factor in fiber growth during foetal development and in certain pathological conditions
(Uitto etal., 1989). Further to this it was postulated that the N-propeptide may act as a
chemical link between fibrils and non collageneous components of the ECM
(Fleischmajer etal., 1990; Gaill etal., 1991).
Cartilage contains mixed fibrils, composed of collagens II, IX and XI in an 8:1:1
ratio. These collagens are found to be distributed uniformly along the fibril (Mendler
et al., 1989). Collagen IX is distributed in a regular D-periodic arrangement along
cartilage fibrils, with the chondroitin sulphate chain of collagen IX suggested to be in
intimate contact with the fibril (Vaughan et al., 1988). Collagen XI may represent the
fibril core as these molecules are buried within the fibril and immunologically masked.
In chick embiyo hyaline cartilage, fibril diameters are tightly controlled. They are thin
(17 nm) and form an apparently random network entrapping large aggregates of
proteoglycans and glycoproteins. Collagen X is also found in cartilage, but is restricted
to the hypertrophic zone and thus may play a role in the transition of cartilage to bone.
The co-assembly of different collagens during fibrillogenesis may be crucial in the
regulation of fibril architecture and the modulation of fibril surface properties. While
collagen II has an N-propeptide which is cleaved for its insertion into fibrils, collagen
XI retains an N-terminal extension composed of a short triple helix and a globular
domain. These domains are thought to contribute to the control of fibril lateral growth
and diameter (Mendler etal., 1989; van der Rest et al., 1991).
The corneal stroma is a highly organised connective tissue in which rigid control of
fibril diameter and the precise arrangement of collagen fibrils are essential for corneal
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transparency (Birk et al., 1988; Mellor et al., 1991). Corneal collagen fibrils are of
narrow uniform diameter (-25 nm) with a constant centre to centre spacing often with a
regular orthogonal arrangement. The corneal stroma is considerably enriched in
collagen V relative to other collagen I containing tissues and comprises approximately
20 % collagen V. It has been demonstrated that collagens I and V are co-assembled
within the same fibril in adult cornea, and that collagen V appears to represent the fibril
core (Birk et al., 1988; Birk et al., 1990a; van der Rest et al., 1990). One consequence
of the formation of these fibrils may be in regulating the lateral growth of fibrils,
evidence from in vitro reconstitution studies appears to support this (Birk et al.,
1990a).
Purified intact collagen V was found to form thin filaments with no apparent
periodicity, while collagen I fibrils had a broad distribution of large diameters.
Mixtures of collagens I and V produced fibrils with intermediate diameters, with the
mean fibril diameter decreasing with increasing amounts of collagen V (Birk et al.,
1990a). In the absence of the amino terminal globular domain of collagen V, the
diameter regulatory activity was substantially reduced.
There are several ways in which a quantitatively minor collagen could function to
regulate fibril diameter. Together with the persistence of the terminal globular region,
collagen V has a longer helix. These features, although they may permit co-assembly
of collagens I and V, may inhibit the further addition of molecules after a certain critical
concentration of collagen V is reached. Another possibility is that collagen V forms
many thin filaments that serve as nucleation sites for collagen I assembly. The presence
of a large number of nucleation sites for a given quantity of collagen I may result in
small fibril diameters. Although collagen V was shown to modulate fibril assembly, the
fibrils which formed were substantially wider than the 25 nm fibrils characteristic of
the corneal stroma (Birk et al., 1990a). Thus other factors such as tissue-dependent
cellular control over the synthesis and mixing of components may regulate the final
fibril morphology.
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Most of the evidence for the co-assembly of different collagens within the same
fibril has come from immunolocalisation studies. However covalent peptides
containing intermolecular cross-linked sequences from collagens I and III as well as II
and IX have been isolated and these further support the existence ofheterotypic fibrils
(Mendler etal., 1989; Fleischmajer etal., 1990). Thus while structural similarities
allow the polymerisation of different collagens within single fibrils, structural
differences among the collagens may incorporate specific steric information necessary
for initiation of fibril growth and regulation of fibril diameter.
1.8.1.2.2 Procollagen Processing
A number of studies have indicated that the order and extent ofprocollagen
processing can, at least in part, modulate collagen assembly and regulate fibril
diameter. (Hulmes etal., 1989b; Mould etal., 1990). Both pN and pC-collagen have
been shown to play a role in collagen fibrillogenesis in skin and bone (Fleischmajer et
al., 1991b). Collagen, procollagen and both processing intermediates can undergo
concentration-dependent supramolecular assembly. The nature of these assemblies are
influenced by the preservation or removal of the propeptide domains. Persistence of the
N or C-propeptide is associated with the formation of small or large diameter fibrils
respectively (Fleischmajer etal., 1988). The persistence of the N-propeptide is also
associated with the thin hieroglypic fibrils in dermatosporactic animals (Keene etal.,
1987). On the basis of in vitro studies, it has been argued that the diameter of collagen
fibrils may depend on the pathway (via pN or pC-collagen intermediates) utilised for
processing procollagen to collagen (Fleischmajer etal., 1988; Mellor etal., 1991). For
example, if the C-propeptide is removed first, subsequent treatment with N-proteinase
results in the formation of thin fibrils, whereas, if the N-propeptide is removed first
followed by treatment with C-proteinase, thick fibrils form (Fleischmajer etal., 1987).
Hence by regulating the respective activities ofboth proteinases, cells may exert precise
control over procollagen processing and thus regulate fibril morphology. The
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preference for both N and C-propeptide domains to be located at the surface of collagen
assemblies, suggests that these domains regulate fibril diameter in vivoby blocking
surface sites on the growing fibril and hence prevent the further addition ofmolecules
(Mould etal., 1990).
1.8.1.2.3 Proteoglycans and Glycosaminoglycans
As well as having a well-defined mechanical role of their own, such as the
maintenance of tissue hydration and providing resistance to deformation of cartilage, it
has been proposed that proteoglycans interact specifically with collagen fibrils and
regulate their assembly and final diameter (Veis & Payne, 1988). In general, the higher
the content ofproteoglycan (PG) the more widely dispersed are the collagen fibrils.
For example, the ordered array ofPG along the collagen fibril has been suggested to
stabilise the regular three dimensional arrangement within the cornea (Scott & Haigh,
1985a), whereas, in bone, the distribution of PG is different and may be imporant in
calcification (Scott & Haigh, 1985b). It was postulated that the repulsion ofnegative
charges on the glycosaminoglycan (GAG) chains orientates the protein core
perpendicular to the longitudinal axis of the fibril, creating a negatively charged field
around the fibre, and thus holds the fibres in defined orientations (Scott, 1991).
Biochemical and electron histochemical studies have shown that collagen fibrils are
associated with keratan sulphate (KS), chondroitin sulphate (CS) and dermatan
sulphate (DS) proteoglycans. Specific binding sites have also been localised along the
fibril (Vaughan etal., 1988; Scott, 1991). It was concluded that DSPG's are
specifically associated with the fibril surface at the gap region and the other PGs are
limited to the interfibrillar space.
The effect of PG and GAG components on fibril formation has been assessed
during in vitro collagen reconstitution experiments. Due to differences in the nature of
the collagen preparations used and the difficulty in fractionating and assessing the
GAG and PG components, much of the early data has been difficult to interpret and is
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often contradictory. Nevertheless it has been shown that the type ofPG or GAG is
important, and that each GAG exerts a different effect on the kinetics and extent of
collagen turbidity increase (Obrink, 1973a, 1973b; Lilja & Barrach, 1983; Vogel etal.,
1984). Obrink (1973a) found that chonroitin sulphate, dermatan sulphate, heparan
sulphate, heparin and proteoglycans of chondroitin sulphate and dermatan sulphate
accelerated the fibril assembly process when they were added before the initiation of
fibrillogenesis. When added later in the lag phase, the proteoglycans markedly delayed
fibril formation, while the GAGs (CS and HS) also inhibited fibril assembly but to a
smaller extent. This last observation was ascribed to an inhibition of fibril growth from
pre-formed nuclei. In a similar study, Oegema etal. (1975) correlated the binding of
PG to collagen with its effects, as well as the point ofaddition of PG during fibril
formation. It was found that when PGS (cartilage proteoglycan subunit) was added to
collagen I early during the lag phase, fibril formation was markedly delayed, but
addition of the same amount ofPGS near the end of the lag phase did not further retard
self-assembly. However the final turbidity of the collagen gel, related to fibril diameter,
was consistently increased in the presence ofPGS, independent of the time of addition.
If the PGS was present in the solution before fibrillogenesis was initiated, binding of
PGS to collagen I occured at a maximum of 1 proteoglycan molecule to 25-30 collagen
molecules. Taken together, these results suggest that the effect ofPGS on collagen
fibril assembly in vitro is related to a limited number ofbinding sites on early collagen
filaments, as they are being organised into mature fibrils. Snowden and Swann (1984)
found that the glycosaminoglycans (dermatan sulphate and hyaluronate) accelerate the
process of fibril assembly, whereas chondroitin sulphate had little effect on the kinetics
of self-assembly. Snowden and Swann (1984) also found that DSPG delayed fibril
formation, and slightly decreased the thermal stability of collagen fibrils formed in the
presence of this proteoglycan. The GAG alone had no significant effect on the thermal
stability. Vogel and Trotter (1987) showed that the small DSPG from bovine tendon
binds both collagens I and II, greatly prolongs the lag phase and results in collagen
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fibrils that are significantly thinner in width. This interaction depends on the core
protein, since the GAG chains alone have no effect on the assembly, whereas the intact
core protein had an identical effect to the small proteoglycan. Large cartilage
proteoglycan had no effect on collagen assembly. The small proteoglycan decorin (PG-
II), which is widely distributed in a variety of connective tissues (Jarvelainen etal.,
1991), binds to the surface of collagen fibrils and may regulate fibril diameter. In a
recent study it was reported that DSPGs from eroded osteoarthritic cartilage produced a
longer lag phase for type II collagen selfassembly than DSPGs isolated from normal
cartilage (Karvonen etal., 1992). On the basis of these in vitro studies, it was
suggested that changes in the proteoglycans ofosteoarthritic cartilage may influence
collagen fibrillogenesis in vivo. Defective proteoglycans may lead to abnormal collagen
fibril formation and result in a weakened cartilage architecture, thus contributing to an
accelerated process of cartilage degeneration (Karvonen etal., 1992). Link protein, a
glycoprotein involved in the assembly ofPG aggregates, also modulates the kinetics of
assembly and modifies the resultant fibres (Chandrasekhar etal., 1984; Smith etal.,
1987). Neither link protein or the small DSPG alone had an effect on the selfassembly
kinetics or the size of the fibrils, but in combination there was a decrease in the rate of
fibril formation and the production ofwider fibrils.
1.8.1.2.4 Sulphated Proteins
Fibromodulin, a 59 K collagen binding protein and a ubiquitous component of the
ECM, appears to have a role in the regulation of collagen fibril assembly (Hedbom &
Heinegard, 1989; Antonsson etal., 1991). The amino acid sequence deduced from its
cDNA predicts a 42 K protein, consisting largely of homologous 23 amino acid repeats
with predominantly leucines in conserved positions. Similar repeats have been
identified in the small interstitial proteoglycans decorin and PGS1. In decorin the
repeats could be responsible for the binding to collagen or to the cell surface. The
leucine repeat in fibromodulin also suggests a role in collagen binding (Oldberg etal.,
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1989). Tyrosine sulphate residues were identified in fibromodulin, these sulphated
residues being located at the N-terminus (Antonsson etal., 1991). Fibromodulin from
tendon, cartilage and sclera contains N-glycosidically-linked oligosaccharides, some of
which are extended to keratan sulphate chains. Thus the discrepancy between the
molecular weight of 59 K previously determined by SDS-PAGE and the predicted
molecular mass of42 K is probably due to anomalies in the electrophoretic behavior of
the protein as a result of carbohydrate substitution. Both fibromodulin and decorin bind
to collagens I and II and inhibit collagen fibrillogenesis in vitro, and the fibrils which
form in the presence of decorin are thinner. The fibromodulin binding site on the
collagen molecule has not been localised but appears to be different to the decorin
binding site, since both molecules have an additive effect on collagen fibrillogenesis
(Oldberg etal., 1989).
Fibronectin, a sulphated protein, also modulates the kinetics of collagen self
assembly but the effect is minimal. This has been attributed to a passive dilution of the
collagen-collagen interactions, the equilibrium constant for fibronectin binding is low
compared with the selfassociation constant for collagen molecules (Speranza etal.,
1987).
1.8.1.3 Fibrillogenesis in Vivo
Molecular interactions driven by physicochemical forces are important during the
in vitro polymerisation of collagen I molecules into fibrils. However it has not yet been
possible to assemble in vitro a functional group of fibril bundles (fibres) organised into
tissue specific macro aggregates such as regular layers in bone and cornea, irregular
layers in skin, and cables in tendons and ligaments (Ploetz etal., 1991). It remains to
be firmly established whether collagen fibrils form at the cell surface or deeper into the
ECM. It has been suggested that OD or segment-long-spacing (SLS) packets of
collagen molecules may form D-periodic fibrils by stacking of the SLS assemblies in
ID shifts (Hulmes etal., 1983). Radiographic studies on the fibroblasts of the rat foot
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pad revealed that after approximately 50 minutes of labelling, label appeared "over"
collagen fibrils, indicating that collagen was being added to existing fibrils rather than
forming new ones (Marchi & Leblond, 1983). More recent studies employing three
dimensional reconstructions from electron micrographs of tissue serial sections
suggests that there is a discontinuous assembly of fibrils from smaller fibril segments
(Birk etal., 1990b; Ploetz etal., 1991). These fibril segments ofaround 10 pm in
length are assembled via linear and lateral fusions to form a functionally continuous
fibril. It has also been postulated that the fusion process is regulated by a surface coat
ofDSPG. Such discontinuous assembly may also allow for angular rearrangement,
intercalatory growth and even repair (Birk etal., 1990b). Collagen fibril formation in
situ appears to to take place in specific cell-defined compartments. During
morphogenesis in both cornea and tendon, the fibroblast partitions the extracellular
space into compartments of increasing size containing collagen fibrils, fibril bundles
and major aggregates. This compartmentalisation allows for cellular control over post-
depositional events which may be important in determining the spatial orientation of
regional matrices (Ploetz etal., 1991).
Although it is concievable that the process of fibril assembly is regulated by the
amount ofavailable procollagen, a combination of factors may be involved in
regulating fibril structure. It was already observed that there was an 8 nm increment in
the diameter distribution in a variety of connective tissues (Parry& Craig, 1979). A
model which accounted very plausibly for the 8 nm increments was proposed by
Hulmes (1983) and depended on the presence of quasi-hexagonal packing of the
molecules. Hulmes suggested that a surface layer ofpN-collagen molecules may
sterically restrict any further increase in fibril diameter, temporary activation ofN-
proteinase may then remove the propeptides and allow fibril growth by accretion of
further pN-collagen molecules. Either these pN-molecules are freshly secreted into the
extracellular compartment or N-proteinase preferrentially acts on an aggregated
substrate, in which case pN-collagen monomers in the interfibrillar space may not be
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significantly processed during the short burst of enzymic activity. Following a further
burst ofN-proteinase activity, growth continues as a further layer ofpN-molecules are
laid down in axial register on a quasi-hexagonal lattice with every 4 nm (the breadth of
the unit cell) increase in radius, this process continues until a limiting diameter is
reached. This model is supported by the observation that the N-propeptides tend to be
associated with thin diameter Fibrils and hence are thought to be involved in limiting
lateral growth (Chapman, 1989). However as pointed out by Chapman (1989) the
diameters quoted by Parry & Craig referred to dehydrated tissue, hence the fibril
increment in living tissue will be proportionally larger. X-ray diffraction data obtained
from hydrated specimens indicate that fibril diameters are multiples ofaround 11 nm.
Therefore an acceptable model has to account for 5-6 nm increments in radius,
although no spacing with such high values occur in the quasi-hexagonal lattice.
Chapman (1989) suggested that a growth inhibitor, possibly a proteoglycan, forms a
complete circumferential layer around the fibril surface. Cell mediated removal of the
inhibitor then allows growth to proceed to a second limiting layer and so on to
subsequent limiting layers. Although the mechanism depends on axial order it does not
require any specific latteral packing of the molecules.
1.9 The Extracellular Matrix of Skin
Collagen is the major component of skin and represents over 70 % of the tissue
dry weight. Six different collagens (I, III, IV, V, VI & VII) have been detected in
human skin, and these and several other collagens have been shown to be synthesised
by cultured human skin fibroblasts in vitro (Uitto etal., 1989). Collagens I and III
represent the major interstitial fibril-forming collagens, and, although collagens IV, V,
VI and VII are quantitatively minor collagens in skin, they may represent major
components in specific regions within the tissue, and they probably have major roles in
maintaining tissue structure and integrity. Collagens form a structural framework
underlying the epidermis, with which other connective tissue macromolecules interact
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(e.g. elastin, fibrillin, proteoglycans, laminin, nidogen (entactin), fibronectin). Such
interactions are necessary for the provision of tissue strength and flexibility (Uitto et
al., 1989).
In adult human skin, the ratio of collagen I: III is approximately 6 : 1. In
contrast, foetal skin has a higher proportion of collagen III and accounts for over half
of the total collagen, suggesting that collagen biosynthesis is developmentally regulated
(Grant & Ayad, 1988). Collagen IV is a major component ofbasement membranes in
the dermal/epidermal junction, and differs from collagens I and III by virtue of several
non-collageneous segments which interrupt the central triple helix (Fig. 1.1). This
feature provides the molecule with enhanced flexibility and permits the assembly of a
meshwork-like structure to which other components may interact (Fox etal., 1991).
The function of collagen V is poorly understood, although it has been reported that the
continued synthesis of this quantitatively minor collagen is a prerequisite for the
migration of epidermal cells (Stenn etal., 1979). The beaded filamentous structure
characteristic of collagen VI (Fig. 1.1) is highly disulphide bonded, and the presence of
large numbers ofRGD squences within the collagen helix suggests that collagen VI
plays a key role in cell-matrix interactions (Ruoslahti, 199 la; van der Rest & Garrone,
1991). Collagen VII is a predominant component ofanchoring fibrils (Fig. 1.1),
structures that extend from the dermal/epidermal junction to the underlying dermis.
These fibrils often entrap interstitial collagen fibrils and appear to anchor the basement
membrane to the dermis (Uitto etal., 1989; Burgeson etal., 1990).
1.10 Introduction to the Present Study
The number of recognised ECM components has increased rapidly in recent
years (Hay, 1991). However, as pointed out by Neame etal. (1989), there are many
small molecular weight components of less than 50 K that have not been characterised
in detail. In many preparations of lysyl oxidase (Sullivan & Kagan, 1982; Kuivaniemi
etal., 1984; Burbelo etal., 1986; Shackleton & Hulmes 1990a), the enzyme (30-34 K)
76
is contaminated with one or more low molecular mass proteins (22-24 K). These
contaminants have been suggested as being either degradation products of lysyl oxidase
(Sullivan & Kagan, 1982; Kuivaniemi etal., 1984; Burbelo etal., 1986) or unrelated
proteins (Kuivaniemi etal., 1984). When lysyl oxidase (34 K) from porcine skin was
purified by selective interaction with Sephacryl S-200, a 24 K protein was found to co-
purify (Shackleton & Hulmes 1990a). The main aims of this study were to characterise
both lysyl oxidase and the 24 K protein (Chapter 3), and to examine the effects of these
proteins on collagen fibril formation (Chapter 4).
It is shown that the 24 K protein has no enzymic activity on an elastin substrate,
however like lysyl oxidase, several variants of 24 K protein can be separated by Mono
Q FPLC. The protein is particularly acidic (pi 4-4.5) and relatively rich in tyrosine, so
the name TRAMP (Tyrosine Rich Acidic Matrix Protein; Cronshaw etal., 1993) is used
to identify it. No amino acid sequence homology was found between TRAMP and the
rat lysyl oxidase sequence recently deduced from cDNA (Trackman etal., 1990;
Trackman etal., 1991), but TRAMP appears to be the same as a 22 K extracellular
matrix protein from bovine skin which co-purifies with dermatan sulphate
proteoglycans (Neame etal., 1989). By amino acid sequence analysis, both TRAMP
and the 22 K protein were found to be identical in all but 4 residues (Cronshaw etal.,
1993). TRAMP appears to contain sulphated tyrosine residues, and seems to promote
cell attachment (Lewandowska etal., 1991). The present study demonstrates that
TRAMP binds to collagen I and modulates the process of fibril assembly (Chapter 4).
Altough lysyl oxidase does not appear to be glycosylated (Sullivan & Kagan,
1982), an N-glycosylation site was found in the sequence encoding the 32 K protein
(Trackman etal., 1990; Trackman etal., 1991; Kagan & Trackman, 1991). By SDS-
PAGE porcine lysyl oxidase often appears as a 34-36 K doublet. Preliminary data
indicates that there may be two structural forms of the enzyme, with N-linked





2.1 Purification of Skin Collagen
2.1.1 Reagents
Male Sprague-Dawley rats were supplied by Banton & Kingman, Universal
Ltd, Field Station, Grimston, Hull. PMSF, NEM and BAPN (fumarate salt) were
obtained from Sigma (Poole, Dorset). EDTA was supplied by BDH/Merck Ltd (Poole,
Dorset). DEAE-Sephacel was obtained from Pharmacia/LKB (Milton Keynes, Bucks).
All other reagents (analytical grade), unless stated otherwise, were supplied by BDH.
2.1.2 Purification Procedure
The method used was a modification of that ofPayne etal. (1986). Semi-sterile
conditions were used throughout, i.e. dissection instruments were autoclaved prior to
use, and phosphate buffers were filtered through aMillipore 0.22 pm disc filter. All
procedures were carried out at 4 °C to minimise bacterial growth, enhance collagen
solubility and ensure retention of the native collagen conformation.
Twelve 21-day-old male Sprague-Dawley rats were fed a diet of rat chow and
water. The water contained 0.17% (wAO BAPN, which renders the animals lathyritic
through the inhibition of collagen cross-linking, thus increasing the extractability of
native monomelic collagen. The activity of the lathyrogen with respect to cross-linking
may be ascribed to an irreversible inhibition of lysyl oxidase (Siegel etal., 1970).
Following a three week exposure to BAPN, the rats were sacrificed and their skins
removed, dehaired, and pieces ofadhering muscle and fat removed. The skins were
diced, then homogenised in aWaring blender for three times ten seconds at high speed.
The skins were then extracted for 1 hour under cold neutral salt conditions (3 ml/g
tissue) using a buffer whose composition was 0.15 M NaCl, 5.4 mM Na2HP04, 1.1
mM KH2P04, pH 7.4, containing enzyme inhibitors, 25 mM EDTA, 1 mM PMSF, 10
mM NEM and 1 pg/ml pepstatin to inhibit each of the four recognised classes of
proteinases (Barrett, 1980). (In general fresh proteinase inhibitors were added
throughout the purification from concentrated stock solutions.) The buffer also
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contained 50 pg/ml BAPN and 0.01 % NaN3. Neutral salt solutions preferentially
extract collagen molecules that are not bound within the fibres through covalent
intermolecular cross-links.
Following centrifugation at 10,000 g in a Beckman J2-20 centrifuge for 30
minutes, the supernatant was collected and filtered through several layers of cheesecloth
to remove fatty material, and diluted if necessary before the first salt precipitation. Salt
precipitation was induced by the slow addition ofNaCl to the solution to give a final
salt concentration of 2 M (to precipitate collagen III). The solution was left to stand for
1 hour after which it was centrifuged (as above) and then NaCl was added to the
supernatant to give a final salt concentration of 3.5 M. The solution was again left to
stand for 1 hour, after which the resulting suspension was centrifuged. The white
precipitate was collected and gently homogenised in a small volume ofphosphate buffer
(62 mM Na2HP04, 14.5 mM KH2P04, pH 7.4). The homogenate was then allowed
to redissolve in a larger volume of the same buffer. After centrifugation at 100,000 g in
a Beckman L60 centrifuge for 4 hours to remove the insoluble material, a second salt
precipitation was carried out at 3.5 M NaCl and the precipitate redissolved in 0.2 M
NaCl, 0.05 M Tris-HCl, pH 7.5 (DEAE start buffer). The solution was dialysed
against two changes of this buffer, and then clarified by centrifugation at 10,000 g for
30 minutes prior to chromatography on DEAE-Sephacel.
A column ofDEAE-Sephacel (2.6 x 10 cm) was prepared and packed at a flow
rate of 50 ml/hour and equilibrated with DEAE start buffer. The partially purified
collagen solution was then applied to the column at a flow rate of 20 ml/hour. After
application of the sample, elution with start buffer was continued until no further UV-
absorbing material was eluted from the column, as monitored by a two channel 276 nm
UV detector (uvicord) and chart recorder. Under these conditions, the relatively basic
collagen molecules are not retained by DEAE-Sephacel. Acidic contaminants were
retained, which were subsequently eluted with 2 M NaCl, 0.05 M Tris-HCl, pH 7.5
(Miller, 1971). The column was then stored in this buffer which contained 0.002 %
hibitane as preservative.
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The collagen solution was then dialysed exhaustively against 0.02 M Na2HP04;
the white precipitate that formed during dialysis was collected by centrifugation at
10,000 g (as above) and then redissolved in 0.5 M acetic acid. This acid solution was
then dialysed against the same solvent. After dialysis, the appropriate volume of
prechilled 20 % (w/v) NaCl solution was slowly added to the stirred acid solution to
give a final salt concentration of 3.5 % (wAO- The solution was left to stand for 15
minutes. Salt precipitation from an acid solution of collagen was included to
preferentially remove large aggregates of collagen, ifpresent (Chandrakasan etal.,
1976). The precipitated solution was centrifuged and the supernatant dialysed against
0.5 M acetic acid, followed by dialysis against several changes of 5 mM acetic acid.
Finally the solution was centrifuged at 100,000 g for 4 hours to produce a clear
solution of collagen for immediate use or storage at -70 °C (for up to 3 months) and re-
centrifugation (100,000 g, 4 h) immediately before use. By hydroxyproline analysis
(section 2.3.3), the yield of type I collagen from the skins of twelve rats was typically
60-90 mg.
Amino acid analysis, SDS-PAGE and electron microscopy of reconstituted
fibrils, were used to determine the quality and suitability of the preparation for fibril
formation studies.
2.2 Purification of TRAMP and Lysyl Oxidase
2.2.1 Reagents
Stillborn piglets were obtained from the Animal Breeding Research
Organisation, Dryden-Mountmarle Field Laboratory, Roslin, Midlothian.
Chromatography media (DEAE-Sephacel, CM-Sepharose CL-6B, Sephacryl S-200 and
Sephadex G25 medium grade) were from Pharmacia/LKB. AG 501-X8 mixed bed
resin was obtained fom BioRad. All other chemicals (analytical grade) unless stated
otherwise were from BDH.
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2.2.2 Purification Procedure
Prior to the finding that the bulk of tissue lysyl oxidase was rendered soluble by
extraction buffers containing 4 to 6 M urea (Narayanan et al., 1974), purification of
lysyl oxidase had been a difficult task often yielding preparations that were significantly
contaminated by other proteins (Kagan, 1986). Urea-extractable enzyme has since been
highly purified from bovine aorta and lung (Kagan et al., 1979; Cronlund & Kagan,
1986), human placenta (Kuivaniemi et al., 1984), and rat lung (Almassian et al.,
1990). In human tissues, Kuivaniemi (1985) demonstrated the richest source of lysyl
oxidase was skin. The enzyme is stable in urea-containing buffers, while
chromatographic recoveries of the enzyme are also improved (Narayanan et al., 1974).
The enzyme is, however, inactive in urea, though activity is restored after dialysis into
physiological buffers.
The method initially used was a modification of a new procedure for the
purification of lysyl oxidase, employing ion-exchange chromatography and selective
interaction with Sephacryl S-200 (Shackleton & Hulmes, 1990a). The extraction and
purification steps were carried out under semi-sterile conditions, between 0 and 4 °C. In
a typical purification, the skins from 10 stillborn piglets were removed within 24 hours
of death. The skins were then either immediately utilised or stored at -30 °C for up to 1
week until required. Diced skin (approximately 900 g wet wt.) was fed through a pre-
chilled fine mincer before homogenisation in PBS (0.1 M sodium phosphate, 0.15 M
NaCl, 1 mM PMSF, pH 7.5) at 3 ml/g, in a Waring blender for 3x10 seconds at high
speed. After centrifugation at 10,000 g for 20 minutes, the supernatant was discarded.
The extraction was repeated once and the pellet was washed three times in PB (20 mM
sodium phosphate, 1 mM PMSF, pH 7.5) at 3 ml/g with centrifugation as above. The
pellet was then extracted overnight with 6 M PBU (PB containing 6 M urea, pH 7.5) at
1 ml/g of original material, and this step repeated once. After centrifugation, the extracts
were pooled and passed through several layers of cheesecloth, followed by a second
filtration through Whatman no. 1 filter paper before the first chromatographic step. (To
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remove cyanate, all urea-containing buffers were prepared from fresh stock solutions of
8 M urea that were de-ionised by passage through a column containing AG 501-X8
mixed bed resin. The buffers were then kept at 4 °C to prevent reformation of cyanate.)
The extract was loaded onto a 2.6 x 40 cm column ofCM-Sepharose CL-6B,
previously equilibrated with 6 M PBU, at a flow rate of 50 ml/hour. The flow through
solution was then immediately applied to a 2.6 x 40 cm column of DEAE-Sephacel,
previously equilibrated in 6 M PBU, at a flow rate of 50 ml/hour. The DEAE-Sephacel
column was then washed with 6 M PBU to elute unbound proteins, until a steady
reading at 280 nm was obtained. Bound proteins were eluted at 40 ml/hour with 6 M
PBU containing 0.5 M NaCl, and collected as 10 ml fractions. (Lysyl oxidase is not
eluted from DEAE using neutral-salt buffers in the absence of urea. While enzyme
binding to DEAE doubtlessly involves ionic interactions with the cationic matrix, the
requirement for urea implies that other nonionic, possibly hydrophobic bonds are also
involved.) Protein bound fractions were pooled and dialysed exhaustively against 10
mM PB, pH 7.5.
The urea-free protein from the DEAE-Sephacel column was clarified by
centrifugation at 10,000 g for 30 minutes, and then loaded on a 2.6 x 60 cm column of
Sephacryl S-200, previously equilibrated with 10 mM PB, at a flow rate of 80 ml/hour.
The column was extensively washed with 10 mM PB, before elution at 20 ml/hour with
6 M PBU. The Shackleton and Hulmes (1990a) protocol did not produce mainly lysyl
oxidase but instead produced both TRAMP and lysyl oxidase, with TRAMP being the
major component, and it could be partially separated from lysyl oxidase by Mono Q
FPLC (see results section 3.1.1 for improvments to the purification protocol). The
purified proteins were then used immediately or stored at -30 °C. The ultrafiltration
assay (section 2.4.3) for lysyl oxidase activity and SDS-PAGE analysis (section 2.3.4)
was carried out on the preparation to assess its suitability for further experiments.
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2.3 Characterisation of Collagen
2.3.1 Amino Acid Analysis
The purity of collagen preparations were determined by comparing the amino
acid composition with the known composition of type I collagen. Glycine is the most
abundant amino acid in collagen (approximately 330 residues/1000). Therefore the
glycine content of a collagen preparation provides a reliable figure for assessing sample
purity.
For fibril formation studies, it is important that both the N and C-terminal
telopeptides remain intact following purification, since it has been shown in vitro that
these extrahelical extensions are necessary for orderly growth and packing ofnative,
uniform-diameter, polarised D-stagger fibrils (Veis & Payne, 1988). The telopeptides
of collagen I contain all 11 tyrosine residues found in the collagen molecule. Therefore
the presence of the telopeptides can be indicated by measuring the tyrosine content.
2.3.1.1 Procedure
Collagen was hydrolysed in 6 N hydrochloric acid at 110 °C for 24 h, in sealed
evacuated tubes. After hydrolysis, acid was removed in a vacuum desicator containing
NaOH pellets, then the samples were re-dissolved in 0.025 % K3EDTA prior to
analysis. Amino acid analysis was carried out (byMr A D Cronshaw) on an Applied
Biosystems 420A Derivatiser with an on-line model 120A phenylthiocarbamyl (PTC)
analyser. The PTC-amino acids were separated at 38 °C on an Applied Biosystems PTC
C-18 column (5 pm particle size; 2.1 x 220 mm) at a flow rate of 0.3 ml/min. The
column was previously equilibrated with 50 mm sodium acetate (pH 5.4), and elution
was achieved by a gradient to 70 % (v/v) acetonitrile in 32 mM sodium acetate (pH 6.1)
over 20 min. The eluate was monitored by absorbance at 254 nm.
2.3.2 Cyanogen Bromide Chemical Cleavage
Hydrolysis of the polypeptide backbone is a prerequisite for any peptide
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mapping strategy and will determine the type and amount of information that can be
obtained from the map. For example limited proteolysis of a protein using a protease of
broad specificity may provide valuable information on the accessibility of a small
number of the total possible sites for cleavage, and hence on the conformation of the
protein. Sites may be more accessible because they are in an exposed stretch of
polypeptide linking two structured regions or domains. Hydrolysis methods for peptide
maps must produce peptides ranging in size from a few residues to larger structured
fragments of several hundred residues.
2.3.2.1 Procedure
Pure fresh cyanogen bromide (CNBr) was used to cleave collagen specifically
on the C-terminal side ofmethionine residues (Gross & Witkop, 1962). In order for
collagen to undergo complete digestion with CNBr, it was necessary to first reduce any
methionine sulphoxide present to methionine (Hill & Harper, 1984). Unless this was
done, a large percentage ofmaterial was incompletely cleaved, particularly in the case
of collagen III, so that inconsistant peptide maps were obtained. The collagen was
reduced by the method ofAdelstein and Kuehl (1970). Lyophilised collagen (1 mg)
was reduced using a 15-fold molar excess of 2-mercaptoethanol in 8 M urea, 0.1 M
NH4HC03, pH 8.0. The thiol was then removed by dialysis against 0.1 M acetic acid
(the low pH also minimises reoxidation of the protein; Jaenicke & Rudolph, (1989))
and the collagen freeze dried. The reduced collagen (0.5 mg) was then dissolved in 100
pi of 70 % (v/v) aqueous formic acid. After transfering the sample to a fume cupboard,
a 50-fold molar excess over methionine residues ofCNBr in 20 pi of 70 % formic acid
was added with gentle shaking. The mixture was bubbled through with oxygen-free
nitrogen (to prevent reoxidation) and sealed tightly in a 10 ml polythene centrifuge tube.
The sample was protected from light and gently agitated for 24 h at room temperature.
Following the digestion period, a 15-fold excess ofwater was added to slow down the
reaction and improve subsequent peptide recovery. The material was then dried in a
Savant Speed Vac vacuum centrifuge, which was connected to a chemical trap
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containing 2 M NaOH to remove any HCN present. For complete removal of the acid,
a further addition ofwater followed by lyophilisation was necessary. The dried samples
were stored at -20 °C until required for SDS-PAGE.
2.3.3 Hydroxyproline Assay
4-Hydroxyproline and 3-hydroxyproline are found almost exclusively in
collagens and a few other proteins with collagen-like amino acid sequences (Adams &
Frank, 1980). So the presence ofhydroxyproline provides a characteristic biochemical
marker. The measurement of hydroxyproline has been used to determine not only the
quantity of collagen in a given tissue, but also the rate at which the collagen is
synthesised or degraded in such tissues.
The colorimetric assay for hydroxyproline was a modification of that of
Woessner (1961). The reaction is based on the oxidation ofhydroxyproline to pyrrole
which is then allowed to react with p-dimethyl-aminobenzaldehyde to form a complex
that is detected and quantified as a chromaphore having an absorbance at 557 nm. The
reagents are as follows:
Buffer.
50 g of citric acid monohydrate, 12 ml ofglacial acetic acid, 120 g sodium acetate
trihydrate, and 34 g sodium hydroxide are made to a final volume of 1 1 in distilled
water, and adjusted to pH 6.0.
Chloramine T.
A 0.05 M solution was prepared on the day of use by dissolving 1.41 g of chloramine
T in 20 ml water. 30 ml of 2-methoxy ethanol and 50 ml buffer were then added. The
solution was kept in a stoppered flask.
Ehrlich's Reagent.
A 20 % solution was prepared shortly before use by adding 2-methoxyethanol to 20 g
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ofp-dimethyl-aminobenzaldehyde to give a final volume of 100 ml. The solution was
warmed to facilitate solubilisation.
2.3.3.1 Procedure
Freeze-dried collagen samples were hydrolysed in 6 M hydrochloric acid in 10
ml pyrex tubes, sealed with teflon-lined screw caps, for 16 h at 116 °C. After
hydrolysis, the hydrochloric acid was removed by evaporation to dryness in a Savant
Speed Vac vacuum centrifuge. Each sample was then dissolved in 2 ml distilled water.
A series of dilutions were usually necessary to obtain a sample containing 1-5 pg of
hydroxyproline in 2 ml. Hydroxyproline standards containing 0-5 pg each in 2 ml were
prepared from a stock solution containing 5 mg^ml.
To each sample in order, 1 ml of chloramine T was added to initiate
hydroxyproline oxidation. The tube contents were then vortexed and allowed to stand
for 20 minutes. The chloramine T was then destroyed by adding 1 ml of a 3.15 M
solution ofperchloric acid to each tube in the same order as before. The contents were
mixed and allowed to stand for 5 minutes. Finally, 1 ml ofEhrlich's reagent was
added. After vortexing, the tubes were placed in a water bath at 60 °C for 20 minutes,
and then cooled with tap water. The developed colour is stable for at least 1 hour. The
absorbance of the solution was determined using an LKB Ultrospec spectrophotometer
(lcm light path). The hydroxyproline values for collagen samples were then determined
directly from a standard curve (Fig. 2.1). A value of 10 was used as the constant of
proportionality to relate hydroxyproline concentration to collagen concentration
(Bornstein & Sage, 1980).
2.3.4 SDS-PAGE
In gel electrophoresis, separation ofmolecules results from both differences in
charge and in size. However only the molecular size is relevant when protein samples
containing 2 % SDS and 3 % (3-mercaptoethanol are denatured by heating at 100 °C for
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Figure 2.1 Hydroxyproline standard curve
Colour response curve showing the absorbance at 557 nm generated from
hydroxyproline standards (0-6 pg) when treated in the assay ofWoessner (1961). Error
bars are standard deviations (n=5).
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unfolds the native protein, binds to it, and confers a charge proportional to the length of
the polypeptide chain. The charge density and the electrophoretic mobility are nearly
constant for most proteins, the exception being glycoproteins. Separation due to size
depends on the pore size of the gel matrix. The pore size of polyacrylamide gels
decreases as the concentration ofgel monomer increases. However it is also affected by
the extent of cross linking. For a separation range from approximately 200 K to 60 K
or 100 K to 15 K, 6 % acrylamide/0.16 % bis-acrylamide or 12 % acrylamide/0.32 %
bis-acrylamide in the separating gels were chosen respectively (see Appendix I). When
the size range of the sample components was too wide to be sieved by a gel of a single
pore size, a gradient separating gel was used.
2.3.4.1 Procedure
The most widely used discontinuous system for electrophoresis ofproteins is
that described by Laemmli (1970) and was the system used throughout this study. Gels
(16 x 14 x 0.15 cm) were cast between 2 glass plates. Gradient gels were cast with the
aid of a gradient mixer and peristaltic pump at a flow of 200 ml/h. The solutions were
precooled to slow down polymerisation during casting. Prior to electrophoresis, protein
sample solutions had one-quarter the volume of 5 x sample buffer added, producing a
final buffer composition of: 25 mM Tris-HCl, 10 % (v/v) glycerol, 2 % (w/v) SDS,
0.01 % (w/v) bromophenol blue, pH 6.8. When protein samples were run under
reducing conditions, 3 % (v/v) (3-mercaptoethanol was also present. Samples were
boiled for three minutes before being applied to the stacking gel. Gels were run on a
vertical LKB electrophoresis unit at a constant current of40 mA per gel (this
corresponded to a maximum power of 25 W in each gel). The unit was equipped with
water cooling, and the lower buffer chamber was stirred continuously. The duration of
the run using bromophenol blue as a tracking dye was generally 3-4 h. When high
resolution was not required, for example the screening of a purification procedure, mini
gels (7.5 x 8.5 cm) were run on an LKB midget electrophoresis unit with water
cooling. Up to 5 (0.75 mm) gels could be set up using the LKB multicast unit, and
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because the gels were thinner and smaller the run time was much shorter, as were
staining and destaining times. Gels were fixed and stained using several methods which
are described in section 2.4.8. Photographs ofall gels were taken on polaroid 665 film
(positive and negative). When necessary gels were scanned in the wet state as described
in section 2.3.5.
A plot of log molecular weight for calibration proteins (Pharmacia) as a function
ofelectrophoretic mobility was used as a standard curve for the determination of sample
protein molecular mass.
2.3.4.2 Transfer of Proteins from Gel to Membrane
The binding of electrophoretically separated proteins from polyacrylamide gel to
a surface matrix (usually nitrocellulose) permits detection of specific proteins by
antibodies. In addition methods have been described for the localisation of
glycoproteins on nitrocellulose membrane using lectins as probes (O'Shannessy etal.,
1987; Haselbeck etal., 1990).
The most widely used technique for transferring proteins onto a membrane
support employs electrophoretic elution, sometimes referred to as electro-blotting. This
procedure provides a rapid and more complete transfer ofprotein compared to the
simple blotting methods originally described (Andrews, 1986). It is necessary however
to select a pH such that all species will be charged and will migrate towards the same
electrode. Methanol should also be present in the blotting buffer as it is necessary for
efficient binding of the protein to the nitrocellulose. Once transferred, the proteins
appear to be held non covalently to the membrane probably through hydrophobic
contacts (Andrews, 1986).
Immediately following SDS-PAGE, separated proteins were electro-blotted onto
a nitrocellulose sheet (pore size 0.45 pm; Schleicher & Schuell). Electrophoretic elution
was achieved by complete immersion of a gel-membrane sandwich into precooled
blotting buffer (20 mM sodium phosphate, 20 % (v/v) methanol, pH 9.4). The gel-
membrane sandwich was assembled as follows:
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A nitrocellulose sheet (14x9 cm) was soaked in blotting buffer and applied
directly to the gel (It is important that no air bubbles are trapped between the membrane
and the gel, as these greatly reduce transfer efficiency. Also the position of the
membrane should not be altered once it is in place, as substantial amounts ofprotein
may have already transferred.) This in turn is supported by two sheets ofwet Whatman
3 mm filter paper, one on each side of the gel-membrane. A porous pad (Scotch Brite)
presoaked in blotting buffer was then placed on each side of the sandwich, next to the
filter paper. Finally the assembly was mounted on a stiffplastic grid (which holds the
gel and membrane in close contact) and placed into a transblot cell (Biorad) filled with
blotting buffer, ensuring that the nitrocellulose is nearest to the positive anode.
The proteins are transferred from a negative to a positive direction by applying a
constant current of 250 mA over 18 hours. To monitor the efficiency of transfer, the
blotted gel was stained with Coomassie Blue (section 2.4.8.1) and the blot stained for 1
minute with 0.4 % (w/v) Ponceau S (Sigma) in 3 % (w/v) TCA. Ponceau S binds
rapidly to protein and because staining is reversible it is compatable with most antigen
visualisation techniques. Destaining of the protein bands is achieved by washing the
blot in tris buffered saline (TBS; 50 mM Tris-HCl, 0.15 M NaCl, pH 7.5).
2.3.5 Densitometry
To quantify the results ofSDS-PAGE separations, stained gels were scanned
using a Joyce-Loebl Chromoscan 3 coupled to a DCS microcomputer for digital
analysis. The Chromoscan was operated in the absorbance mode with an aperture of
0.3 x 5 mm. The light source was a 100 W tungsten halogen lamp, and scans were
carried out with a red (626 nm) filter for blue stained gels and a green (530 nm) filter
for PAS stained gels. Before calculating the integrated peak areas, a background
subtraction was made.
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2.4 Characterisation of TRAMP and Lysyl Oxidase
2.4.1 Bicinchoninic Acid Protein Assay
Protein concentrations were measured using bicinchoninic acid (BCA) first
described by Smith etal. (1985). This method combines the reaction of protein with
Cu2+ in an alkaline medium (yielding Cu1+) namely BCA. The purple reaction product
formed by the interaction of 2 molecules ofBCA with one cuprous ion (Cu1+) is water
soluble and exhibits a strong absorbance at 562 nm. This allows the spectrophotometric
quantitation of protein in aqueous solution. The main advantages of the assay include
compatability with ionic and non-ionic detergents, a stable working reagent and less
protein-to-protein variation compared to other methods.
2.4.1.1 Procedure
Protein concentrations were measured using the BCA protein assay (Pierce).
Working reagent was prepared by adding 1 part solution B (4 % copper sulphate) to 50
parts ofsolution A which contains the BCA detection reagent. Each standard (BSA) or
unknown protein (0.1 ml) was placed in a test tube. For blanks, 0.1 ml of the protein
diluent was used. Working reagent (2 ml) was then added to each sample, and mixed
well. After incubation at 60 °C for 30 minutes, the tubes were cooled and absorbance at
562 nm measured. Protein concentrations for each unknown were determined using a
standard curve of varying BSA concentrations (Fig. 2.2).
Using the above method collagen concentrations could be measured, which was
not possible using the assay by Bradford (1976). Presumably the increased temperature
used during the assay denatures the collagen allowing an enhanced reaction of the
peptide bonds with divalent copper.
A standard curve ofvarying collagen concentrations was used to determine the
amount of collagen in purified preparations (Fig. 2.2). The results were comparable to
the hydroxyproline assay for collagen, making the BCA assay the most convenient
method for measuring collagen in purified preparations.
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Figure 2.2 BCA assay response for collagen and bovine serum albumin
The standard curves shown for the BCA assay were obtained using the 60 ^C/30 min
protocol (Pierce, manufacturers instruction). Error bars are standard deviations (n=3).
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2.4.2 Mono Q FPLC
To test whether lysyl oxidase and TRAMP contained different ionic variants, a
procedure similar to that ofBurbelo etal. (1986) was used, employing anion exchange
FPLC.
Using a Gilson HPLC system at room temperature, lysyl oxidase and TRAMP
preparations were separated on a Pharmacia Mono Q HR 5/5 column. Prior to sample
application the column was sequentially washed with 5 ml of 6 M TBU, (20 mM Tris-
HC1, containing 6 M urea, pH 7.5) followed by 10 ml of 6 M TBU containing 1 M
NaCl. Finally, the column was equilibrated in 6 M TBU. Samples were loaded in 6 M
TBU and, after washing the column with 6 M TBU, bound proteins were eluted at 1
ml/min with a 20 ml linear gradient 0 to 1 M NaCl in 6 M TBU. Protein was monitored
by absorbance at 280 nm and peak fractions were collected and stored at -30 °C. All
solutions were prepared from HPLC or analytical grade reagents, and buffers
containing urea were prepared from freshly deionised stock solutions of 8 M urea. All
buffers and samples were Filtered and degassed using 0.22 pm Filters.
2.4.3 Ultrafiltration Assay for Lysyl Oxidase
2.4.3.1 Preparation of Elastin Substrate
2.4.3.1.1 Materials
Fertile hen eggs were supplied by Ross Breaders, Newbridge. [4, 5-3H] Lysine
(1.18 TBq/mol) was obtained from Amersham. BAPN (fumarate salt) was from Sigma;
MEM Select-Amine kit was from Gibco. Unless stated otherwise all other chemicals
(analytical grade) were from BDH.
2.4.3.1.2 Procedure
Lathyritic [4,5-3H] lysine-labeled elastin was prepared, using essentially the
procedure described by Kagan etal. (1979). Dissection instruments and Erlenmayer
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flasks (Nalgene) were autoclaved prior to use. The aortas from 120 seventeen-day
chick embryos were dissected out and pre-incubated for 1 h at 37 °C in 125 ml Nalgene
flasks (30 aortas per flask) containing 50 mis of sterile MEM without lysine, but
supplemented with 50 mg/1 valine, 50 mg/1 alanine, 50 mg/1 glycine, 50 mg/1 proline,
50 mg/1 ascorbic acid, 50 mg/1 BAPN, 105 units/1 penicillin, 100 mg/1 streptomycin and
adjusted to pH 7.4. By using culture media supplemented with the most abundant
amino acids in elastin, alanine, glycine, proline and valine (Sandberg etal., 1981), the
yield was approximately twice that obtained without the supplements (Shackleton &
Hulmes, 1990b). The aortas were then incubated on an Labtherm orbital shaker for 20
h in 200 ml of the above medium (50 ml per flask) containing 0.56 MBq/ml [4,5-3H]
lysine at 37 °C in an atmosphere of 5 % CO/95 % air.
The following procedures were at 0-4 °C. The aortas were washed and
homogenised in 50 ml of 0.15 M NaCl and then centrifuged at 10,000 g for 5 minutes.
The saline-insoluble aortic pellet is 88 % elastin and 12 % collagen; ifnecessary the
collagen may be removed by treatment with purified bacterial collagenase (Narayanen
etal., 1974; Stassen, 1976). The pellet was retained and the saline extraction repeated.
Background rates of tritium release may be substantial, due to endogeneous lysyl
oxidase tightly bound to the elastin pellet (Kagan etal., 1974). Therefore to inactivate
endogenous enzyme, the pellet was further homogenised in 1 N hydrochloric acid and
centrifuged as above, this step was repeated. The pellet was then homogenised in assay
buffer (0.1 M sodium borate, 0.15 M NaCl, pH 8.0) and centrifuged as above, this
step was repeated. Finally the pellet was resuspended in assay buffer to give a
concentration of 3 x 105dpm in 100 pi. A typical yield from 10 dozen embryos was
2.5 x 108dpm which was sufficient for 800 assays.
2.4.3.2 Ultrafiltration Assay
In vitro assays have been developed to measure the activity of lysyl oxidase
against collagen or elastin substrates (Pinnell & Martin, 1968; Siegel etal., 1970;
Siegel, 1974) as well as against nonpeptidyl amines (Trackman & Kagan, 1979;
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Trackman etal., 1981) and other protein substrates (Kagan etal., 1984). The assay
used during this study relies on the addition of lysyl oxidase to the [4,5-3H] lysine-
containing form of elastin, this leads to the catalytic release of a tritium ion which can
exchange with water. The 3HHO formed is then separated by ultrafiltration (Shackleton
& Hulmes, 1990b). Although the method is discontinuous, other methods using
synthetic peptide substrates, following oxygen uptake with an oxygen electrode (van
derMeer & Duine, 1986), or measuring H202 release by a fluorometric-peroxidase
coupled reaction (Trackman etal., 1981) are useful for studies on enzyme specificity
and mechanism, but are inappropriate for routine assays.
2.4.3.2.1 Procedure
The ultrafiltration assay (Shackleton & Hulmes, 1990b) was initiated in 1.5 ml
Eppendorf tubes by the addition of 100 pi of enzyme to 100 pi [4,5-3H] elastin
(300,000 dpm) suspended in assay buffer (0.1 M sodium borate, 0.15 M NaCl, pH
8.0). After vortexing, the mixture was incubated at 37 °C for 16 h. Following
incubation, the reaction was stopped by placing the tubes on ice, and adding 50 %
(w/v) trichloroacetic acid to a final concentration of 5 % (w/v). After centrifugation at 4
°C for 5 minutes at 15,600 g to pellet the bulk of the elastin substrate, 400 pi aliquots
of the supernatant were then ultrafiltered at 4 °C for 1 h at 5000 g usingMillipore
Ultrafree-MC units (10 K cut-off) in a Beckman JA 18.1 rotor. During centrifugation,
low molecular weight material passes through the ultrafiltration membrane and collects
in the lower chamber of the unit. Tritium release is measured by mixing 0.3 ml of the
ultrafiltrate with 2.7 ml of BDH Cocktail T and then counted in a liquid scintillation
counter for 10 minutes. Assays were usually conducted in triplicate, control assays
contained 0.2 mM BAPN, a specific inhibitor for lysyl oxidase (Tang et al, 1983).




Isoelectric focussing separates proteins on the basis of surface charge alone, as
a function of pH. The separation is done in a non-sieving medium, in the presence of
carrier ampholytes, which establish a pH gradient increasing from the anode to the
cathode. Since a protein contains both positive (amine) and negative (carboxyl) charge
bearing groups, the net charge of the protein will vary as a function ofpH.
A pH gradient is established concomitantly with protein separation. As the
protein migrates into an acidic region of the gel it will gain positive charge. At some
point the overall positive charge will cause the protein to migrate away from the anode
(+) to a more basic region of the gel. As the protein enters a more basic environment it
will lose positive charge and gain negative charge, and consequently will migrate away
from the cathode (-). Eventually the protein reaches a position in the pH gradient where
its net charge is zero (defined as its isoelectric point or pi). At that point the
electrophoretic mobility is zero, migration will cease and a concentration equilibrium of
the focussed protein is established.
The pH gradient is formed by the presence ofampholytes in the separation
medium. Carrier ampholytes are complex mixtures ofamphoteric buffers that form a
smooth pH gradient in an applied electric field. During electrofocussing these buffers
stack according to their individual pi's across the gel, producing a step gradient. In
order for the gradient to appear smooth, a large number of these buffering components
must be present.
2.4.4.1 Procedure
Analytical isoelectric focussing was carried out essentially according to
manufacturers instruction, using a Biorad Mini IEF Cell Model III. Prior to loading,
samples were dialysed into 4 M urea and adjusted to a protein concentration of
approximately 1 mg/ml. Protein samples (2 pi) were focussed on 5 % polyacrylamide
gels (125 x 65 x 0.4 mm) containing 2 % ampholines (Pharmacia/ LKB; ampholine
mixture ofpH 3.5 to 5 (5 parts) and pH 3.5 to 10(1 part)). A mixture of ampholines
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ensures rapid generation of the pH gradient. Gels also contained 4 M urea, which was
found necessary to prevent sample precipitation. Focussing was carried out under
constant voltage conditions in a stepped fashion; 100 V for 15 min, 200 V for 15 min
and Finally 450 V for 1 h. Step increases in voltage were necessary to prevent
overheating and subsequent dehydration of the gel. When focussing was complete,
proteins were stained for 1-2 h in 0.04 % (w/v) Coomassie Brilliant Blue R250, 0.5 %
(w/v) CuS04, 0.05 % (w/v) Crocein Scarlet 7B, 27 % (v/v) ethanol, 10 % (v/v) acetic
acid. Crocein Scarlet, is a highly soluble dye which binds to protein, and is included to
assure rapid Fixation of the bands. The gels were destained in 12 % (v/v) ethanol, 7 %
(v/v) acetic acid, 0.5 % (w/v) CuS04 (three changes over 45 minutes) followed by
destaining in 25 % (v/v) ethanol, 7 % (v/v) acetic acid until the background cleared.
The cupric sulphate in the staining and destaining solutions effectively eliminates any
background staining due to the presence ofampholytes. Finally gels were air dried in a
dust-free area.
2.4.5 Deglycosylation
The deglycosylating enzymes used in this study were shown to be free of
proteolytic activity by unmodiFied SDS-PAGE migration of electrophoresis calibration
proteins (Pharmacia) treated with these enzymes.
2.4.5.1 Neuraminidase
Neuraminidase (Sialidase) hydrolyses terminal bonds which join sialic acid (5-
N-acetylneuraminic acid, NANA) to oligosaccharides, glycoproteins or glycolipids
(Montreuil etal., 1986).
For neuraminidase treatment, 50 pg ofTRAMP in 50 mM sodium acetate, pH
5.5, 4 mM CaCl2, 100 pg/ml BSA, 0.2 mM PMSF, 0.2 pM TPCK, was incubated in a
total volume of40 pi, with 0.8 mU of neuraminidase (Boehringer, from Vibrio
cholerae) for 18 h at 37 °C, followed by a further 6 h at 37 °C with the same amount of
freshly added enzyme. BSA in the digestion buffer was included to improve the
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stability of the neuraminidase. Fetuin (Sigma) was used as a positive control. The
reaction was stopped by the addition of 10 pi of 5 x SDS-PAGE reducing sample
buffer and heating for 3 min at 100 °C, followed directly by electrophoresis or storage
at -20 °C.
2.4.5.2 Endoglycosidase F/N-Glycosidase F
This mixed (1:1) preparation from Sigma provides a wide range in specificity.
Endoglycosidase F (Endo F) cleaves glycosidic bonds in the diacetylchitobiosyl core
region of both polymannose and complex type N-linked oligosaccharides, leaving only
a single N-acctylglucosamine (GLcNAc) residue attached to asparagine on the
polypeptide (Elder& Alexander, 1982). Endo F does not affect O-linked carbohydrates
ofglycoproteins. The efficiency of digestion depends on unfolding and partial
denaturation of the glycoprotein substrate (Plummer etal., 1984).
N-Glycosidase F cleaves an intact oligosaccharide from a native or denatured
glycoprotein. The cleavage occurs between the innermost residue ofN-N'-
diacetylchitobiose and the asparagine to which the oligosaccharide is linked. The
enzyme readily cleaves most high mannose oligosaccharides, hybrid oligosaccharides
and biantennary, triantennary and tetraantennary complex oligosaccharides (Tarentino
etal., 1985; Chu, 1986).
For Endoglycosidase F/N-Glycosidase F treatment, 50 pg ofTRAMP was first
denatured by heating at 100 °C for 3 min in the presence of 10 mg/ml SDS. The enzyme
preparation is inhibited by SDS in the absence of non-ionic detergents, therefore the
protein in 10 mg/ml SDS was diluted 10 times with 90 pi of digestion buffer (0.25 M
sodium acetate, 20 mM EDTA, 10 mM 2-mercaptoethanol, 6 mg/ml Nonidet P-40, 5
mg/ml CHAPS, 0.2 mM PMSF, 0.2 pM TPCK, pH 6.25). 7 pi ofEndoglycosidase
F/N-Glycosidase F (0.36 Units) was then added to the mixture, which was incubated at
37 °C for 18 h. Incubations were also carried out at pH 4.5 and pH 7.5 to favour the
activities of Endo F and N-Glycosidase F respectively. Fetuin (Sigma) was used as a
positive control. Reactions were stopped by the addition of 25 pi of 5 x SDS-PAGE
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reducing sample buffer and heating for 3 min at 100 °C, followed immediately by
electrophoresis or storage at -20 °C.
2.4.5.3 O-Glycosidase
O-Glycosidase (Boehringer, BSA free, from Diplococcuspneumoniae) releases
the disaccharide Gal (3(1-3) GalNac from O-glycans, which is bound to serine or
threonine as a core unit.
For treatment with O-glycosidase, 200 pg ofTRAMP (in 100 pi of 20 mM
sodium cacodylate buffer, pH 6.0) was incubated with 1 mU of enzyme for 16 h at 37
°C, and the reaction stopped by the addition of 25 pi 5 x SDS-PAGE reducing sample
buffer and heating for 3 min at 100 °C, followed directly by electrophoresis or storage
at -20 °C. Fetuin was used as a positive control, and as the presence of sialic acid
interferes with O-glycosidase activity, incubations with O-glycosidase were done both
with and without prior neuraminidase treatment.
2.4.6 Further Carbohydrate Analysis
2.4.6.1 Concanavalin A Affinity Chromatography
Concanavalin A (Con A) serves as an affinity adsorbent for glycoproteins
containing a-D-glucopyranosyl or a-D-mannopyranosyl residues (Montreuil etal.,
1986).
Affinity chromatography, with immobilised Con A, was performed at 4 °C as
follows: samples ofTRAMP and lysyl oxidase from the Sephacryl S-200 column were
applied to a 3 x 1.6 cm column ofCon A-Sepharose (Pharmacia) equilibrated in 50 mM
Tris-HCl, 0.5 M NaCl, 1 M urea, 1 mM CaCl2, 1 mM MnCl2, pH 7.4 (at room
temperature) at 20 ml/h. Elution was achieved using 1 M a-D-methyl mannoside
dissolved in equilibration buffer, at 10 mVh.
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2.4.6.2 Lectin Blotting
Lectins are a group of proteins which posses the ability to react reversibly and
specifically with different carbohydrate structures. Thus the detection of glycoproteins
on electroblots is frequently achieved using lectins as probes. Several methods of
visualising bound lectins have been described which include radioactively labelled,
fluorescently labelled or enzyme labelled lectins. (O'Shannessy etal., 1987; Haselbeck
etal., 1990). The lectins used in this study (wheat germ agglutinin (WGA); Con A)
were provided by Dr D K Apps. The WGA (supplied as a conjugate with horseradish
peroxidase; HRP) binds to N-acetyl glucosamine containing carbohydrate structures
(Montreuil etal., 1986). Con A has an affinity for HRP (Clegg, 1982), thus
glycoproteins were detected with this lectin by a sequential incubation with Con A
followed by HRP (Sigma; type VI).
Following SDS-PAGE and transfer of the separated proteins to nitrocellulose
(section 2.3.4), the blot was stained briefly (1 min) with Ponceau S (section 2.3.4.2).
Ifnecessary individual lanes of protein were cut from the membrane and reacted
protein-side up in an incubation tray (Biorad). The incubation tray consists of several
wells to allow the screening ofmany different lectin/glycoprotein reactions under
separate conditions.
For glycoprotein detection a modification of the procedures described by several
workers were used (Harlow & Lane, 1988; Haselbeck etal., 1990). Excess protein
binding sites on the transfers were blocked by incubation in Tris buffered saline (TBS;
50 mM Tris-HCl, 0.15 M NaCl, pH 7.5) containing 0.5 % (vA) Tween-20 (Sigma) for
1 h at room temperature with agitation. (Solutions used for blocking need to be devoid
ofglycoproteins.) The transfers were then incubated for 1 h at room temperature with a
lectin (WGA-HRP or Con A, 10 pg/ml in TBS containing 0.1 % (w/v) BSA, 1 mM
MnCl2, 1 mM CaCl2, pH 7.5). The membrane was then washed (5x5 min) as
follows: twice with TBS, twice with TBST (TBS containing 0.1 % (v/v) Tween-20)
followed by a final wash in TBS. Blots (labelled with Con A only) were further
incubated with HRP (50 pg/ml) for 60 minutes in the same buffer used to dilute the
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lectins. Excess enzyme was removed by washing (5x5 min) in buffer as before.
Bound horseradish peroxidase (HRP) was then located by incubating the blot with
freshly prepared chloronaphthol substrate, (40 ml 4-chloro- 1-naphthol (3 mg/ml in
methanol)) added to 200 ml TBS and filtered immediately before use, followed by 80
pi of 30 % (v/v) H202) which is converted to a highly insoluble blue-black coloured
product. After suitable colour development (usually 10-15 min), the blots were washed
in distilled water and dried in the dark.
This method is very sensitive and capable of detecting as little as 60 ng of a
purified glycoprotein after electrophoresis. To achieve this level of detection only HRP
with a high specific activity should be used. It is also important that buffers do not
contain azide as this inhibits HRP activity.
Con A was also labelled with I125 (by Dr D K Apps) which was then incubated
with protein blots. The conditions during incubation were identical to that already
described for the WGA-HRP conjugate. However no chloronaphthol development was
required, and Con A (30,000 dpm/ml) was used. For development the blots were
covered in cling film and exposed to pre-flashed X-ray film (Kodak XAR 5 X-OMAT;
Laskey & Mills, 1975). Films were developed in Devalex solution and fixed with
Fixaplus (both obtained from Champion photochemistry) using a Fugi X-ray film
processor RGII. Procollagen C-propeptide was used as a positive control and
Pharmacia molecularweight electrophoresis standards were a negative control. The
specificity of the method was demonstrated by the abolition ofCon A binding in the
presence of a-D-methyl mannoside.
2.4.7 Desulphation
Tysosine sulphation ofTRAMP following SDS-PAGE was suggested by Alcian
Blue staining (section 2.4.8.4). To investigate whether TRAMP contained any tyrosine
sulphate, purified TRAMP variants were treated with 1 M HC1 or sulphatase prior to
SDS-PAGE.
The tyrosine sulphate bond is particularly labile to acid hydrolysis (Huttner,
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1984). Therefore TRAMP was dialysed against distilled water and diluted with 2 M
HC1 to a final 1 M HC1, heated for 5 min at 100 °C, freeze dried, and finally dissolved
in SDS-PAGE reducing sample buffer, with heating at 100 °C for 3 min, followed
immediately by electrophoresis. TRAMP boiled in distilled water for 5 min was used as
a control.
To further investigate tyrosine sulphation, TRAMP was incubated with
sulphatases (either type V from limpet or type VII from abalone, both obtained from
Sigma).
For sulphatase treatment, 30 jug ofTRAMP was dialysed into 0.1 M sodium
acetate (pH 5.0), 0.1 unit of sulphatase was added in a total volume of 0.2 ml, and the
reaction mixture incubated for 2 h at 37 °C. Aliquots (20 pi) were removed at set times
and added to 5 pi of 5 x SDS-PAGE reducing sample buffer, followed by heating at
100 °C for 3 min. The small amount ofP-glucuronidase activity that was present as a
contaminant in the sulphatases was inactivated by temporarily adjusting the pH to 2.2
(Dodgson & Spencer, 1953). Separate experiments with purified P-glucuronidase (E.
coli;Boehringer) at two times the level present in the sulphatase preparations, had no
effect on the electrophoretic migration ofTRAMP variants or their staining with
Coomassie Blue, Alcian Blue or PAS.
2.4.8 Gel Staining Methods
2.4.8.1 Proteins
A typical staining method for proteins after SDS-PAGE involved placing the gel
into an excess of staining solution, (0.25 % (w/v) Coomassie Brilliant Blue-R250, 50
% (v/v) methanol, 10 % (v/v) acetic acid). This solution also served to fix the proteins
in the gel and therefore avoid loss due to diffusion. Gels were stained for a minimum of
2 h and then transferred to destaining solution (10 % (vAO methanol, 10 % (vAO acetic
acid) for at least 24 h with several changes of the solution. The staining and destaining
times were reduced when carried out at 45 °C. The dye solution was reused several
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times, and the lower limit of detection corresponded to about 1 pg protein per band.
Coomassie Brilliant Blue-R250 is about 3 times more sensitive than Amido black 10B
and forms electrostatic bonds with NH3+ groups and non-covalent bonds with non-
polar regions in the proteins. The staining is uniform, stable and suitable for
densitometry although the binding begins to deviate from Beers law at higher protein
levels and it is therefore not suitable for quantitative measurements in gels having
widely differing amounts of proteins in the various stained bands.
For some purposes, very high sensitivity is required for adequate localisation of
separated proteins. This may be achieved by silver staining which is claimed to be 100
times more sensitive than Coomassie Blue-R250 (Andrews, 1986). The method used
for silver staining was based on that ofMorrissey (1981). Gels were fixed in 25 %
(v/v) methanol, 10 % (v/v) acetic acid for 2 h, followed by washing the gel in distilled
water over 1 h. Proteins in the gel were then reduced with 5 pg/ml dithiothreitol (DTT)
for 2 h. This step does not seem to be necessary but does improve the sensitivity a little
(Sammons etal., 1981). The DTT solution was then poured off. Without rinsing, the
gel was incubated in 0.1 % (w/v) silver nitrate, and after 2 h the gel was rapidly rinsed
twice with distilled water. To visualise the protein bands, the gel was developed with
100 pi of 40 % formaldehyde in 200 ml of 3 % (wAO sodium carbonate, until the
desired level of staining was reached. Finally 10 ml of 2.3 M citric acid was added to
stop the reaction, after 30 min the gel was placed in 2 % (vAO glycerol, prior to
photography or drying down. Throughout the procedure gloves were worn, and
incubations were done with gentle agitation to produce an even stain. Overstained gels
could be destained with photographic reducers, such as kodak rapid fixer, the
destaining may then be stopped with 5 % sodium thiosulphate, followed by thorough
washing in distilled water.
The precise mechanism of silver staining is not known but it appears that silver
ions initially bind to protein zones and then act as nucleation sites for the deposition of
further amounts of silver. Silver staining can be applied perfectly satisfactorily to gels
that have already been stained with Coomassie Blue (Hallinan, 1983). This can be
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useful to detect minor components after the principal ones have been detected with dye
staining. Greater reliability and sensitivity of silver staining after preliminary staining
with Coomassie Blue, has been observed by several groups. It appears that the
provision of extra silver binding sites by sulphonic acid groupings on the dye
molecules bound to proteins in the gel are responsible for the improved staining
(Nielsen & Brown, 1984).
2.4.8.2 Glycoproteins
Glycoproteins can be stained by the methods described above for proteins, but
the presence of carbohydrate means that other procedures can be used, both for their
localisation and in order to distinguish which components of a mixture are
glycoproteins. The most widely used specific glycoprotein staining method, and the
one which was used in this study, is the very sensitive (lower limit of detection about 2-
3 pg ofprotein bound carbohydrate) periodic acid-Schiff (PAS) procedure ofZacharius
etal. (1969).
The fuchsin-sulphite (Schiff's reagent) staining solution was prepared as
follows: 2 g basic fuchsin (pararosaniline) were dissolved in 400 ml ofdistilled water,
with warming, and then cooled and filtered. 10 ml of 2 N HC1 and 4 g ofpotassium
metabisulphite was then added. The solution was placed in a stoppered amber bottle
and kept cool overnight. Activated charcoal (1 g) was stirred in, filtered, and sufficient
2 N HC1 added (approximately 10 ml) until a drop dried on a glass slide did not turn
red. The solution was stored in a stoppered bottle, protected from light. The stain could
be used several times, and was discarded if it turned pink.
The procedure for localising glycoproteins in gels followed a 30 min fixation
step in 12.5 % TCA, followed by a brief rinse in distilled water. After oxidation with 1
% periodic acid in 3 % aqueous acetic acid for 50 min, the gel was washed thoroughly
in distilled water (at least 6 changes over 2 h). Gels were then transferred into fuchsin-
sulphite and stained for 50 min in the dark. After washing with 3 changes (10 min
each) of 0.5 % sodium metabisulphite, gels were finally washed in frequent changes of
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distilled water to remove excess stain.
After localisation ofglycoproteins, subsequent staining with Coomassie Blue
revealed other non-glycosylated proteins.
2.4.8.3 Phosphoproteins
Interaction of the cationic carbocyanine dye Stains-All with proteins, nucleic
acids and substituted polysaccharides causes a change in the absorption spectrum of the
dye. Green etal. (1973) reported that many proteins stained red (Xmax 500-520 nm),
some proteins did not stain, while phosphoproteins stained blue (Xmax 640-660 nm),
therefore this could be used for differentiating between them. The sensitivity varies
according to the degree ofprotein phosphorylation but is generally in the range 1-5 pg.
The method used was as described by Green etal. (1973).
Working stain was prepared just before use, from a 0.1 % stock solution of
Stains-All (Sigma) in formamide, as follows: 10 ml stock stain, 10 ml formamide, 50
ml isopropanol, 1 ml 3 M Tris-HCl, pH 8.8 and distilled water were combined in a
total volume of 200 ml.
Following SDS-PAGE, gels were fixed in 25 % isopropanol at 45 °C for at least
30 min to remove SDS which interferes with subsequent staining. After a brief rinse in
distilled water, the gels were placed in the dark and stained overnight. The gel was then
destained in the dark with several changes of distilled water, until a good contrast
between the bands and background was observed. Phosvitin (Sigma), a
phosphoprotein, was used as a positive control.
Similar studies have shown that calcium-binding proteins and sialoglyco-
proteins also stain blue with Stains-All (Campbell etal., 1983). Therefore controls
should be run using neuraminidase or phosphatase treated samples which remove the




Alcian Blue (8GX) is a cationic dye which stains polyionic groups such as
negatively charged glycosaminoglycan (GAG) chains of proteoglycans. In practice
however, Alcian Blue gives high levels of background staining, and occasional staining
ofprotein bands which do not contain attached GAGs. By adding MgCl2 to the stain,
this non-specific staining is abolished, since each polyanion has its own "critical
electrolyte concentration" (CEC) above which it ceases to take up stain (Scott, 1985).
The method for Alcian Blue staining following SDS-PAGE was as described by
Wall and Gyi (1988). To remove SDS, gels were fixed in 50 % (v/v) methanol, 7 %
(v/v) acetic acid for 1 h, followed by washing in distilled water for 1 h. These 2 steps
were repeated before staining the gels overnight in 0.2 % (w/v) Alcian Blue 8GX, 3 %
(v/v) acetic acid, 0.05 M MgCl2. Gels were then destained in several changes of 3 %
(v/v) acetic acid, 0.05 M MgCl2 until the background was clear. Gels could then be
photographed and scanned using a densitometer for quantitative analysis.
2.4.9 Production of Antibodies
Polyclonal antibodies to porcine TRAMP were obtained from female New
Zealand white rabbits (City Farms, West Calder) by the methods described by Harlow
and Lane (1988). Initial immunisation required an intradermal injection (at 6 sites in the
back of a rabbit) of 200 pg Mono Q purified TRAMP diluted in 0.15 M NaCl and
emulsified in complete Freund's adjuvant (Sigma). (The TRAMP was free of lysyl
oxidase and other contaminating proteins as judged by the ultrafiltration assay and
SDS-PAGE. The adjuvant is included to stimulate the immune response and to protect
the TRAMP antigen from rapid catabolism by the host animal). This was followed by a
booster injection of 100 pg TRAMP in Freund's incomplete adjuvant (Sigma) after
three weeks. Further boosts of 50 pg TRAMP in Freund's incomplete adjuvant were
given at six week intervals.
Before the immunisations were started and also at ten days after each injection,
approximately 10 ml of blood was collected from each rabbit. The blood was obtained
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by heart puncture under anesthesia after the last injection. The blood was allowed to
clot for 30 minutes at 37 °C. Following overnight storage at 4 °C, to allow the clot to
contract, the serum was collected after centrifugation at 10,000 g for 10 minutes. The
sera was then stored at -20 °C until required. Technical support was provided by staff in
the departments animal house.
2.4.9.1 Enhanced Chemiluminescence (ECL) Detection of TRAMP on
Immunoblots
TRAMP antigen immobilised on nitrocellulose was detected by the ECL system
(Amersham), which is a light emitting non-radioactive technique. The main advantage
ofECL over other methods is its sensitivity, with detection limits of less than 1 pg of
antigen. Thus low-affinity antibodies or small amounts of antibody can be used.
Purified TRAMP and crude tissue extract containing TRAMP were subjected to
SDS-PAGE followed by transfer of the separated proteins onto nitrocellulose (section
2.3.4). Antigen detection was carried out according to manufactures instruction but
with some modifications. Antibody dilutions were first optimised to give the highest
signal with minimum background. Generally, membranes were blocked with 5 % (wA)
dried milk in TBST for 1 h at room temperature with agitation, followed by washing
three times in TBST (1x15 min; 2x5 min). The antisera containing the primary
antibody directed against TRAMP, was diluted 1:5000 in TBST and incubated with the
blot for 1 hour at room temperature, followed by washing (as before). A 1:5000
dilution of the second antibody in TBST (HRP-anti rabbit IgG; supplied by the Scottish
antibody production unit, Law hospital, Carluke, Lanarkshire) was then incubated with
the transfer for 20 minutes. Following a further wash (as before), antigen was detected
on the membrane surface by mixing the two ECL reagents (1:1) and incubating for
precisely 1 minute. Excess reagent was drained off and the blots covered with cling
film, care was taken to smooth out any air pockets. Blots were immediately exposed to
pre-flashed X-ray film for 30 seconds-10 minutes, and developed (section 2.4.6.2).
Sera taken from rabbits before the TRAMP immunisations began was used to correct
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for non specific binding. To ensure there was no spurious binding of the second
antibody directly to the blotted proteins, the procedure above was repeated but with no
primary antibody.
2.5 In Vitro Fibril Formation
Purified lathyritic rat skin collagen, free ofaggregates and with intact non-
helical telopeptides, was used to study the effect ofTRAMP and lysyl oxidase on
collagen fibril formation.
Fibrils were reconstituted by the "warm start" technique (Holmes etal., 1986),
in which collagen solutions in 5 mM acetic acid (pH 2.5), and double strength fibril
formation buffer (60 mM disodium phosphate, 60 mM TES, 270 mM NaCl, pH 7.4;
Williams etal., 1978) were preincubated separately at 34 °C before mixing 1:1 to
initiate fibril formation. Purified variants ofTRAMP were dialysed into double strength
fibril formation buffer and diluted in the same buffer prior to mixing with collagen.
Turbidity at 313 nm (using a Philips PU 8720 UV/VIS scanning spectrophotomer)
monitored the kinetics of fibril formation, and the products were examined by electron
microscopy, or SDS-PAGE.
2.5.1 Electron Microscopy
2.5.1.1 Negative Staining of Collagen Fibrils
Negative staining is used as a method for contrast enhancement in electron
microscopy ofbiological specimens. It is a simple and rapid method for studying the
morphology and structure ofparticulate specimens, such as viruses, cell components,
and macromolecules. The sample shows well preserved order, since the stain preserves
macromolecular structure. The negative staining method is based on the principle that
there is no reaction between the stain and the specimen. This is accomplished by using
a pH which minimises the attraction between the stain and protein. The specimen
substructure is revealed by the penetration of the stain into holes and crevices, with the
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stain drying into a relatively electron-opaque layer around the specimen. In
transmission electron microscopy (TEM) the sample appears as a light image on a dark
background. Uranyl acetate (UA) and phosphotungstic acid (PTA) are the most
commonly used stains (Hayat, 1989).
For negative staining a suspension of collagen Fibrils formed both in the
absence and presence ofTRAMP, was applied to carbon-colloidon-coated copper 400-
mesh grids (Spiess et al., 1987). After 1 min the grids were blotted with filter paper
and a drop of 1 % PTA in water (pH adjusted to 7.4 with NaOH) was added, then
removed by blotting after a further 1 min, and the grid then air dried.
2.5.1.2 Rotary Shadowing
Although negative staining provides higher resolution than metal shadowing
when viewing biological material under TEM. The contrast provided by negative
staining when studying long, slender, rod-shaped proteins is inadequate. In this case,
metal shadowing provides a good alternative. The specimen is shadowed in vacuowith
heavy metal from a shallow angle, the angle being chosen to give optimal contrast of
the structural features of interest. Rotation of the specimen during evaporation (rotary
shadowing) gives an "all round" view. For a review of rotary shadowing see
Furthmayr and Madri (1982).
To study the interaction between TRAMP and collagen during the lag phase of
fibril formation, the mica sandwich technique for preparing molecules for rotary
shadowing was used (Mould et al., 1985). Spraying is the usual method for depositing
the sample onto the mica surface. However it has been shown that the shear forces
induced by spraying can cause fragmentation of extended macromolecules. To reduce
this risk a gentler spreading technique is used. The mica sandwich procedure involves
forming a thin film of sample solution between 2 pieces of freshly cleaved mica.
Fibrils were reconstituted at 34 °C for 1-2 min, with and without TRAMP, and
then diluted with fibril formation buffer to a final collagen concentration of 20 pg/ml. A
small volume (5 pi) of the solution was then spread between 2 (20 x 20 x 0.125 mm)
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pieces of freshly cleaved mica, and allowed to adsorb for 1 min. To ensure that the
specimen was not obscured by any non-volatile salts, the mica sandwich was placed
into 0.2 M ammonium acetate buffer (pH 7.2) and separated under the liquid surface.
After agitation to remove the salts, the mica pieces were reapposed, removed from the
solution, and blotted on the outside before plunging into liquid nitrogen. After
separation of the mica pieces under liquid nitrogen, the pieces with sample uppermost,
were placed onto a brass block submerged in liquid nitrogen. The block was
immediately transferred into the chamber ofan Edwards vacuum coating unit. The
pressure in the unit was reduced to 104-105 Torr, and the ice layer sublimed off after
10 min. A thermocouple monitored the temperature of the brass block, which showed
the temperature of the sample was at least -90 °C during freeze drying. Although drying
from glycerol gives good preservation of single extended molecules, it was shown by
Fowler and Aebi (1983) that freeze drying had significant advantages over glycerol
drying in preserving molecular structural integrity. After approximately 30 min when
any frost on the block had cleared, the specimen was returned to room temperature by
admitting dry nitrogen (evaporated from liquid N2) into the chamber. The specimen was
removed after a further 30 min.
An 8 cm length ofplatinum wire, 0.1 mm in diameter was coiled around a 1
mm diameter tungsten filament to occupy about 1 cm at the centre of the filament.
Samples (on a rotating stage) were shadowed with platinum at a glancing angle of 5° by
resistive heating of the tungsten fiament, at about 10 cm from the source and at a
pressure of 2 x 10"5 Torr. The metal replicas were stabilised by coating with carbon.
The carbon was evaporated by resistive heating ofa carbon fibre. The replicas were
then floated off onto a clean distilled water surface by inserting the mica slowly into the
water at an angle ofabout 30°, and picked up from below on uncoated 400-mesh
copper grids, which were blotted and left to dry before TEM.
2.5.1.3 Embedding and Sectioning
To asses whether TRAMP influenced the diameter of collagen fibrils, collagen
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fibrils were reconstituted, in the presence and absence of TRAMP over 4 h at pH 7.4,
34 °C, and then pelleted at 15600 g for 1 min at room temperature. The pellets were
fixed overnight in 4 % formaldehyde, 0.1 M sodium phosphate, pH 7.2. The
formaldehyde arrests self assembly by stabilising existing aggregates without itself
inducing further aggregation (Kadler & Chapman, 1986). After blotting the samples
dry, 1-2 mm cubes were dehydrated in ascending grades ofethanol, from 30 % to 50 %
(15 min each), and then transferred to 70 % (30 min), this step being repeated. The
samples were then placed into a 2:1 LR-White/70 % ethanol mixture for 1 h (This
solution should be clear, it is also important not to exceed the shelf life of LR-White).
Following a further 1 h in 100 % LR-White, samples were blotted with filter paper and
placed in fresh LR-White overnight. Finally the samples were blotted and sealed in
gelatin capsules containing fresh LR-White. Polymerisation proceeded over 24 h at 50
°C.
100 nm sections were cut on an ultramicrotome, and then picked up on carbon-
colloidon-coated copper grids (technical support was provided by staff at the Pathology
department). Sections were stained with unbuffered 1 % PTA for 8 min followed by 1
% UA for 15 min. PTA binds to positive ions such as the e- amino groups of lysine and
hydroxylysine. UA is a weak electrolyte in aqueous solution, and exists not only as
uranyl ions but also as anionic and cationic complexes. By using a combination of PTA
and UA, all charged residues should be bound by stain (Chapman & Hulmes, 1984).
2.5.1.4 Electron Microscopy
TEM was performed on a Phillips CM 12 operating at 80 kV. Micrographs were
taken and calibrated using a replica line grating with 2160 lines/mm.
2.5.1.5 Measurement of Fibril Diameters
Fibril diameters from embedded sections were measured directly from the
negative using a calibrated eyepiece with 5 x magnification. The minimum width of
each fibril was taken, and fibril diameters were calculated using the a calibration from a
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replica line grating (2160 lines/mm). Around 300 fibril diameters were recorded for
each sample, and the accuracy ofmeasurement was within ± 5nm.
2.5.2 TRAMP Binding Assays
2.5.2.1 Cosedimentation
To study the interaction between collagen and TRAMP, fibrils were formed as
before, but over a range ofTRAMP concentrations, and with a fixed 200 pg/ml
collagen. The mixture was incubated for 4 hours at 34 °C, then centrifuged at 15,600 g
at room temperature for 1 min. Both supernatant and pellet were analysed by SDS-
PAGE.
2.5.2.2 Fluorescence Polarisation
Several workers have used the technique of fluorescence polarisation (P) to
study the binding properties of fibronectin (Forastieri & Ingham, 1983; Forastieri &
Ingham, 1985; Bentley etal., 1985; Benecky etal., 1990). In this approach one
member of a pair of interacting molecules is labelled with a fluorescent dye, whose
fluorescence polarisation provides a measure of its rotational freedom. Hence P permits
the observation ofbinding events by monitoring the decrease in the rotational diffusion
coefficient of a relatively small labelled molecule upon its binding to a much larger
molecule (Bentley etal., 1985).
In this study TRAMP was labelled with fluorescein isothiocyanate (FITC) and
its fluid-phase interaction with collagen investigated (under non-fibrillogenic
conditions).
For fluorescein labelling, the method ofForastieri and Ingham (1983) was
used. TRAMP (1.5 mg/ml) was incubated for various times in a suspension containing
7.5 mg/ml FITC (isomer 1 bound to cellite; Sigma) in 0.05 M NaHCO^ at pH 8.5 and
25 °C. Following centrifugation at 15600 g for 5 min, to pellet the cellite, excess dye
was removed from the supernatant by gel filtration. For gel filtration a small amount
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(1.5 ml) ofBiogel P-6DG (Biorad) previously swollen and equilibrated in double
strength fibril formation buffer (60 mM disodium phosphate, 60 mM TES, 270 mM
NaCl, pH 7.4; Williams etal., 1978) was placed in an Eppendorf tube with a small
hole punched in the base of the tube which was plugged with glass wool. A small
volume (200 pi) of the sample was placed on top of the gel. The TRAMP-FITC
conjugate was then collected from the bottom of the tube after centrifugation at 1000 g
in a bench centifuge (MSE) for 1 minute. The degree of labelling at 16 h was between
0.75 and 1.25 mol of fluorescein per mol ofTRAMP as estimated from the relative
absorbance at 495 and 280 nm based on E495 = 72,000 M"1 cm"1 for the dye (Forastieri
& Ingham, 1983). Labelled TRAMP was utilised immediately or stored at -20 °C.
Polarisation measurements were recorded on a Perkin Elmer LS-3B
fluorescence spectrophotometer equiped with a thermostated cell holder and Perkin
Elmer polarisation accessory 5212-3269. Excitation and emmision wavelengths were
set at 495 and 540 nm respectively, all slit widths were maintained at 10 nm and
fluorescence was excited and viewed through rotatable polarisers. All measurements
were made at 20 °C in single strength fibril formation buffer unless stated otherwise.
Titrations of FITC-TRAMP were performed in 1 cm quartz cuvettes, small aliquots of
concentrated collagen were added to 1 ml ofFITC-TRAMP solutions and mixed. Any
changes in polarisation were recorded upon addition of the collagen. Corrections for
background were made using samples equivalent in all respects to the sample in which
P was being determined except for the absence of fluorophore.
The polarisation was computed using the expression:
h/V " *VH ^IHV/IHH)
P =
lyy + IVH (IHV/IHH^
where I is the fluorescence intensity. The first subscript of each intensity is the
orientation of the excitation polariser and the second subscript denotes the orientation of
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Characterisation of TRAMP and Lysyl Oxidase from Porcine Skin
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3.1 Results
3.1.1 Purification of TRAMP and Lysyl Oxidase
TRAMP and lysyl oxidase were prepared from urea extracts ofporcine skin by
DEAE-Sephacel chromatography and selective interaction (at low ionic strength) with
Sephacryl S-200, as described in section 2.2. The chomatogram in Figure 3.1 shows
the 6 M PBU (pH 7.5) elution profile from the S-200 column. The ultrafiltration assay
for lysyl oxidase (section 2.4.3) shows that enzyme activity was eluted with the major
protein peak (Fig. 3.1). Substantial purification was achieved by these methods as
evidenced by SDS-PAGE and Coomassie Blue staining (sections 2.3.4 & 2.4.8.1) of
fractions at different stages ofpurification (Fig 3.2, lanes 2 and 3). The final
preparation consisted almost entirely of two protein bands (Fig. 3.2, lane 4). The major
band (TRAMP) often represented 60-90% of the total protein, and had an apparent
molecular mass of 24 K under reducing conditions. Lysyl oxidase was a minor
component which migrated with an apparent molecular mass of 34 K. It was observed
that lysyl oxidase sometimes appeared as a doublet with a weak slowly migrating
component (Fig. 3.2, lane 5).
Attempts were made to modify the purification procedure, to improve the
separation between TRAMP and lysyl oxidase and reduce the time required. Omitting
the DEAE-Sephacel step and applying the extract directly onto the Sephacryl S-200
column resulted in a preparation that was significantly contaminated with other proteins
(not shown). It was not possible to separate TRAMP and lysyl oxidase by selective salt
precipitation as both proteins precipitated at 30 % saturation of ammonium sulphate,
although this did provide a means of concentrating the proteins from dilute solutions.
However, it was found that although these two proteins co-purify when prepared at pH
7.8 (Cronshaw etal, 1993), lowering the pH to 6.0 for the DEAE-Sephacel step
resulted in TRAMP that was uncontaminated with lysyl oxidase (Fig. 3.2, lane 6).
Alternatively lysyl oxidase was almost completely separated from TRAMP when the
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Volume (ml)
Figure 3.1 Sephacryl S-200 chromatography of porcine TRAMP and
lysyl oxidase
The elution profile is shown after the addition of 6 M urea to the 10 mM phosphate
buffer. Enzyme activity was completely inhibited by 0.2 mM BAPN. , Absorbance
(280 nm); > «, enzyme activity.
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Figure 3.2 SDS-PAGE of lysyl oxidase and TRAMP preparations
Proteins were electrophoresed on 12 % SDS-polyacrylamide gels and Coomassie Blue
stained. 1, molecular weight marker proteins; 2, 6 M urea extract from porcine skin; 3,
partially purified proteins after DEAE Sephacel chromatography; 4, lysyl oxidase (34
K) and TRAMP (24 K) purified by DEAE Sephacel and Sephacryl S-200
chromatography; 5, lysyl oxidase (showing that it also occurs as a doublet, 34-36 K);
6, TRAMP purified at pH 6.0 for the DEAE Sephacel step; 7, lysyl oxidase purified by
DEAE Sepharose and Sephacryl S-400 chromatography (see Cronshaw etal., 1993); 8
& 9, TRAMP. All samples (except 9) were reduced with p-mercaptoethanol.
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DEAE-Sephacel and Sephacryl S-200 columns were eluted at different urea
concentrations (Shackleton, personal communication). Lysyl oxidase eluted from
DEAE-Sephacel in the presence of 3 M PBU containing 0.3 M NaCl, while 6 M PBU
was required to elute the enzyme from Sephacryl S-200 (Fig. 3.2, lane 7). TRAMP
eluted from the DEAE-Sephacel column with 6 M PBU containing 0.5 M NaCl, and
was subsequently eluted from the S-200 column with 1.5 M PBU. The electrophoretic
mobility ofTRAMP was found to depend on whether the protein was reduced prior to
SDS-PAGE (Fig. 3.2, lanes 8 and 9), while the mobility of lysyl oxidase was not
affected (not shown).
3.1.2 Identification of Lysyl Oxidase and TRAMP Variants
After further purification by anion exchange Mono Q FPLC (section 2.4.2),
both proteins eluted in the form of several peaks, with some overlap between individual
lysyl oxidase and TRAMP variants (Fig. 3.3). Lysyl oxidase purified using the method
ofCronshaw etal. (1993) contained four peaks of lysyl oxidase activity when eluted
from the Mono Q column with a salt gradient from 0 to 1 M NaCl in 6 M PBU (20 mM
sodium phosphate, 6 M urea, pH 7.8; Fig. 3.3). Similar results have been reported for
human umbilical cord lysyl oxidase (Burbelo etal., 1986). The specific activity of each
enzyme variant appears to be the same (Cronshaw, personal communication). Peaks
from the Mono Q column were analysed by SDS-PAGE and silver staining (sections
2.3.4 & 2.4.8.1), and the electrophoretic mobilities of the four lysyl oxidase variants
were identical (Mr 34 K; Fig. 3.4(a)). It was found that chromatographic resolution
between individual lysyl oxidase and TRAMP variants was further improved ifa salt
gradient from 0 to 1 M NaCl in 6 M TBU (20 mM Tris-HCl, 6 M urea, pH 7.5) was
used (Fig. 3.4(b)). By the same criteria Mono Q FPLC ofTRAMP (prepared at pH 6.0
for the DEAE-Sephacel step) identified five ionic variants (Fig. 3.5(a)). When analysed
by SDS-PAGE and Coomassie Blue staining, the five variants of TRAMP (Mr 24 K;
Fig. 3.5(b)) were found to be pure, with no trace of contaminating proteins including
Elution volume (ml)
Figure 3.3 Mono Q FPLC of porcine lysyl oxidase and TRAMP
Separation of lysyl oxidase and TRAMP variants by Mono Q FPLC using a linear
gradient of 0-1 M NaCl in 6 M PBU, following partial purification by elution from
DEAE-Sepharose and Sephacryl S-400 columns at different urea and salt
concentrations (Cronshaw etal, 1993). Lysyl oxidase variants LI to L4, with small
amounts ofTRAMP variants T1 to T5 are indicated.
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Figure 3.4 SDS-PAGE of lysyl oxidase variants
Protein peaks from the Mono Q FPLC column (Fig. 3.3) were analysed by SDS-PAGE
(12 % separating gel) and silver staining (a). By the same criteria (but using Tris-HCl
buffered urea instead of phosphate buffered urea to equilibrate and elute the column) a
silver stained gel of protein peaks from the Mono Q FPLC column is shown for
comparison (b). In both cases identical amounts of the same lysyl oxidase preparation
were applied to the column. The positions ofTRAMP (24 K) and lysyl oxidase variants
(L1-L4, 34 K) are indicated. The two bands near the top of the gel are staining
artefacts, which also appear when only reducing sample buffer is loaded (b, lane S).
122
Figure 3.5 SDS-PAGE of TRAMP variants following Mono Q FPLC
(a) Separation ofTRAMP variants (T1 to T5) by Mono Q FPLC, following partial
purification by DEAE-Sephacel (at pH 6.0) and Sephacryl S200 chromatography, (b)
Analysis of TRAMP variants from (a) by SDS-PAGE. Samples are reduced with |3-
mercaptoethanol and the gel was stained with Coomassie Blue. Molecular weight
markers and TRAMP variants T1 to T5 are indicated.
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lysyl oxidase. Staining ofproteins (separated by SDS-PAGE) with Stains-All
suggested that TRAMP was not phosphorylated (section 2.4.8.3). All 5 variants of
TRAMP stained red with Stains-All, whereas phosphoproteins are reported to stain
blue (Green etal., 1973). Electrophoresis marker proteins (Pharmacia) also stained red,
and the phosphoprotein phosvitin stained blue, indicating that the technique can
differentiate between the proteins. No lysyl oxidase activity was associated with
TRAMP.
3.1.3 Amino Acid Analysis and Sequencing
Variants ofTRAMP and lysyl oxidase (separated in denaturing conditions by
reverse phase HPLC; Cronshaw etal., 1993) were subjected to amino acid analysis.
These analyses were carried out byMr A D Cronshaw on an Applied Biosystems 420A
Derivatiser with automatic hydrolysis and an on-line Model 120A phenylthiocarbamyl
(PTC) analyser (Cronshaw et al., 1993). The amino acid composition ofTRAMP
(variant T3) is shown in Table 3.1. It is remarkably rich in tyrosine with a low level of
lysine and a moderately high level of cysteine. No obvious differences were found in
the compositions of the five TRAMP variants (not shown). Also shown in Table 3.1 is
the amino acid composition of a 23 K contaminant found in lysyl oxidase preparations
from human placenta (Kuivaniemi etal., 1984) and of a 22 K bovine protein which co-
purifies with dermatan sulphate proteoglycans (Neame etal., 1989). The composition
ofTRAMP shows some similarities with the 23 K protein ofKuivaniemi etal. (1984)
and is almost identical to that of the bovine protein. The amino acid composition of
porcine lysyl oxidase (variant L3) is shown in Table 3.2. The composition is similar to
that of the rat aorta (Trackman etal., 1990; Trackman etal., 1991) and human placental
(Hamalainen etal., 1991) enzymes derived from the cDNA sequence, given certain
assumptions as to the position of the pro-enzyme cleavage site (see Table 3.2). No
obvious differences were found in the compositions of the four lysyl oxidase variants
(not shown).
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Table 3.1 Amino acid composition of TRAMP and related proteins
Amino acid Porcine skina Bovine skin^ Human placenta0
(22 K protein) (Contaminant, pool II)
Aspartic acid 19.6 20 14.1
Glutamic acid 23.6 24 21.9
Serine 11.9 13 10.5
Glycine 13.1 13 14.3
Histidine 2.9 4 2.5
Arginine 12.3 12 9.0
Threonine 7.4 9 6.8
Alanine 7.0 7 7.0
Proline 6.7 6 5.9
Tyrosine 18.1 20 8.4
Valine 8.0 9 6.4
Methionine 6.8 7 ND
Cysteine 9.2 10 ND
Isoleucine 3.8 4 4.1
Leucine 3.7 5 4.1
Phenylalanine 7.7 8 5.4
Lysine 4.0 4 4.8
Tryptophan ND 8 ND
ND = not determined
a variant T3 (see Fig. 3.5(a)). Values are expressed as residues per molecule,
normalised to 7 alanine residues (Neame etal., 1989; Cronshaw etal., manuscript in
preparation).
k from protein sequence data ofNeame etal. (1989), expressed as residues per
molecule
c from Kuivaniemi etal. (1984), re-expressed as residues per molecule, assuming 7
alanine residues.
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Table 3.2 Amino acid composition of lysyl oxidase from various species
Amino acid Porcine skina Rat aorta** Human placenta0
Aspartic acid 28.7 32 33
Glutamic acid 18.0 19 17
Serine 22.2 23 18
Glycine 14.0 13 15
Histidine 12.7 12 11
Arginine 19.1 18 18
Threonine 11.6 12 14
Alanine 16.0 15 15
Proline 21.6 16 16
Tyrosine 26.1 30 31
Valine 12.7 13 12
Methionine 3.0 3 3
Cysteine 6.4 11 11
Isoleucine 7.5 7 7
Leucine 16.1 13 14
Phenylalanine 6.9 6 6
Lysine 4.0 5 6
Tryptophan ND 3 4
ND = not determined.
a variant L3 (see Fig. 3.3. Values are expressed as residues permolecule, normalised
on the assumption that the mature form of lysyl oxidase contains 16 lysine residues (see
note b).
k from the rat lysyl oxidase precursor sequence derived from the cDNA (Trackman et
al., 1990; Trackman etal., 1991), assuming the mature enzyme consists of the entire
C-terminal region beginning at residue 161 (based on preliminary observations of
porcine skin lysyl oxidase by mass spectrometry (Cronshaw, unpublished
observations)).
c from the human lysyl oxidase precursor sequence derived from the cDNA
(Hamalainen etal, 1991), assuming the mature enzyme consists of the entire C-
terminal region beginning at residue 167 (see note b).
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Reverse phase HPLC analysis ofCNBr peptides from TRAMP and lysyl
oxidase variants were carried out byMr A D Cronshaw according to the methods
described by Cronshaw et ah (1993). All five TRAMP variants showed similar profiles
(not shown), as did the four variants of lysyl oxidase (not shown). No similarities were
observed between the CNBr profiles ofTRAMP and lysyl oxidase (Cronshaw etal.,
1993).
Amino acid sequence analysis was carried out on TRAMP and lysyl oxidase
(separated in denaturing conditions by reverse phase HPLC) by Mr A D Cronshaw
using an Applied Biosystems 477A pulsed-liquid microsequencer (Cronshaw etal.,
1993). The entire amino acid sequence ofTRAMP (variant T3) has been determined on
peptides generated by cyanogen bromide or clostripain digestion (see appendix II). The
sequence has a tyrosine-rich region at the N-terminus and is identical (differing in only
4 positions) to a 22 K dermatan sulphate proteoglycan-associated extracellularmatrix
protein from bovine skin (Neame etal., 1989). It is concluded that TRAMP is the same
as the protein ofNeame etal.,{ 1989). The sequence of a 36 residue peptide from
porcine lysyl oxidase (Cronshaw etal., 1993) is identical to residues 291-326 in the rat
lysyl oxidase precursor (Trackman etal., 1990; Trackman etal., 1991) and differs in 4
positions from residues 299-334 in the human placental enzyme precursor (Hamalainen
etal., 1991). The amino acid sequence of the 36 residue lysyl oxidase peptide was not
found in TRAMP. From amino acid analysis, sequence data and CNBr peptide
mapping it is concluded that TRAMP and lysyl oxidase are unrelated.
3.1.4 Further Characterisation of TRAMP
Complete sequence data ofTRAMP (Cronshaw etal., manuscript in
preparation) agrees well with the amino acid analysis and shows it to be rich in acidic
amino acids (Table 3.1). The calculated isoelectric point (pi) determined with the
University ofWisconsin GCG software package, and allowing for pyroglutamate at the
N-terminus is 4.53. To experimentally determine the pi, TRAMP variants in 4 M urea
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were analysed by isoelectric focussing using a Biorad mini IEF cell (section 2.4.4).
TRAMP variants T1 to T5 were found to be increasingly acidic, with pi's in the range
4.43 to 4.07 (Table 3.3). The observed pi's are less than the theoretical value and they
decrease as expected from the Mono Q elution profile (Fig. 3.5(a)).
Precise mass determinations for TRAMP (carried out by staff at Finnigan Mat
Ltd, Hemel Hempstead) were made by mass spectrometry using a LaserMat laser
desorption ion source coupled to a time-of-flight mass analyser. TRAMP variants were
prepared for mass analysis as described by Cronshaw etal. (1993), and the results are
shown in Table 3.3. Based on the complete amino acid sequence for porcine TRAMP
(Cronshaw et al., manuscript in preparation), the molecularmass found in non
reducing conditions was 21989 daltons. The observed molecular mass of all TRAMP
variants was greater than the calculated value, and the mass increase was linear between
adjacent variants, with a concomitant decrease in isoelectric point (Table 3.3).
The differences between the observed and calculated isoelectric points
suggested that some amino acids may have been modified at the post-translational level.
The modifications would be acid labile to account for the absence ofmodified amino
acids by sequence analysis, and would increase the net negative charge on the protein to
account for the low pi. The presence of an acidic post-translational modification was
suggested by the observation that TRAMP stains strongly with Alcian Blue following
SDS-PAGE (section 2.4.8.4; Fig. 3.6). The staining was quantified by densitometry
(section 2.3.5) and found to be linear up to 5 pg ofTRAMP (Fig. 3.7). Alcian Blue is
normally used to identify proteoglycans (Wall & Gyi, 1988), however TRAMP does
not appear to be a proteoglycan as mass spectrometry ofvariant T1 (Table 3.3) indicates
a molecular mass only about 160 daltons greater than that predicted on the basis of the
amino acid sequence. Following SDS-PAGE, a protein with the electrophoretic
migration ofTRAMP was the only one to stain with Alcian Blue in the original 6 M
urea extract from skin (Fig. 3.6). On the basis ofAlcian Blue staining followed by
densitometry of the stained gel (sections 2.4.8.4 & 2.3.5) it was possible to estimate
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Table 3.3 Molecular masses and isoelectric points (pi) of TRAMP
variants.
Variant T1 T2 T3 T4 T5
Mass3 (Da) 22144 ±22 22208 ± 22 22278 ± 22 22328 ± 22 22377 ± 22
plb 4.43 ±0.1 4.34 ± 0.06 4.27 ± 0.08 4.18 ± 0.08 4.07 ± 0.06
3 Errors are standard deviations based on standards (carbonic anydrase, n = 8).
b Errors are standard deviations based on standards (soyabean trypsin inhibitor, n = 6).
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L T E L T E
Figure 3.6 SDS-PAGE of porcine skin TRAMP and lysyl oxidase
TRAMP and lysyl oxidase were partially purified by elution from DEAE-Sepharose and
Sephacryl S-400 columns at different urea and salt concentrations (Cronshaw etal.,
1993). L = lysyl oxidase, T = TRAMP, E = initial 6 M PBU extract. Gels were run in
duplicate and equal amounts of protein were loaded in corresponding lanes for staining
with either Coomassie Blue or Alcian Blue. The diffuse bands in the lower part of the





Figure 3.7 Linear relationship between the intensity of Alcian Blue
staining and known amounts of TRAMP
Different amounts ofTRAMP (determined by the bicinchoninic acid assay) were
analysed by scanning densitometry after SDS-PAGE. Samples were reduced with (3-
mercaptoethanol and the gel was stained with Alcian Blue.
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that lg of piglet skin (wet weight) contained approximately 4 p.g of TRAMP.
Tyrosine sulphation represents one possible post-translational modification.
There are five tyrosine residues in TRAMP that meet four of the five empirically
determined rules for tyrosine sulphation (Hortin et al, 1986) involving the specific
positioning of tyrosine residues in exposed protein domains adjacent to acidic amino
acids, and relative paucity of hydrophobic residues, basic residues and cysteine.
Residues 5,15, 148,149 and 176 in the TRAMP sequence represent these putative
sulphation sites. The tyrosine sulphate bond is particularly labile to acid hydrolysis
(Huttner, 1984). Following treatment of TRAMP with 1 M HC1 (section 2.4.7) for 5
min at 100 °C, and prior to SDS-PAGE, Alcian Blue staining almost halved relative to
Coomassie Blue staining (Fig. 3.8(a)), though there was evidence of partial hydrolysis.
By the same criteria, TRAMP boiled in distilled water did not affect subsequent Alcian
Blue staining relative to Coomassie Blue staining (not shown). To further investigate
tyrosine sulphation, TRAMP was incubated with sulphatase (either type V from limpet
or type VII from abalone; section 2.4.7) prior to SDS-PAGE. Following treatment with
either enzyme, Alcian Blue staining decreased almost three fold with no change in
Coomassie Blue staining (Fig. 3.8(a)). A small amount of (3-glucuronidase activity was
present as a contaminant in the sulphatases. To examine any effects of such
contamination, separate experiments with purified (3-glucuronidase (E. coli;
Boehringer) were carried out at two times the level present in the sulphatase
preparations. There was no effect on the electrophoretic migration of TRAMP or
staining with Alcian Blue and Coomassie Blue (Fig. 3.8(a)). To further establish
whether TRAMP contained sulphated tyrosine residues, the chromatographic behavior
of a mixture of variants (T3, T4 & T5) was examined on Mono Q FPLC before and
after sulphatase treatment. The results (Fig. 3.9) show that, while small protein peaks
elute at the original positions of T3, T4 and T5, three prominent peaks appear earlier in
the elution gradient By SDS-PAGE analysis (not shown), all three peaks co-migrated
with T3, T4 and T5. No protein peaks were observed on the Mono Q elution profile of
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Con E/N Neu O-G Glu
Figure 3.8 Effects of various deglycosylation and desulphation
treatments on TRAMP staining by (a) Alcian blue and (b)
periodic acid Schiff (PAS) reagent
Staining of SDS-PAGE gels was quantified with a scanning densitometer and
expressed relative to Coomassie Blue staining of equal amounts of protein treated in
identical conditions. Error bars are standard deviations based on at least three
measurements. TRAMP was analysed after purification by DEAE-Sephacel and
Sephacryl S200 chromatography, without subsequent separation of ionic variants. Con
= control; E/N = endoglycosidase F/N-glycosidase F; Neu = neuraminidase; O-G - O-
glycosidase; Glu = P-glucuronidase; HC1 = 1 M HC1; Sul = sulphatase (type V).
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Figure 3.9 Chromatography of TRAMP variants following sulphatase
treatment
Chromatograhy of TRAMP variants (T3, T4, & T5) on Mono Q FPLC, before (a) and
after (b) treatment with sulphatase (type V).
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sulphatase alone (when used at the same level used for the TRAMP incubations; data
not shown).
Sequence analysis, mass spectrometry and susceptibility to mild acid hydrolysis
and sulphatase treatment suggest that TRAMP contained two sulphate residues.
However the chemical basis of the five variants ofTRAMP is not understood (see
discussion). Carbamylation at lysine residues (due to prolonged exposure in urea
containing buffers) is a possible explanation, as conversion to more acidic forms would
be expected. However, when separated by Mono Q FPLC, TRAMP variants (T2 or
T3) did not interconvert on further exposure to 6 M urea for prolonged periods (up to
10 days) at 37 °C, as evidenced by an unaltered Mono Q elution profile following
rechromatography ofT2 and T3 (not shown). Similarly, isoelectric focussing data also
confirmed that the pi ofvariant T3 was not changed on further exposure to urea (not
shown).
Possible glycosylation of TRAMP was investigated by the following
experiments. There are no hexosamines in the amino acid composition ofTRAMP, as
also observed by Neame etal. (1989). The presence of carbohydrate was suggested by
periodic acid Schiff (PAS) staining (section 2.4.8.2; Fig. 3.8(b)) ofTRAMP following
SDS-PAGE. However, after digestion ofTRAMP variants with endoglycosidase F/N-
glycosidase F, neuraminidase, O-glycosidase and (3-glucuronidase (section 2.4.5),
there were no changes in the apparent molecular mass, band sharpness, PAS orAlcian
Blue staining intensity when analysed by SDS-PAGE (Fig. 3.8). Control experiments
with fetuin (which contains sialic acid residues, and N and O-linked carbohydrate;
manufacturers literature) treated with the above enzymes (excluding (3-glucuronidase)
caused a decrease in the apparent molecular mass indicative of enzyme activity (not
shown). Possible glycosylation of TRAMP was further investigated by incubating
lectins (wheat germ agglutinin (WGA) and concanavalin A (Con A) with protein blotted
onto nitrocellulose (sections 2.3.4.2 & 2.4.6.2). TRAMP was not detected with the
WGA (cojugated to horseradish peroxidase; HRP), however when incubated with con
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A and peroxidase, some staining ofTRAMP was observed (Fig. 3.10), and indicated
that the protein was glycosylated. To examine whether con A orHRP was binding
directly to TRAMP the following experiments were carried out. By fluorography of
proteins in nitrocellulose transfers after incubation with the iodinated con A, there was
no binding of the lectin to TRAMP, Con A-I125 did however detect the target
glycoprotein (procollagen C-propeptide). By incubating protein electroblots with HRP
alone, it was found that the enzyme bound to TRAMP (Fig. 3.10). These results taken
together indicate that TRAMP is not glycosylated, and that TRAMP may have an
affinity for the enzyme glycoprotein HRP.
Polyclonal antibodies to Mono Q purified TRAMP were raised in rabbits
(section 2.4.9). The specificity of the antiserum was tested by immunoblotting
experiments after SDS-PAGE of the denatured proteins (section 2.3.4). Using the ECL
detection system for localisation of the antigen (section 2.4.9.1), TRAMP was the only
protein to be stained in the original 6 M urea crude extract from porcine skin (Fig.
3.11), no staining was observed with purified lysyl oxidase (not shown). Similarly,
TRAMP was the only protein to be stained in urea extracts of several porcine tissues
(Fig. 3.11). Control experiments with serum taken before the TRAMP immunisations
had began did not detect any protein in immunoblots.
Because lysyl oxidase and TRAMP frequently copurify, possible interactions
between them were examined. The activity of lysyl oxidase on an elastin substrate
(section 2.4.3) was not affected in the presence of increasing concentrations of
TRAMP, up to a 40 : 1 molar ratio ofTRAMP to lysyl oxidase (Shackleton, personal
communication).
3.1.5 Further Characterisation of Lysyl Oxidase
SDS-PAGE analysis of lysyl oxidase showed that the protein often occured as a
doublet (Mr 34-36 K; Fig. 3.2, lane 5) with a weak slowly migrating component.






Figure 3.10 Detection of glycoprotein in lysyl oxidase and TRAMP
preparations
Proteins were partially purified by DEAE Sephacel and Sephacryl S-200
chromatography (Fig. 3.2, lane 4), electrophoresed on a reducing 12 % SDS-
polyacrylamide gel and then transferred to nitrocellulose. 1, TRAMP (24 K) and lysyl
oxidase (34-36 K) stained with the concanavalin A-peroxidase procedure; 2, stained
with peroxidase only.
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Figure 3.11 Immunoblotting of porcine TRAMP from different tissues
Samples were electrophoresed on a reducing 12 % SDS-polyacrylamide gel, blotted
onto nitrocellulose and incubated with polyclonal antibodies. All porcine tissue samples
are crude 6 M urea extracts, and equal amounts of each protein were loaded. TRAMP
(lane 6) was purified by DEAE Sephacel and Sephacryl S-200 chomatography. 1, heart;
2, lung; 3, liver; 4, skeletal muscle; 5, skin; 6, purified TRAMP; 7, umbilical cord.
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the enzyme. By concanavalin A affinity chromatography (section 2.4.6.1), the minor
component (36 K) was retained, and was subsequently eluted with 1 M a-D-
methylmannoside. The 34 K component which was not retained by the column had
enzyme activity, as did the 36 K component; both activities were inhibited with 0.2 raM
BAPN, a specific inhibitor oflysyl oxidase (Tang et al., 1983). Further experiments
using lectins incubated with protein electroblots (section 2.4.6.2) demonstrated binding
of con A to the 36 K protein (Fig. 3.10), which was abolished in the presence of a-D-
methylmannoside. Control experiments with the procollagen C-propeptide (which has
carbohydrate groups mannose and N-acetylglucosamine present) also showed binding
to con A. The binding of both proteins to con A appears to be specific as molecular
weight standards (Pharmacia) were not detected by the lectin on nitrocellulose blots.
3.2 Discussion
The interaction that occurs between lysyl oxidase and TRAMP with Sephacryl
S-200, and recently Sephacryl S-400, in conditions of low ionic strength, is not
understood (Cronshaw etal., 1993). Kagan and Trackman (1991) suggested that
removing urea from the extracted preparation induces polymerisation of the enzyme.
The aggregated enzyme is retained at the top of the S-200 gel filtration column, which,
after washing with urea-free buffer, is disaggregated and eluted with urea-
supplemented buffer. However, the observation that both lysyl oxidase and TRAMP do
not interact with either the polyacrylamide based Biogel or agarose based Sepharose 4B
gel filtration media under the same conditions (MacBeath, unpublished observations)
suggests that there is a more specific interaction with S-200.
Amino acid sequence data from peptide fragments confirm that the enzyme
(purified from urea extracts ofporcine skin, followed by DEAE ion exchange
chromatography and selective interaction with Sephacryl S-200; Shackleton & Hulmes,
1990a; Cronshaw etal., 1993) corresponds to both rat aorta (Trackman etal., 1990;
Trackman etal., 1991) and human placenta (Hamalainen etal., 1991) lysyl oxidase.
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It was surprising to find that TRAMP was unrelated to lysyl oxidase, as several
workers had reported the presence of a degradation product in enzyme preparations
with approximately the same molecular mass as TRAMP (Sullivan & Kagan, 1982;
Kuivaniemi etal., 1984; Burbelo etal., 1986). The identity between TRAMP and the
22 K extracellular matrix protein from bovine skin (Neame etal., 1989) became
apparent only after searching a protein sequence database (Collins, personal
communication). By urea extraction followed by DEAE ion exchange chromatography
and then gel filtration on Sepharose CL-6B, the 22 K protein from bovine skin
copurified with dermatan sulphate proteoglycans (Choi etal., 1989; Neame etal.,
1989). A similar procedure was used to purify lysyl oxidase from porcine skin, but
with TRAMP copurifying using a specific interaction with Sephacryl S-200 as the final
step. It is possible that TRAMP is also related to the 23 K protein contaminant found in
preparations of human placental lysyl oxidase (Table 3.1; Kuivaniemi etal., 1984),
although, in the absence of sequence data, it is impossible to confirm this. TRAMP
does not appear to be present in urea extracts ofbovine cartilage (Choi etal., 1989),
although preliminary data from immunoblots indicate that porcine TRAMP has a
widespread tissue distibution (MacBeath & Forbes, unpublished observations). Using
polyclonal antisera, TRAMP was the only protein to be detected in extracts from several
porcine tissues (Fig. 3.11); this appears to suggest that TRAMP is not derived from a
precursor form.
From the data, TRAMP is clearly not a degradation product of lysyl oxidase,
although a distinct protein of similar molecular mass (22-24 K) exists which from
peptide mapping (Sullivan & Kagan, 1982) or immunoblotting (Kuivaniemi etal.,
1984; Burbelo et al., 1986) does appear to be a genuine degradation product of the
enzyme.
It is not clearwhy both TRAMP and lysyl oxidase occur as several variant
forms. The existence ofmultiple ionic forms of lysyl oxidase has been observed in
enzyme preparations from chick cartilage (Stassen, 1976), bovine aorta (Sullivan &
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Kagan, 1982), human placenta (Kuivaniemi etal., 1984) and umbilical cord (Burbelo
etal., 1986). As only one gene has been found in rat genomic DNA (Trackman etal.,
1990), molecular heterogeneity of lysyl oxidase may stem from post-translational
modifications. Another possibility is carbamylation ofamino groups on the enzyme due
to cyanate derived from urea (Meens & Feeney, 1971). Both TRAMP (Neame etal.,
1989) and lysyl oxidase (Trackman etal., 1990; Trackman etal., 1991; Hamalainen et
al., 1991) contain only a few lysine residues (Tables 3.1 & 3.2). The decreasing
isoelectric point for TRAMP variants T1 to T5 are consistent with an increased extent of
carbamylation since, from complete amino acid sequence data (Cronshaw etal.,
manuscript in preparation), the theoretical pi's would be 4.53, 4.44, 4.36, 4.28 and
4.20 (with pyroglutamate at the N-terminus and 0, 1,2, 3, or 4 lysines carbamylated,
respectively; cf. Table 3.1). Mass spectrometry data is also consistent with
carbamylation, since the additional mass for each lysine residue carbamylated (43 Da) is
within the experimental range of the average mass increment between consecutive
TRAMP variants (32-76 Da). However carbamylation is probably not the basis for
multiple forms ofTRAMP, since Mono-Q-separated variants T2 and T3 retain their
original chromatographic behaviour when further exposed to urea for prolonged
periods. Isoelectric focussing also confirmed that TRAMP was not converted to more
acidic forms, following prolonged storage in urea-containing buffers. Furthermore,
amino acid analysis (Cronshaw, personal communication) ofacid hydrolysates from the
five variants ofTRAMP did not contain detectable amounts ofhomocitrulline, the
carbamylated derivative of lysine (Kagan etal., 1979). Similar observations were
reported by Kuivaniemi etal. (1984) for human placenta lysyl oxidase variants.
Although lysyl oxidase does not appear to be glycosylated (Sullivan & Kagan,
1982), preliminary data indicates that a small proportion ofporcine lysyl oxidase (or an
enzyme precursor) appears to contain N-linked sugars. This observation is consistent
with the finding ofpossible N and O-linked glycosylation sites in the enzyme sequence
derived from the cDNA (Trackman etal., 1990; Trackman etal., 1991; Hamalainen et
141
al., 1991). Staining ofproteins (separated by SDS-PAGE) with Stains-All indicate that
TRAMP is not phosphorylated. However, several observations indicate the presence of
tyrosine sulphation in TRAMP. Sequence data analysis indicates five possible sites. All
five TRAMP variants stain strongly with Alcian Blue, which is relatively specific for
sulphated biopolymers in 50 mM MgCl2 (Scott, 1973), and susceptibility to mild acid
hydrolysis and sulphatase treatment are also consistent with sulphation at tyrosine
residues. The difference of around 154 Da between the observed and calculated
molecular mass is consistent with sulphation at two tyrosine residues (i.e. additional
mass 2 x 79 Da). The presence of two sulphated tyrosines would be expected to lower
the isoelectric point of each TRAMP variant by about 0.17 pH unit, which is also in
agreement with the difference between the observed and calculated pi's. Re-
chromatography ofTRAMP variants following sulphatase treatment demonstrates that
there is a shift to less acidic forms of the protein and hence earlier elution from the
column. Even more interesting was the observation that sulphatase treatment caused the
variants to elute closer together, indicating that they have been converted to more
similar ionic species. Although the results are consistent with the presence of tyrosine
sulphation in TRAMP, in the absence ofmass spectrometry data (following
desulphation ofTRAMP), it is not yet possible to conclude that variants T1 to T5 differ
in their extents of sulphation. Tyrosine sulphation is, however a widespread post-
translational modification in extracellular matrix proteins, e.g. nidogeiVentactin,
fibronectin, dermatan sulphate proteoglycans (Huttner, 1988), Procollagens III and V
(Jukkola etal., 1990), bone sialoprotein II (Ecarot-Charrier etal., 1989; Midura etal.,
1990) and fibromodulin (Antonsson etal., 1991). In types III and V procollagen, the
anion is located at the N-terminus (Jukkola etal., 1990), and in fibromodulin tyrosine
sulphation is also in the N-terminal region, in a tyrosine-rich sequence where tyrosine
occurs every second or third residue (Antonsson etal., 1991). This feature is also
present in TRAMP (Neame etal., 1989), though the sequences are not homologous.
Multiple variants of fibromodulin have also been observed (Lauder, R.M.,
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Nieduszynski, I.A. & Huckerby, T.N., personal communication). The role of tyrosine
sulphation has not been extensively investigated for extracellular matrix proteins,
although desulphation of fibronectin affects its binding affinities to several ligands
(Suiko & Liu, 1988).
The biological properties ofTRAMP are not fully understood. The primary
structure contains three repeat regions, each having a similar pattern of looped
disulphide bonds (Neame etal., 1989). A six amino acid consensus sequence Asp-Arg-
Glx-Trp-Asn/Gln/Lys-Phe/Tyr is found in each loop. This domain may be involved in
association of the molecule with othermatrix components (Neame etal., 1989). The
equivalent 22 K protein from bovine skin, appears to show binding activity to cell
surface receptors, possibly of the integrin class (Lewandowska etal., 1991). TRAMP
has no lysyl oxidase activity on an elastin substrate, nor does it affect the activity of
added lysyl oxidase. The apparent lack of interaction with elastin is consistent with the
absence ofTRAMP in lysyl oxidase purified from rat skin by an elastin affinity
procedure (Romero-Chapman etal., 1991). It has been shown, however, that TRAMP
binds to collagen and accelerates the formation of fibrils in vitro (Chapter 4). Since it is
already known that the activity of lysyl oxidase on a collagen substrate is markedly
increased by prior assembly of the molecules into fibrils (Siegel, 1974), it is possible
that TRAMP may influence enzyme activity indirectly, via aggregation of the substrate.
The observations that the bovine 22 K protein interacts with dermatan sulphate
proteoglycans (Neame etal., 1989; Lewandowska etal., 1991) and that DSPG II
(decorin) is known to inhibit collagen fibril formation (Brown & Vogel, 1989) suggest
a complex regulatory role for TRAMP interactions with other components of the
extracellularmatrix (see Chapter 4).
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Chapter 4
Influence of TRAMP on Collagen I Fibrillogenesis
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4.1 Results
4.1.1 Characterisation of TRAMP and Collagen
The five variants of TRAMP (separated by Mono Q FPLC; Fig. 3.5(a)) were
analysed for purity by SDS-PAGE (see Chapter 3, Fig. 3.5(b)). No trace of
contaminating proteins, including lysyl oxidase, was present in these preparations.
Further SDS-PAGE analysis (Fig. 4.1) revealed that the purified lathyritic rat skin
collagen (section 2.1) used for fibril formation consisted almost entirely of a-chains,
with the remaining protein bands (approximately 5 % of the total) in the form of
multimeric cross-linked, collagen (3 and y components. Scanning densitometry of the
gel stained with Coomassie Blue showed that the al and a2 chains were in a 2:1 ratio,
indicative of the absence of type III collagen which is also found in skin and migrates
under reducing conditions with a similar electrophoretic mobility to the al chain of
collagen I. Identical gels were obtained under both reducing and non-reducing
conditions (not shown). This also indicated the absence of collagen III, which contains
reducable disulphide bonds. Collagen preparations were further characterised by SDS-
PAGE after CNBr cleavage (section 2.3.2). The peptide pattern (Fig. 4.1) was as
expected for pure type I collagen (Bornstein & Sage, 1980). Further to this, no
appreciable 280 or 260 nm absorbing material was found, suggesting low levels of
contaminating non-collageneous proteins and/or nucleic acids, respectively. Amino acid
analysis (section 2.3.1) of the purified collagen indicated 330 residues ofglycine/1000
(Table 4.1) which was also consistent with the preparation being 100 % collagenous.
The amino acid composition for the skin collagen is also in agreement with that
obtained by other workers (Table 4.1). The tyrosine content was 3.2 ± 0.64 (SD, N =
3) per 1000 residues. Since all the tyrosine residues are located in the terminal, non-
helical telopeptide regions of the collagen molecule (approximately 4/1000 residues)
which are susceptible to proteolytic cleavage, it was concluded that the telopeptides
were intact following extraction and purification (Payne etal., 1986).
145
1 2 3
Figure 4.1 SDS-PAGE of collagen I and peptides produced after CNBr
cleavage
Collagen I was electrophoresed on a 6 % SDS-PAGE gel (track 1). CNBr peptides of
collagen I were separated by SDS-PAGE on a 12 % gel (track 2). The CNBr peptide
pattern produced from collagen III is shown for comparison (track 3). Samples were
reduced with (3-mercaptoethanol and the gels were stained with Coomassie Blue.
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Table 4.1 Amino acid composition of rat skin collagen
Amino acid (Piez etal., 1963) This study3
Hydroxyproline 93 96
Aspartic acid 46 51
Threonine 19.7 18
Serine 42 38














ND = not determined.
Values are residues per 1000
a The average of triplicate analyses are presented. The error was approximately 5 %,
values lower than 10 residues/1000 tended to have larger errors (10-20 %).
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4.1.2 Kinetics of Fibril Assembly and Disassembly
Collagen fibril assembly was initiated by the "warm start" technique (section
2.5; Holmes et al, 1986), in which collagen in 5 mM acetic acid and double-strength
fibril formation buffer (60 mM disodium phoshate, 60 mM TES, 270 mM NaCl, pH
7.4) are pre-incubated separately at 34 °C before mixing 1:1. Fibril formation was
monitoring by changes in turbidity at 313 nm. Prior to this, collagen solutions were
centrifuged (100,000 g for 4 hours) to remove large aggregates, if present. All other
solutions were filtered with 0.22 (im Millipore filters. When TRAMP was present it
was dialysed against double-strength fibril formation buffer at 4 °C for 24 hours with 2
changes. In the absence of TRAMP and with a final collagen concentration of 0.2
mg/ml, fibrils were reconstituted with a typical sigmoidal turbidity curve (Fig. 4.2).
(Collagen concentrations were determined by the hydroxyproline or BCA assay;
sections 2.3.3 & 2.4.1, respectively). The curve shown in Figure 4.2 is characterised
by a lag phase (t^ ; measured by extrapolating the linear region of the growth phase to
the time axis) of about 20 minutes during which there is no detectable change in
turbidity, a growth phase during which turbidity changes rapidly, and finally a plateau
region after about 150 minutes where turbidity again remains constant. When TRAMP
was present, however, fibril formation was accelerated, as also shown in Figure 4.2 by
a decrease in tlag and an increase in growth rate (i.e. maximum slope of growth
phase). These changes were concentration dependent, with progressive acceleration of
fibril formation in the presence of increasing amounts of TRAMP (Fig. 4.2).
Acceleration of fibril formation was observed at very low concentrations of TRAMP,
down to a 1 to 20 molar ratio of TRAMP to collagen. Table 4.2 represents data
collected from several experiments, and shows that the kinetics (t^g, maximum slope of
growth phase and tj/2 (time required to reach the middle point of the final fibril
opacity)) of collagen reconstitution and the total turbidity change (Ah) are consistently
increased in the presence of TRAMP. All five TRAMP variants were found to be
equally effective in accelerating fibril formation. TRAMP also stimulated collagen
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Figure 4.2 Turbidity-time curve showing the acceleration of collagen
fibril formation by TRAMP
Initial assembly at 34 °C with a fixed concentration of collagen (200 ^ig/ml) and
increasing concentrations (|ig/ml) of TRAMP variant T5.
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Table 4.2 Effect of TRAMP on the kinetics of collagen fibril formation
tlag t1/2 maximum slope final turbidity













Kinetic parameters are indicated as means, with standard errors in parentheses, where
the number of experiments in each group was 24. Significant differences at the
p<0.001 level (Student's t test) are indicated (**). tjag = lag time, determined by the
intercept of the line ofmaximum slope in the turbidity-time curve with the time axis.
ty2 = bme to reach halfmaximum turbidity. Data for TRAMP variants T4 and T5 were
combined as the results obtained with each variant were indistinguishable (not shown).
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fibrillogenesis when fibril formation was initiated by a "cold start" procedure (Holmes
etal., 1986; not shown). In this approach cold neutral collagen solutions (4 °C; pH
7.4), were centrifuged (100,000 g for 4 hours) to remove any large aggregates,
followed by warming the solution to 34 °C to allow fibril assembly to proceed.
Fibrillogenesis experiments also showed that the presence of 1 mg/ml bovine serum
albumin had no effect on collagen fibril formation or on the ability ofTRAMP to
accelerate the rate of fibril formation (not shown).
Taking t]/2 as a measure of the rate of fibril assembly, the dependence of t1/2 on
collagen concentration was determined in the range 0.05 to 0.4 mg/ml. It was found
that the rate of fibril assembly in the absence and presence ofTRAMP expressed as a
reciprocal of tj/2 was directly proportional to collagen concentration. The slope of the
line plotted as log (l/t1/2) as a function of log concentration fitted with a least squares
straight line was 1, when fibrils were formed in the presence and absence of TRAMP
(Fig. 4.3). This finding suggests that fibrils formed in the absence or presence of
TRAMP assemble by a similar mechanism (Williams etal., 1978).
The maximum turbidity values reached for collagen fibrils formed in the
absence of TRAMP was less than that when TRAMP was present (Table 4.2). The final
turbidity level for collagen formed in the presence of 20 pg/ml TRAMP (i.e.
approximately equimolar concentrations of collagen to TRAMP) was about 20 % higher
than that seen for collagen alone (Fig. 4.2). As the final turbidity is a measure of fibril
diameter and/or the amount of collagen participating in fibril formation, it may be that
TRAMP either enhances the efficiency of the incorporation of collagen into those fibrils
and/or increases the final fibril diameter. In order to ascertain whether TRAMP
increased the extent of fibril formation, fibrils were sedimented by centrifugation
(15,600 g, 2 min) at room temperature 1-2 hours after the turbidity plateau was
reached, and hydroxyproline in the supernatants was determined and compared to the
total hydroxyproline present in the experiments. It was found that 7.5 % of the total
collagen remained in the clear supernatant of fibrils formed in the presence of 20 jug/ml
151
LOG CONCENTRATION
Figure 4.3 Dependence of t1/2 °f fibril formation on initial concentration
of collagen
Fibrils were formed at 34 °C in the presence (■) and absence (•) of TRAMP (variant
T4, 5 |ig/ml). The least squares line through both sets of points has a slope of 1.
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TRAMP (Fig. 4.4). Increasing amounts of collagen were detected in the supernatants
after fibrillogenesis in the presence of decreasing amounts ofTRAMP (Fig. 4.4). In the
absence ofTRAMP, only 75 % of total collagen was incorporated into the Fibrils, as
ascertained by the amount of sedimentable collagen (Fig. 4.4).
The kinetics of fibril disassembly were examined by a temperature jump method
(Brennan & Davison, 1980). TRAMP was found to partially stabilise fibrils against
dissociation following a temperature drop from 34 °C to 4 °C (Fig. 4.5). The rate and
extent of dissociation were progressively smaller when fibrils were initially formed in
the presence of increasing amounts ofTRAMP. The disassembly reaction was initially
very rapid and was complete within 40 minutes. This was followed by a much slower
rate of dissociation which was complete within 16 hours. After this period fibrils
formed without TRAMP had completely solubilised. This complete reversibility of the
fibril assembly reaction demonstrates the absence of lysine-derived aldehydes which are
known to form covalent inter-molecular cross-links, thus stabilising the fibrillar
aggregate against low temperature solubilisation (Na, 1989). However, for fibrils
formed in the range ofTRAMP concentrations used, dissociation was only 85-95%
complete after 16 hours, and no further changes were observed on further storage (up
to 72 hours) at 4 °C (Fig. 4.5). Again, all TRAMP variants were found to stabilise
fibrils in this way.
As lysyl oxidase was also present in the early stages ofTRAMP purification,
and as lysyl oxidase is known to bind to collagen (Cronlund et al., 1985), it was
possible that the apparent effect ofTRAMP on the kinetics of fibril assembly and
disassembly may have been due to trace amounts of lysyl oxidase. Several observations
indicated that this was not the case. First, when large amounts (5-10 pg) of each
TRAMP isoform were subjected to SDS-PAGE followed by Coomassie Blue, no trace
of lysyl oxidase was found (Chapter 3; Fig. 3.5(b)), and subsequent silver staining of
the Coomassie stained gel also showed the absence of contaminating enzyme. Second,
no enzyme activity (as judged by the ultrafiltration assay using an elastin substrate) was
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TOTAL TRAMP (jig)
Figure 4.4 The binding of TRAMP to collagen fibrils and its effect on
increasing the amount of fibrillar collagen
Amounts of collagen in the supernatant (determined by hydroxyproline assay) and
TRAMP in the pellet (determined by scanning densitometry) after centrifugation of
fibrils formed at 34 °C from a fixed concentration of collagen (200 pg/ml) and
increasing concentrations ofTRAMP (variant T5). The volume of the incubation
mixture was 1 ml.
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Figure 4.5 Turbidity-time curve showing the acceleration of collagen
fibril formation by TRAMP and partial stabilisation of fibrils
against low temperature dissociation
Assembly at 34 °C as in Figure 4.2 followed by a rapid temperature drop to 4 °C.
Turbidity values (A313 nm) after 16 h and 72 h at 4 °C are indicated. TRAMP variant T5
was used.
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associated with the TRAMP preparations in fibril formation buffer. Third, when
preparations containing lysyl oxidase and TRAMP elute from a Mono Q FPLC column,
TRAMP variants (T4 & T5) are completely resolved from the enzyme (Chapter 3; Fig.
3.4(b)). Therefore, because all TRAMP variants have a similar effect on fibril assembly
and disassembly, it is unlikely that these effects are due to contaminating enzyme.
Fourth, when Fibril formation was carried out in the presence of 0.2 mM (3-
aminopropionitrile, a specific inhibitor of lysyl oxidase (Tang etal., 1983), TRAMP
(pre-incubated in 0.2 mM (3-aminopropionitrile for 30 minutes) continued to accelerate
fibril formation and inhibit subsequent low temperature dissolution of the formed fibrils
(not shown). Fifth, SDS-PAGE analysis showed that there was no increase in (3 and y
components (cross-linked aggregates of collagen I) in fibrils formed in the presence of
20 pg TRAMP. Finally, preliminary observations with 3-5 pg of purified lysyl oxidase
variant LI (Chapter 3; Fig. 3.4(b)), at concentrations comparable to that ofTRAMP
used in the above experiments, showed no effect on the kinetics of fibril assembly (Fig.
4.6).
4.1.3 Morphological Studies
To examine any effects ofTRAMP on fibril morphology, the following
experiments were done. Fibrillar collagen samples were obtained by centrifugation at
room temperature 1-2 hours after the turbidity plateau was reached (approximately 3-4
h after the initiation of fibril formation). When analysed by electron microscopy after
negative staining (sections 2.5.1.1 & 2.5.1.4) fibrils reconstituted in the presence and
absence ofTRAMP appeared to be well formed with no apparent differences in their D-
periodic banding pattern (Figs. 4.7(a) & 4.7(b)). The banding pattern consisted of a
fine polarised band pattern superimposed on alternate light and dark regions. When
viewed in the electron microscope at lower magnification, the fibrils were of
undetermined length and fibril ends were seen only occasionally. When the ends were
seen they had highly tapered tips (Figs. 4.7(c) & 4.7(d)). However, measurements of
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Figure 4.6 Effect of lysyl oxidase on the kinetics of collagen fibril
formation
Turbidity-time curve showing the effect of TRAMP (T, variant T5, 4 jig/ml) and lysyl
oxidase (L, variant LI, 4 jig/ml) on fibril formation at 34 °C from a fixed concentration
of collagen (200 |ig/ml). Assembly in standard buffer conditions in the absence of
TRAMP or lysyl oxidase (B) is shown for comparison.
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Figure 4.7 Morphology of collagen fibrils formed in the absence and
presence of TRAMP
Electron micrographs of fibrils assembled from collagen (200 jug/ml) in the absence (a
& c) and presence (b & d) of TRAMP (variant T5, 10 pg/ml). Specimens were
negatively stained with 1 % (w/v) phosphotungstic acid at pH 7.4. Panels a and b are at
a magnification of 28,000x and panels c and d at a magnification of 169,000x. The D-
periodicity is 65 nm.
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fibril diameter obtained from micrographs ofultra-thin sections (sections 2.5.1.3,
2.5.1.4 & 2.5.1.5) revealed consistent differences (Fig. 4.8). The mean diameter of
collagen fibrils formed in the absence ofTRAMP was 116 ± 29.7 nm (SD; n = 659). In
the presence ofTRAMP, the fibrils were thinner, and had a mean diameter of 85.5 ±
21.3 nm (SD; n = 705). The maximum diameter observed was 200 nm for collagen
alone, and 149 nm for fibrils formed with TRAMP. Thus in the presence ofTRAMP,
both the mean diameter and the maximum diameter are decreased by a factor of
approximately 0.75.
4.1.4 TRAMP-Collagen Interactions
The possible binding ofTRAMP to collagen was investigated by SDS-PAGE
analysis of pellets and supematents after fibril formation and centrifugation as above
(section 2.5.2.1). Following electrophoresis and subsequent Coomassie Blue staining
of the gel, TRAMP remained in the supernatant in the absence of collagen. (The
staining ofTRAMP previously quantified by densitometry was linear up to 5 pg
protein; Fig. 4.9). When collagen was present however, increasing amounts of
TRAMP were found in the pellet as the total TRAMP concentration increased (Fig.
4.4). The amounts ofTRAMP in the pellet approached saturation at 8 pg TRAMP to
200 pg collagen. Taking 22 kDa and 300 kDa as the respective molecular masses of
TRAMP and collagen, this corresponds to a stoichiometric ratio of 1 mol TRAMP to 2
mol collagen. The results shown in Figure 4.4 also demonstrate that the amount of
TRAMP bound was appreciably higher than that due to simple entrapment of the
protein, as explained below. A constant proportion of total TRAMP would be expected
to appear in the pellet by trapping alone (Carr & Hermans, 1978). Thus specific
incorporation was evaluated by adding bovine serum albumin (BSA) in the place of
TRAMP and it was shown that only 3% of the total BSA occured in the pellet when
fibrils were assembled at 200 pg/ml collagen and up to 200 pg/ml BSA. In contrast,
when fibrils were formed in a total concentration of 20 pg/ml TRAMP, the amount
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Figure 4.8 Diameter distributions of fibrils formed in the presence and
absence of TRAMP
Diameters of fibrils (determined by electron microscopy of sectioned pellets) formed at
34 °C in the presence (a) and absence (b) of TRAMP (variant T5, 5 pg/ml). The
collagen concentration was 200 pg/ml. Both distributions are significantly different at














Figure 4.9 Linear relationship between the intensity of Coomassie Blue
staining and known amounts of TRAMP
Different amounts ofTRAMP (determined by the bicinchoninic acid assay) were
analysed by scanning densitometry after SDS-PAGE. Samples were reduced with (3-
mercaptoethanol and the gel was stained with Coomassie Blue.
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bound was 8 pg/ml, or 42 % of the total.
The results from the kinetics of fibril assembly revealed that TRAMP had a
pronounced effect during the lag phase. Thus attempts were made to study possible
interactions between TRAMP and collagen during the early stages of fibril assembly.
Samples taken 2-3 minutes after the initiation of fibril formation were examined by
electron microscopy, after rapid freeze drying and rotary shadowing (sections 2.5.1.2
& 2.5.1.4). The results (Fig. 4.10) show representative electron micrographs of the
first formed aggregates in the assembly process. In the presence and absence of
TRAMP, a similar meshwork of filamentous microfibrils were observed. However, it
was found that when TRAMP was present, collagen monomers occasionally had a
globular region bound to one end of the molecule. These molecules were often seen
projecting from the surface of the microfibrils (Fig. 4.10). By comparison with electron
micrographs of rotary shadowed procollagen molecules, the globular region was
similar in size to the C-propeptide (i.e. approximately 100 kDa). This was much larger
than expected for TRAMP (22 kDa), though gel filration ofTRAMP in phosphate
buffered saline (0.1 M sodium phosphate, 0.15 M NaCl, pH 7.8) indicated that
TRAMP forms high molecular weight complexes in physiological buffers (Shackleton,
personal communication). In order to determine whether TRAMP was bound to the N
or C-terminal part of the the collagen molecule, similar rotary shadowing experiments
were carried out but using procollagen (a gift from Mr A. Choglay) in place of
collagen. However the results (not shown) were difficult to interpret as the procollagen
appeared to be highly contaminated with other small molecules, therefore the location of
the binding site(s) could not be confirmed.
The binding ofTRAMP to collagen was further investigated by the following
fluorescence polarisation experiments (section 2.5.2.2). Since an increase in
polarisation over the polarisation of free (Pf) fluorescein isothiocyanate-labeled TRAMP
(FITC-TRAMP) indicates an increase in bound TRAMP, binding here is reported in




Figure 4.10 Rotary shadowed transmission electron micrographs of
collagen monomers and early aggregates formed during
fibril assembly
Collagen (50 |ig/ml) in the presence ofTRAMP (variant T4, 5 pg/ml) were rotary
shadowed with platinum and examined by transmission electron microscopy. Samples
were examined immediately (a) and 3 min (b) after the initiation of fibril formation at 34
°C. A small percentage of the molecules have a terminal globular region (arrows, a &
b). Collagen I in 5 mM acetic acid at 20 pg/ml is shown for comparison (c). Bar, 300
nm. Magnification, 53,000x.
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collagen molecules, non-fibrillogenic conditions (i.e. 20 °C) were used. Only a small
increase (0.02-0.03) in the polarisation of the FITC-TRAMP/collagen mixture was
observed upon addition of collagen (Fig. 4.11), indicating that the majority of TRAMP
was not bound. When collagen was added to FITC-TRAMP and examined
approximately 1 min after the addition, an immediate increase in the measured
polarisation (Pm) was observed over the polarisation of free FITC-TRAMP (Pf FITC-
TRAMP = 0.095), and which remained constant for at least 1 hour (Fig. 4.11). As the
collagen concentration was increased from 50 pg/ml to 100 pg/ml the polarisation
increased (relative to Pf) from 0.023 ± 0.004 (SD; n=3) to 0.038 ± 0.003 (SD; n=3) in
the presence of a fixed amount (1 pg) of FITC-TRAMP. These results suggest that
FITC-TRAMP binds to monomelic collagen at 20 °C, and that the binding is rapid.
However it is not known if the binding affinity ofFITC-TRAMP is similar to that of
the unlabelled protein.
4.1.5 Nature of the TRAMP-Collagen Interaction
To further study the effect ofTRAMP on fibril formation, the kinetics of
assembly were modified in the presence of increased ionic strength (Williams etal.,
1978), urea (Fessler & Tandberg, 1975) or glucose (Rathi etal., 1989) in the fibril
formation buffer. The ionic strength was varied by changing the NaCl concentration.
From 0.135 M to 0.27 M NaCl, and in the absence ofTRAMP there was an
approximately three fold increase in t1/2 (Fig. 4.12(a)). Similar results have been
reported by Williams etal. (1978), though this effect was partially reversed by the
presence ofTRAMP (Fig. 4.12(a)). There were no obvious differences in the final
turbidity. A delay in fibril formation was also observed in the presence of 25 mM urea,
as observed elsewhere (Fessler & Tandberg, 1975), though again TRAMP accelerated
the assembly process (Fig. 4.12(b)). The final turbidity in the presence of TRAMP also
appeared to be slightly greater. D-glucose at 0.05 M also reduced the rate of









Figure 4.11 Time course of TRAMP binding to collagen
TRAMP binding was monitored as the increase in polarisation, using 50 pg4nl collagen
in the presence of 1 pg/ml of fluorescently labeled TRAMP at 20 °C. Pp, the
polarisation of fluorescein-labeled TRAMP in the absence of collagen, did not change
during the course of the experiment.
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Figure 4.12 The effect of ionic strength, urea and glucose on Collagen I
self-assembly in the presence of TRAMP
Turbidity-time curves showing the effect of TRAMP (T, variant T4, 5 |J.g/ml) on fibril
formation at 34 °C from a fixed concentration of collagen (200 (ig/ml) at (a) increased
ionic strength (S, 0.27 M NaCl), or in the presence of (b) 25 mM urea (U) or (c) 50
mM D-glucose (G). Assembly in standard buffer conditions in the absence of TRAMP
(B) is shown for comparison.
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opacity in the presence of 0.05 M glucose was also reduced by approximately 30 %,
with respect to fibrils formed in the absence ofglucose. However these effects were not
reversed by TRAMP (Fig. 4.12(c)).
In an attempt to determine whether a native protein conformation was required
for TRAMP to exert its effects on fibril assembly, fibrils were reconstituted in the
presence ofTRAMP which had been denatured by heating for 3 minutes at 100 °C. The
results (not shown) demonstrate that denatured TRAMP still accelerated fibril assembly,
and to the same extent as native TRAMP.
4.2 Discussion
In recent years, several collagen binding proteins have been identified,
including fibronectin, laminin and link protein. Fibronectin and laminin bind to one or
more collagen types and also to cell surfaces and thus link cells to the ECM (Albelda &
Buck, 1990; Yamada, 1991b; Fox etal., 1991). These collagen binding proteins may
also influence the organisation of extracellular matrices. Fibronectin, a large
glycoprotein, binds to collagen I at a distinct region on the a 1(1) chain (Dessau etal.,
1978). The presence of fibronectin affects the rate of collagen fibril formation in vitro
(Kleinman etal., 1981; Speranza etal., 1987). Link protein, although primarily
involved in the stabilisation of cartilage proteoglycan aggregates (Smith etal., 1987),
appear in combination with proteoglycans to modulate collagen fibril formation in vitro
(Chandrasekhar etal., 1984). A 54 K collagen II binding protein isolated from Swarm
rat chondrosarcoma (Chandrasekhar etal., 1986), is also cabable of regulating collagen
fibril formation, but only in the presence of proteoglycans. More recently fibromodulin,
a 59 K protein with the ability to bind collagens I and II, has been isolated from bovine
articular cartilage (Hedbom & Heinegard, 1989; Antonsson etal., 1991). In the
presence of this protein, fibril formation is markedly delayed, even when present at
small concentrations. The ECM contains many constituents many ofwhich remain
uncharacterised (Neame etal., 1989). This study begins the functional characterisation
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ofTRAMP, a 24 K protein isolated from porcine skin that co-purifies with lysyl
oxidase.
In the present study it was shown that reconstituted collagen fibrils which are
similar to fibrils formed in vivo can be obtained reproducibly from purified lathyritic
(i.e non-cross-linked) rat skin collagen I. The results also show that the kinetics of the
assembly reaction are markedly accelerated in the presence ofhighly purified TRAMP.
Acceleration of collagen fibrillogenesis was observed at low, sub-stoichiometric molar
ratios of TRAMP to collagen. This observation suggests that the effect ofTRAMP may
be on the early, nucleation stage of fibril assembly. The size and nature of the nuclei has
been the subject of several investigations (Veis & Payne, 1988). One of the first
interactions to be detected in vitro is the assembly of 4 D staggered dimers, where D is
the axial periodicity of collagen fibrils (Silver etal., 1979; Silver & Trelstad, 1980;
Ward etal., 1986). It is possible that TRAMP may facilitate and/or stabilise the
formation of such dimers and therefore hasten fibril formation by increasing the number
of nuclei (Fig. 4.13).
The shape of the turbidity curve is characteristic of a nucleation-growth
mechanism for collagen fibril assembly (Na etal., 1986a). However a power
dependence of 11/2 on collagen concentration of 1 apparently refutes the cooperative
nucleation growth mechanism as this value is half the number ofmonomer units in the
nucleus, and lends support to an accretion mechanism for collagen fibril formation
(Williams etal., 1978). In juxtaposition with the kinetic studies, electron microscopy
after rotary shadowing was used to examine the morphology of collagen aggregates
shortly after the initiation of fibrillogenesis. The electron micrographs shown in Figure
4.10 confirm the results reported by Gelman etal. (1979), indicating that collagen
forms long thin microfibrils during the lag phase of fibril assembly. However the
interpretation of the results presented here is based entirely on EM data, thus it is very








Figure 4.13 Model of the proposed binding sites for TRAMP on the
collagen molecule, and the possible role of TRAMP in stabilising the 4D
stagger association between collagen molecules
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TRAMP was shown to bind to newly formed collagen fibrils by co-
sedimentation. From the kinetic results, fluoresence polarisation and electron
microscopy after rotary shadowing, it seems likely that TRAMP also binds to collagen
during the early nucleation stages of fibril assembly. By co-sedimentation TRAMP and
collagen demonstrate a binding stoichiometry of 1 mol TRAMP to 2 mol collagen. The
large amount ofTRAMP found bound to the fibril further suggested that the protein
may be stably integrated into the fibril aggregate rather than restricted to the fibril
surface. However the suggestion that TRAMP may self-aggregate under physiological
conditions to form high molecular weight complexes, and that these complexes may
also bind to collagen is not ruled out. The location of the TRAMP binding site (or sites)
has not been firmly established. Electron microscopy after rotaiy shadowing indicates
that the collagen telopeptides are involved. A further clue to the binding site(s) was
provided by fibrillogenesis experiments in the presence of glucose. Unlike the effects
of increased ionic strength or urea which inhibited fibril assembly but were partially
reversed by TRAMP, inhibition of fibril formation in the presence ofglucose was
unaffected by TRAMP. It has been suggested that hydrophobic interactions in the
telopeptide are a prerequisite for the initiation of fibril formation, but that glucose delays
fibrillogenesis by binding to the C-telopeptide of collagen (Lien etal., 1984; Rathi et
al., 1989) preventing the formation of 4 D staggered dimers. Thus it is possible that
TRAMP binds to the C-telopeptide and therefore facilitates the 4 D association of
collagen molecules, but in the presence of excess glucose (50 mM) binding ofTRAMP
is prevented. Alternatively TRAMP may bind to glucose, thereby preventing its
interaction with collagen. The possibility that TRAMP may also bind to other regions
on the collagen molecule is not excluded by the present study. The observation that
TRAMP stabilises fibrils against low-temperature solubilisation suggests that TRAMP
may bind to regions on the collagen triple helix. Therefore it is the provision ofmultiple
contacts between TRAMP with neighbouring collagen molecules which stabilise the
fibrillar assembly.
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The final turbidity in the presence ofTRAMP was consistently increased
relative to the control, and hydroxyproline analysis indicated that the amount of fibrillar
collagen that could be pelleted by centrifugation also increased with TRAMP
concentration. The presence ofTRAMP during fibril formation also reduced the fibril
diameter compared to controls, while the protein did not alter the D-periodic banding
pattern of the fibril. Turbidity is determined by both the total mass of assembled
polymers and also there average mass per unit length, and therefore turbidity is not
necessarily a direct measure of the amount of sedimentable collagen (Vogel et al.,
1984). The results show that any reduction in light scattering due to decreased mass per
unit length (i.e. smaller diameter) was outweighed by the increased amount of fibrillar
collagen.
There are several ways in which TRAMP could cause a decrease in fibril
diameter. First, TRAMP may increase the number of nucleation sites. The presence of
more nucleation sites for a given quantity of collagen I might result in smaller
diameters, than fewer nucleation sites for the same amount of collagen. Second,
TRAMP may alter the nature of the nuclei, such that the rate ofaxial growth is
increased relative to lateral growth. Third, TRAMP may form a circumferential layer
around the fibril once a "critical" diameter is reached, and which blocks further addition
ofmonomers by steric exclusion.
The effect ofTRAMP on collagen fibrillogenesis can be compared with that of
other components of the ECM, particularly glycosaminoglycans (GAGs) and
proteoglycans. A number of studies have examined the effects ofGAGs (Wood, 1960;
Mathews & Decker, 1968; Hayashi & Nagai, 1972; Obrink, 1973a; Snowden &
Swann, 1980; Vogel etal., 1984; Gavriel & Kagan, 1988). In most cases chondroitin
sulphate has been shown to accelerate fibril formation (Wood, 1960; Hayashi & Nagai,
1972; Obrink, 1973a; Snowden & Swann, 1980), while accelerating, neutral or
inhibitory effects have been reported with heparin and dermatan sulphate (Wood, 1960;
Obrink, 1973a; Snowden & Swann, 1980; Vogel etal., 1984; Gavriel & Kagan, 1988).
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The accelerating effect of chondroitin sulphate appears to be greatest when present at
the start of fibril formation (Wood, 1960; Obrink, 1973a), and the effect is enhanced
when fibrillogenesis is initiated by the "warm start" procedure (Holmes etal., 1986),
rather than the "cold start" procedure in which chondroitin sulphate retards fibril
assembly (Wood, 1960). These observations suggest that the effects of chondroitin
sulphate are on the early, nucleation stage of fibril assembly. The effect of low
concentrations of SDS in promoting collagen fibril formation is of interest (Hayashi &
Nagai, 1972; Dombi & Halsall, 1985). There is evidence that some tyrosine residues in
TRAMP may be sulphated (Chapter 3), but it has yet to be established whether this
post-translational modification is involved in accelerating fibrillogenesis.
There have been a number of reports showing that proteoglycans modulate
collagen fibril assembly in vitro (Toole & Lowther, 1968 a, b; Toole, 1969; Obrink,
1973a; Oegema etal., 1975; Snowden& Swann, 1980; Birk& Lande, 1981; Vogel et
al, 1984; Vogel & Trotter, 1987; Kuijer etal., 1988; Hedbom & Heinegard, 1989;
Karvonen etal, 1992). Complex results were obtained in some of the early studies
(Toole & Lowther, 1968 a, b; Toole, 1969) where the presence of chondroitin sulphate
and dermatan sulphate proteoglycans in the fibrillogenesis assay led to a rapid
precipitation of fibrillar collagen. These proteoglycans also stabilised fibrils against low
temperature solubilisation (Toole, 1969), similar to the effect ofTRAMP discussed
here. A consistent feature in most of the subsequent reports have shown that the
addition ofproteoglycans results in retardation of fibril assembly (Oegema etal., 1975;
Snowden& Swann, 1980; Birk& Lande, 1981; Vogel etal, 1984; Kuijer etal., 1988;
Hedbom & Heinegard, 1989; Karvonen etal., 1992), and therefore it seems likely that
some of the early collagen and proteoglycan preparations were contaminated with other
matrix components (Veis & Payne, 1988). It is quite possible that TRAMP was present
in some of the early preparations of dermatan sulphate proteoglycans from skin, since
the bovine equivalent ofTRAMP is found to co-purify with dermatan sulphate
proteoglycans (Choi etal., 1989; Neame etal., 1989). TRAMP may also be related to
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an acidic protein, identified in rat skin, that has been reported to accelerate collagen
fibrillogenesis (Adelmann etal., 1966).
It has been demonstrated that TRAMP from porcine skin interacts with collagen
I in an in vitro self-assembly assay, and that the interaction results in acceleration of
collagen fibril assembly and eventual formation of collagen fibrils of thinner diameter.
These findings imply that TRAMP may be a regulatory element in fibril assembly and
the control of fibril structure in vivo, though it is likely to be integrated with other
regulatory mechanisms in collagen fibrillogenesis. Several potentially important
domains have been recognised in the equivalent 22 K protein from bovine skin (Neame
etal., 1989; Lewandowska etal., 1991), that have been proposed to interact with
several components of the ECM and with the cell surface. The small dermatan sulphate
proteoglycan decorin (PG-II or PG-S2) from bovine tendon and bovine cartilage
specifically inhibit fibril formation of collagens I and II (Vogel etal., 1984), and using
morphological techniques Scott (1991) concluded that DSPG bind to specific regions
on the collagen fibril. The 22 K bovine equivalent ofTRAMP co-purifies with DSPGs
(Choi etal., 1989; Neame etal., 1989), and direct binding ofDSPG (mediated by DS
chains) to the 22 K protein has also been observed (Lewandowska etal., 1991). The
complementary effects of decorin and TRAMP on fibril formation may suggest
potential interactions between these two molecules and with collagen, in the control of
fibril assembly in the ECM. The ability ofTRAMP to bind native collagen is
physiologically significant in that the resultant matrix may support cell adhesion
(Lewandowska etal., 1991) and provide tissue integrity. Cell adhesion to TRAMP
(Lewandowska etal., 1991) further suggests that this protein may regulate cellular
control of fibril deposition. Interestingly osteoarthritic eroded cartilage has a high level
ofDSPG compared to normal cartilage (Karvonen etal., 1992). Preliminary data
indicates that TRAMP is also present in cartilage, therefore it is possible that in vivo an
ideal combination ofDSPG and TRAMP supports collagen fibrillogenesis in normal
cartilage. Thus qualitative or quantitative changes in DSPGs from osteoarthritic
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cartilage could contribute or result in abnormal collagen fibrillogenesis. Fibril formation
is also a critical step in collagen cross-linking. TRAMP also co-purifies with lysyl
oxidase (Cronshaw etal., 1993), and lysyl oxidase activity is greatly enhanced by the
assembly of collagen into fibrils (Siegel, 1974). Therefore decorin and TRAMP
through their different effects on collagen fibril formation, may modulate assembly,
cross-linking and hence the biomechanical stability and metabolism of collagen in the
ECM. If the scenario (described above) for regulating collagen cross-linking operates
in vivo, the biological function of the sugar derived cross-links (Reiser etal., 1992)
takes on an added significance. For example, in diabetic subjects, the high levels of
tissue glucose may inhibit fibril formation, as has already been observed in vitro (Rathi
etal, 1989). The effect ofTRAMP on stimulating collagen fibrillogenesis is also
inhibited by glucose, hence the level of enzyme-derived cross-links may also be
reduced in diabetic patients. Therefore it is possible that the presence of increased
amounts of sugar derived cross-links serve to maintain tissue integrity. The collagen
binding domain in TRAMP appears to be remarkably heat stable, and probably reflects
the high level of disulphide bonds in the protein (Neame etal, 1989). By heating
TRAMP at 100 °C for 3 minutes, the protein could still accelerate collagen
fibrillogenesis, and to the same extent as native TRAMP. Thus in a wound or inflamed
tissue where TRAMP may be partially degraded, its collagen binding domain might






The present study is an investigation of the interaction of TRAMP with collagen
I in the context of fibril formation. It was demonstrated that low, sub-stoichiometric
amounts of TRAMP increased both the rate of assembly and the amount of fibrils
precipitating from purified solutions of collagen. Precipitates formed in the presence
and absence ofTRAMP consisted almost entirely of fibrils with a 64 nm periodicity,
though electron microscopy revealed that fibrils reconstituted in the presence of
TRAMP were significantly thinner. This last observation suggests that TRAMP
accelerates the early nucleation stages of fibril assembly, perhaps by promoting the
formation of and/or stabilising the initial aggregates. The provision ofmore nucleation
centres for a given amount of collagen would produce larger numbers of smaller
diameter fibrils (Wood & Keech, 1960).
Analysis of the primary structure of TRAMP shows that the protein contains
five disulphide bonds that define three loops (Neame etal., 1989), each loop containing
a six-residue consensus sequence of Asp-Arg-Glx-Trp-Asn/Gln/Lys-Phe/Tyr. That the
ability of TRAMP to accelerate fibril formation was not altered by heating the protein to
100 °C suggests that the collagen binding domain(s) within TRAMP is (are) either
resistant to or unaffected by denaturation. That TRAMP also stabilises fibrils against
low temperature solubilisation suggests that it may form multiple contacts within the
fibril aggregate. These observations support the idea that the repeating domains within
TRAMP have collagen binding activity, and that these domains could be orientated to
promote binding between collagen molecules arranged in D-staggered array. The
disulphide bonds that define these domains may also be expected to stabilise them
against thermal denaturation and it would therefore be of interest to reduce the
disulphide bonds within TRAMP and examine the effect of this on fibrillogenesis.
Monoclonal antibodies to various domains of TRAMP and/or synthetic peptides could
also be used to further examine which regions within the TRAMP molecule are
important for its interaction with collagen. It also remains to be determined whether
TRAMP can interact with other components of the ECM, and in particular whether it
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can influence the kinetics of fibril formation for other collagen types. It also remains to
be established whether the short repeating domains within TRAMP represent another
connective tissue sub-domain such as the RGD sequence identified in several ECM
molecules (Ruoslahti, 1991b).
The 22 K bovine equivalent of TRAMP (Neame etal., 1989) has been
implicated in mediating cell adhesion (Lewandowska etal., 1991). It was also found
that dermatan sulphate proteoglycans (DSPGs) inhibited cell adhesion to TRAMP.
Further to this, a synthetic Arg-Gly-Asp-Ser (RGDS) containing peptide also inhibited
cellular adhesion to the 22 K protein, thus implicating a cell-surface integrin as a
possible receptor for TRAMP. Examination of the TRAMP primary structure (appendix
II) reveals a candidate sequence (Arg-Gly-Ala-Thr (RGAT)) at residues 151-154 for
potential reactivity with such an integrin (Lewandowska etal., 1991). The tetrapeptide
sequence varies from the conventional RGDS sequence at the last two positions. It has
been shown however that threonine effectively substitutes for serine in the fourth
position (Hautanen etal., 1989), and an alanine substitution at the third position may
also provide a relatively small side chain.
How size and form are regulated in the growth of supra-molecular assemblies is
poorly understood. Although indeterminate in length and having diameters that vary
over a large range (10-500 nm, depending on age and tissue), individual collagen fibrils
tend to be uniform in diameter (except at their ends). In young tissues however, the
fibrils often occur in bundles, and they exhibit sharp diameter distributions (Parry &
Craig, 1984). As diameter distributions of fibrils formed in vitro are much broader, the
additional information required for diameter limitation here does not reside within the
collagen molecule alone. The present study demonstrates that in the presence of
TRAMP there is more stringent control over fibril diameter. It would be of interest to
compare the diameters of fibrils from collagen reconstituted in the presence and absence
of TRAMP, with those from the original tissue in which the collagen was extracted.
Although it has been suggested that TRAMP may limit the lateral growth of
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fibrils, the role of TRAMP in vivo is not understood. TRAMP has been found to co-
purify with lysyl oxidase (Cronshaw etai, 1993) and with DSPGs (Neame etal.,
1989). Indirect evidence suggests binding of DSPG (mediated through the DS chains)
to TRAMP (Lewandowska etal., 1991). TRAMP does not affect the activity of lysyl
oxidase on an elastin substrate, although this does not mean that no physical interaction
exists between these two proteins. From rotary shadowing electron microscopy,
TRAMP appears to bind mainly to the telopeptide regions of the collagen molecule,
therefore it may be that TRAMP is involved in localising lysyl oxidase to this part of the
molecule in preparation for cross-linking. Alternatively TRAMP and lysyl oxidase may
exist under physiological conditions, either as a complex or as separate molecules with
TRAMP acting to aggregate the collagen substrate prior to lysyl oxidase initiated cross-
linking.
Much remains to be done to examine the nature and reason for the various ionic
species of TRAMP, the physiological significance of TRAMP with regard to collagen
fibril formation and the nature of the interactions that exist between TRAMP, lysyl
oxidase, DSPGs and the cell surface. To further examine the nature of the TRAMP
isoforms, dermal fibroblasts could be cultured in media containing [35S] sulphate.
Secreted proteins could then be immuno-precipitated with anti-sera to TRAMP.
Examination by SDS-PAGE and fluorography would then show whether the radiolabel
was incorporated into TRAMP. Enzymatic digestion of radiolabeled TRAMP would
make it possible to localise [35S] sulphate to specific peptide fragments within TRAMP,
and hence asses whether the position of the radiolabel agrees with the position of the
putative tyrosine sulphation sites (Hortin etal., 1986) predicted from the TRAMP
sequence (see appendix II). Lasermat mass analysis following treatment of each of the
TRAMP isoforms with sulphatase may also help establish whether the reason for the
various isoforms is due to different extents of tyrosine sulphation. Despite the
considerable observations made in the identification of tyrosine sulphated proteins
(Huttner, 1984), little is known about the functional relevance of this type of covalent
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modification in ECM proteins. The effect of desulphation of TRAMP in the collagen
fibrillogenesis assay may provide some insight as to whether this post-translational
modification is important for its interaction with collagen.
The nature of the TRAMP-collagen interaction needs further investigation. By
pelleting fibrils formed in the presence of TRAMP and then washing the pellet with salt
or non-ionic detergent solutions, it could be determined whether ionic or hydrophobic
interactions were involved in TRAMP binding. In Chapter 4 it was proposed that the
telopeptide regions of the collagen molecule were involved in TRAMP binding. To
further investigate this possibility, the interaction ofTRAMP with pepsin-treated
collagen (collagen with telopeptides removed) could be studied in the fibrillogenesis
assay.
Future studies should also be directed toward determining the cell source of
TRAMP and in evaluating its possible derivation from a precursor. As TRAMP
contains a large number of tyrosine residues, it should be possible to label TRAMP in
cell culture with radiolabelled tyrosine and use TRAMP antisera to immuno-precipitate
proteins either from cell lysates or secreted into the media.
Although preliminary data show TRAMP to have a widespread tissue
distribution (Chapter 4), the polyclonal antisera may also be used to examine the tissue
localisation of TRAMP. Using gold labelled second antibody it should be possible to
immunolocalise TRAMP, by electron microscopy, to specific areas on and around
collagen fibrils. The extent to which the gold label appears over fibrils from different
tissues or at various stages in growth and development could be examined, as could the
preferential association of TRAMP with thin fibrils. Therefore, by examining various
tissues, it may be possible to correlate the amount of TRAMP in a given tissue with the
gross morphology of the fibrils in that tissue.
Preliminary data by Alcian Blue staining (Chapter 3) showed that TRAMP was
present at very low concentrations in skin. This may not be unexpected if the
physiological role ofTRAMP is only to influence the initiation of fibril assembly.
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Cellular control of the stoichiometry of the different ECM components, as well as their
vectorial discharge, are important in the determination of matrix structure. A
developmental study would therefore be useful to examine any correlation between the
tissue concentrations of TRAMP with the level of newly secreted collagen. It is my
view that TRAMP may be important during periods of active fibrillogenesis, and hence
it may play a vital role during tissue remodelling. Finally, a study ofTRAMP and its
effect on lysyl oxidase should be carried out, to establish whether TRAMP has a role in
modulating collagen cross-linking, thus influencing both the mechanical properties of
tissues and collagen turnover.
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Appendix I - SDS-PAGE
Large format (16 x 14x0.15cml gels
(To make 2 gels)
Separating gel (Sg) 6% 12%
Water 37.3 ml 22.3 ml
1.5 M Tris-HCl (pH 8.8) 18.75 ml 18.75 ml
2% (w/v) ammonium persulfate 1.85 ml 1.85 ml
10% (w/v) SDS 1.5 ml 1.5 ml
Acrylamide : Bis (30 : 0.8% (w/v)) 15.0 ml 30.0 ml
TEMED 50 pi 120 pi
Focusing gel (Fg) 3% for a 6% Sg 4.5% for a 12% Sg
Water 15.1 ml 13.85 ml
0.5 M Tris-HCl (pH 6.8) 6.25 ml 6.25 ml
2% (w/v) ammonium persulfate 0.65 ml 0.65 ml
10% (w/v) SDS 0.5 ml 0.5 ml
Acrylamide : Bis (30 : 0.8% (w/v)) 2.5 ml 3.75 ml
TEMED 25 pi 25 pi
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Mini gels (7.5 x 8.5 cm)
(To make 5x1.5 mm gels)
Separating gel 6% 12%
Water 28.25 ml 16.9 ml
1.5 M Tris-HCl (pH 8.8) 14.2 ml 14.2 ml
2% (w/v) ammonium persulfate 1.4 ml 1.4 ml
10% (w/v) SDS 1.15 ml 1.15 ml
Acrylamide : Bis (30 : 0.8% (w/v)) 11.35 ml 22.7 ml
TEMED 35 [il 70 (tl
Focusing gel 3% for a 6% Sg 4.5% for a 12% Sg
Water 9.5 ml 8.70 ml
0.5 M Tris-HCl (pH 6.8) 3.9 ml 3.9 ml
2% (w/v) ammonium persulfate 0.4 ml 0.4 ml
10% (w/v) SDS 0.3 ml 0.3 ml
Acrylamide : Bis (30 : 0.8% (w/v)) 1.56 ml 2.35 ml
TEMED 16 til 16 |il
Water saturated butanol was overlaid on the separating gel during during
polymerisation, and was removed before applying the focussing gel.
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Appendix II - Amino Acid Sequence of TRAMP



















The primary structure of TRAMP variant T3 is shown using the single-letter code for
amino acids (from Cronshaw, with permission). Putative tyrosine sulphation sites are
denoted by *.The one-letter notation for amino acids is as follows: A, alanine; C,
cysteine; D, aspartic acid; E, glutamic acid; F, phenylalanine; G, Glycine; H, histidine;
I, isoleucine; K, lysine; L, leucine; M, methionine; N, asparagine; P, proline; Q,
glutamine; R, arginine; S, serine; T, threonine; V, valine; W, tryptophan; Y, tyrosine.
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